cyclosporine has been researched along with Graft-Versus-Host Disease in 1072 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 365 (34.05) | 18.2507 |
| 2000's | 387 (36.10) | 29.6817 |
| 2010's | 235 (21.92) | 24.3611 |
| 2020's | 85 (7.93) | 2.80 |
| Authors | Studies |
|---|---|
| Book, BK; Lemonte, A; Pescovitz, MD; Smedema, M; Wheat, LJ; Zhuang, D | 1 |
| Aljurf, M; Bazarbachi, A; Bondarenko, S; Bourhis, JH; Brissot, E; Bug, G; Canaani, J; Choi, G; Ciceri, F; Cornelissen, JJ; Dholaria, B; Esteve, J; Gedde-Dahl, T; Giebel, S; Koc, Y; Labopin, M; Meijer, E; Mohty, M; Nagler, A; Niittyvuopio, R; Savani, B; Socié, G; Spyridonidis, A; Wu, D | 1 |
| Akpinar, S; Kayikci, O; Tekgunduz, E | 1 |
| Arranto, C; Baldomero, H; Halter, JP; Heim, D; Héritier, J; Kleber, M; Medinger, M; Passweg, JR | 1 |
| Chen, C; Gerbitz, A; Kim, DDH; Kumar, R; Lam, W; Law, AD; Lipton, JH; Mattsson, J; Michelis, FV; Novitzky-Basso, I; Pasic, I; Remberger, M; Salas, MQ; Viswabandya, A | 1 |
| Bakunina, K; Broers, AEC; Cornelissen, JJ; de Groot, MR; de Jong, CN; Hazenberg, MD; Kuball, J; Meijer, E; van der Holt, B; van Gelder, M; van Marwijk Kooy, M | 1 |
| Fan, G; Feng, Y; Gao, X; Guo, Y; He, S; Li, XR; Qi, Y; Salahdiin, K; Shang, T; Shen, R; Shi, ZX; Wang, M; Wang, Y; Yang, J; Zhao, X; Zhou, Z; Zhu, Y | 1 |
| Beddek, K; Bobe, R; Boittin, FX; Cosler, G; Drouet, M; Pateux, J; Riccobono, D; Thery, H | 1 |
| Atsuta, Y; Doki, N; Eto, T; Fujita, S; Fukuda, T; Ichinohe, T; Kasahara, H; Katayama, Y; Kato, J; Mori, T; Okamoto, S; Onizuka, M; Ozawa, Y; Sekiya, T; Takada, S; Takaki, S; Takanashi, M; Takemura, R; Yoshimura, A | 1 |
| Huang, H; Kong, D; Li, X; Li, Y; Lin, Y; Qian, P; Shi, J; Si, X; Yang, L; Yu, Q; Zeng, X | 1 |
| Arai, Y; Kanda, J; Kitawaki, T; Kondo, T; Mizumoto, C; Takaori-Kondo, A; Wada, F; Yamagiwa, T; Yamamoto, R; Yamashita, K | 1 |
| Arcuri, LJ; Lerner, D; Tavares, RCBDS | 1 |
| Arcuri, LJ; Colares, M; da Silva, AF; da Silva, CF; de Lima, VJT; Hamerschlak, N; Kerbauy, LN; Kerbauy, MN; Lerner, D; Ribeiro, AAF | 1 |
| Blosser, N; Dersch-Mills, D; Duggan, P; Ghosh, S; Jamani, K; Kwan, ACF; Leyshon, C; Puckrin, R; Savoie, L; Stewart, D; Storek, J; Zepeda, V | 1 |
| Bajel, A; Barmanray, RD; Collins, J; Hillman, M; Lim, ABM; Mason, K; Ramanan, R; Ritchie, D; Szer, J; Tan, JLC | 1 |
| Battipaglia, G; Bazarbachi, A; Blaise, D; Castagna, L; Chevallier, P; Daguindau, E; Diez-Martin, JL; Grillo, G; Koc, Y; Labopin, M; López-Jiménez, J; Mohty, M; Nagler, A; Ruggeri, A; Vitek, A | 1 |
| Djebrani-Oussedik, N; Dupuis, M; Lemonnier, C; Poupon, J; Rieger, F; Rongvaux-Gaïda, D | 1 |
| Bisbal, M; Blaise, D; Chow-Chine, L; Faucher, M; Furst, S; Gonzalez, F; Legal, PH; Mokart, D; Saillard, C; Sannini, A; Servan, L; Vey, N | 1 |
| Grigg, A; McClelland, J; Wong, E | 1 |
| Altan-Yaycıoğlu, R; Aydın Akova, Y; Dönmez, O | 1 |
| Carreras, E; Diaz-Ricart, M; Escolar, G; Martinez-Sanchez, J; Moreno-Castaño, AB; Palomo, M; Pascual-Diaz, R; Rovira, M; Salas, MQ; Ventosa, H | 1 |
| Balaguer-Rosello, A; Chorao, P; de la Rubia, J; Facal, A; Gómez-Seguí, I; Guerreiro, M; Marco-Ayala, J; Montoro, J; Sanz, J; Sanz, MÁ; Solves, P; Villalba, M | 1 |
| Cracchiolo, MJ; Davini, DW; Gilman, KE; Katsanis, E; Matiatos, AP; Simpson, RJ | 1 |
| Abolghasemi, H; Ehsani, MA; Eshghi, P; Jafari, MR; Jamee, M; Kazemi Aghdam, M; Latifi, A; Shahgholi, E; Shamsian, BS | 1 |
| Chavoshzadeh, Z; Jamee, M; Paksaz, A; Shamsian, BS; Sharafian, S; Tabatabaee Yazdi, SM | 1 |
| Aichinger, C; Binder, M; Buxhofer-Ausch, V; Clausen, J; Hasengruber, P; Kaynak, E; Machherndl-Spandl, S; Milanov, R; Nikoloudis, A; Petzer, A; Stiefel, O; Strassl, I; Weltermann, A; Wipplinger, D | 1 |
| Akdemir, NB; Büyükaşık, Y; Demiroğlu, H; Göker, H; Haznedaroğlu, İC; Karakulak, EA; Malkan, ÜY; Özcebe, Oİ; Sayınalp, N; Tekin, F | 1 |
| Akahoshi, Y; Date, H; Gomyo, A; Ishikawa, T; Kako, S; Kameda, K; Kanda, Y; Kawamura, M; Kawamura, S; Kimura, SI; Kusuda, M; Matsumi, S; Matsumoto, K; Matsuoka, A; Meno, T; Misaki, Y; Nakamura, Y; Nakasone, H; Okada, Y; Takeshita, J; Tamaki, M; Tanaka, S; Wada, H; Yoshimura, K; Yoshino, N | 1 |
| Ara, T; Chen, X; Endo, T; Goto, H; Harada, S; Hasegawa, Y; Hashimoto, D; Kikuchi, R; Kubota, SI; Miyashita, N; Murakami, M; Ohigashi, H; Okada, S; Onozawa, M; Senjo, H; Tanaka, Y; Tateno, T; Teshima, T; Zhang, Z | 1 |
| Al-Azab, G; Samra, M; Shams, MEE; Sharaf El-Deen, MO; Soliman, MM | 1 |
| Andersen, NS; Friis, LS; Gjærde, LK; Kornblit, B; Petersen, SL; Schjødt, I; Sengeløv, H; Wegener, A | 1 |
| Abdel-Fattah, RM; El Gammal, MM; Elhaddad, AM; Maher, MA; Mahmoud, HK; Mansour, OM; Samra, MA; Shouman, MT | 1 |
| He, S; Huang, L; Li, H; Lu, R; Lu, X; Qin, Y; Qiu, X; Shi, W; Shi, Y; Xin, L; Yang, C; Yang, M; Yang, N; Zeng, L; Zhang, L; Zou, K | 1 |
| Beshensky, D; Comis, LE; Cowen, EW; Holtzman, NG; Joe, GO; Magone, MT; Mays, JW; Pavletic, SZ; Pirsl, F; Schulz, E; Steinberg, SM; Waldman, MA | 1 |
| Furlong, T; Gooley, T; Lee, SJ; Martin, PJ; Mielcarek, M; Rashid, N; Storb, R | 1 |
| Fan, Q; Hui, X; Li, Q; Li, X; Wang, Y; Yang, D | 1 |
| Frączkiewicz, J; Gorczyńska, E; Kałwak, K; Król, A; Mielcarek-Siedziuk, M; Owoc-Lempach, J; Salamonowicz, M; Szmit, Z; Ussowicz, M | 1 |
| Audia, S; Bedgedjian, I; Bordet, JC; Daguindau, E; De Maistre, E; Deconinck, E; Favier, M; Favier, R; Gkalea, V; Hirsch, P; Neuhart, A; Nurden, P; Roussel, X | 1 |
| Fan, Z; Huang, F; Lai, Y; Lin, R; Liu, Q; Lv, W; Qu, H; Sun, J; Wu, M; Xu, N; Xu, Y; Xuan, L; Zhao, K | 1 |
| Cantú-Rodríguez, OG; Garza-Acosta, AC; Gómez-Almaguer, D; Gómez-De León, A; González-Cantú, GA; González-Llano, O; González-Treviño, JL; Gutierrez-Aguirre, CH; Hawing-Zarate, JA; Herrera-Rojas, MA; Jaime-Pérez, JC; Mancías-Guerra, C; Martínez-Garza, DM; Sada-Ovalle, I; Vázquez-Mellado, A | 1 |
| Escribano, A; Ferrer, C; Glaría, L; Huertas, C; Morera, R; Ocanto, A; Pérez, A; Rodríguez, I | 1 |
| Goto, T; Julamanee, J; Kamoshita, S; Kiyoi, H; Koyama, D; Miyamura, K; Miyao, K; Murata, M; Nishida, T; Okuno, S; Ozawa, Y; Takagi, E; Terakura, S | 1 |
| Ara, T; Chen, X; Hasegawa, Y; Hashimoto, D; Hayase, E; Ogasawara, R; Ohigashi, H; Takahashi, S; Tateno, T; Teshima, T; Yokoyama, E | 1 |
| Anguita, J; Bailén, R; Balsalobre, P; Buño, I; Díez-Martin, JL; Dorado, N; Gallardo-Morillo, AI; García Sola, A; Kwon, M; Martínez-Laperche, C; Muñoz, C; Pascual-Cascón, MJ; Serrano, D; Solán, L | 1 |
| Behfar, M; Ghavamzadeh, A; Hamidieh, AA; Khodayari-Namini, N; Koochakzadeh, L; Rostami, T; Salajegheh, P; Yazdanian, N | 1 |
| Brennan, TV; Leuthner, T; Lin, L; Meyer, JN; Nash, A; Samoylova, M; Zhu, M | 1 |
| Couban, S; Couture, F; Devins, G; Elemary, M; Foley, R; Gallagher, G; Kerr, H; Kuruvilla, J; Lee, SJ; Moore, J; Nevill, T; Panzarella, T; Popradi, G; Roy, J; Schultz, KR; Szwajcer, D; Toze, C; Walker, I | 1 |
| Bajel, A; Lim, ABM; Ramanan, R; Ritchie, DS; Tan, JLC; Wong, E | 1 |
| Bertrand, Y; Bleyzac, N; Garnier, N; Gauthier, A; Goutagny, MP; Goutelle, S; Joly, P; Kebaili, K; Mollet, I; Renard, C | 1 |
| Jiang, Z; Wan, D; Wang, M; Zhang, J; Zhao, H | 1 |
| Huang, R; Ji, D; Li, F; Peng, H; Ren, S; Zou, D | 1 |
| Bacopoulos, AJ; Dara, C; Deotare, U; Ho, L; Kim, DD; Lipton, JH; Loach, D; Messner, HA; Michelis, FV; Ng, P; Thyagu, S; Viswabandya, A; Yang, A | 1 |
| Cai, C; Han, Y; Lv, X; Pan, T; Qi, J; Shi, B; Tang, Y; Zhou, M | 1 |
| Chung, EK; Gwak, HS; Kim, JY; Yee, J | 1 |
| García-Basas, L; Gómez de Salazar-López de Silanes, E; Herrera-Puente, P; Núñez-Torrón-Stock, C; Pueyo-López, C; Sánchez-Cuervo, M | 1 |
| Gehlsen, U; Siebelmann, S; Steven, P | 1 |
| Andersen, NS; Chauncey, TR; Flowers, MED; Kornblit, B; Maloney, DG; Maris, MB; Petersdorf, EW; Sandmaier, BM; Storb, R; Storer, BE; Woolfrey, AE | 1 |
| Chang, YJ; Chen, FP; Du, X; Hu, J; Hu, JD; Hu, Y; Huang, H; Huang, XJ; Jiang, M; Lai, YR; Li, J; Li, W; Li, YH; Liang, YM; Lin, DJ; Liu, QF; Ren, HY; Song, YP; Sun, YQ; Wang, JB; Wang, SQ; Wu, DP; Xiao, Y; Zhang, X; Zhou, JF | 1 |
| Arber, D; Avigan, DE; Foss, FM; Gascoyne, RD; Hogan, WJ; Horning, SJ; Jegede, O; Lazarus, HM; Litzow, MR; Luger, SM; Miller, KB; Sprague, KA; Stadtmauer, EA; Strair, RK; Tallman, MS; Wagner, H; Wang, XV; Whiteside, TL | 1 |
| Ahmed, P; Anwer, F; Chaudhry, QUN; Farhan, M; Ghafoor, T; Humayun, S; Iftikhar, R; Khan, MA; Khattak, TA; Mahmood, SK; Rehman, J; Risalat, A; Satti, HS; Satti, TM; Shahbaz, N; Shamshad, GU; Wahab, A | 1 |
| Li, Z; Liu, W; Ma, H; Qin, M; Wang, T; Wei, A; Yang, Y; Zhang, L; Zhang, R; Zhao, X | 1 |
| Haghighat, S; Haghighinejad, H; Namdari, N; Ramzi, M | 1 |
| Amit, O; Pasvolsky, O; Pek, A; Raanani, P; Ram, R; Rozovski, U; Rubinstein, M; Sela-Navon, M; Shargian-Alon, L; Wolach, O; Yeshurun, M; Zuckerman, T | 1 |
| Gathof, B; Gehlsen, U; Holtick, U; Müller, C; Sauerbier, L; Scheid, C; Stern, ME; Steven, P; Tahmaz, V; Wiesen, MHJ | 1 |
| Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Yerushalmi, R | 1 |
| Dahllöf, G; Garming Legert, K; Mattsson, J; Remberger, M; Ringdén, O; Törlén, J | 1 |
| Atsuta, Y; Ichinohe, T; Iida, H; Katayama, Y; Kato, J; Miyamoto, T; Mori, T; Onishi, Y; Onizuka, M; Ota, S; Ozawa, Y; Shingai, N; Takenaka, K; Uchida, N; Yamaguchi, H; Yamazaki, H; Yoshioka, S | 1 |
| Bagłaj, M; Giebel, S; Kamińska-Winciorek, G; Szlauer-Stefańska, A | 1 |
| Defor, TE; Engle, JA; Rashidi, A; Rogosheske, J; Wasko, JA | 1 |
| Ahmed, P; Ansar, I; Anwer, F; Ashraf, R; Chaudhry, QUN; Farhan, M; Ghafoor, T; Iftikhar, R; Khan, M; Khan, MA; Khattak, TA; Mahmood, SK; Marsh, J; Neupane, K; Rafae, A; Rehman, J; Satti, TM; Shahbaz, N; Shamshad, GU | 1 |
| Chatterjee, G; Kapoor, R; Nivargi, S; Rastogi, N; Sharma, A; Yadav, SP | 1 |
| Buizen, L; Butler, JP; Chang, K; Cooney, J; Curley, C; Durrant, S; Gartlan, KH; Gottlieb, D; Henden, AS; Hill, GR; Kennedy, GA; Misra, A; Moore, J; Morton, AJ; Olver, SD; Paul, SK; Ritchie, D; Subramoniapillai, E; Tey, SK; Varelias, A | 1 |
| Azzali, A; Bigagli, E; Ciullini Mannurita, S; Coniglio, ML; D'Elios, MM; Favre, C; Fotzi, I; Frenos, S; Gambineri, E; Goda, R; Grassi, A; Luceri, C; Sanvito, MC; Schiavo, E; Tintori, V; Tondo, A; Vignoli, M | 1 |
| Chiba, S; Hasegawa, Y; Kato, T; Kurita, N; Kusakabe, M; Nishikii, H; Obara, N; Sakamoto, T; Sakata-Yanagimoto, M; Yokoyama, Y | 1 |
| Corbett, JM; Coulter, IS; English, K; Hawthorne, I | 1 |
| Al-Shaibani, Z; Chen, C; Kim, DDH; Kumar, R; Lam, W; Law, AD; Lipton, JH; Loach, D; Mattsson, J; Michelis, FV; Nampoothiri, RV; Viswabandya, A | 1 |
| Hu, J; Ren, J; Wang, Y; Wen, J; Yang, T; Yuan, X; Zheng, Y | 1 |
| Bertrand, Y; Beyron, C; Bleyzac, N; Ceraulo, A; Philippe, M | 1 |
| Ashwell, JD; Dutta, D; Gaida, MM; Melis, N; Otsuka, S; Weigert, R | 1 |
| Ahmed Nacer, R; Ait Ouali, D; Baazizi, M; Benakli, M; Bouarab, H; Hamladji, RM; Harieche, F; Mehdid, F; Rahmoune, N; Zerkout, S | 1 |
| Chonghaile, MN; Corbett, JM; Coulter, I; Dunbar, H; English, K; Flynn, CM; Hawthorne, I | 1 |
| Barbieri, S; Craddock, C; Croft, W; Inman, CF; Kinsella, FA; Malladi, R; Moss, P; Pearce, H; Zuo, J | 1 |
| Celen, S; Daloglu, H; Karasu, G; Öztürkmen, S; Pashayev, D; Uygun, V; Yalcin, K; Yesilipek, A; Zhumatayev, S | 1 |
| Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
| Akcay, S; Atay, A; Hagverdiyeva, S; Malbora, B; Sarbay, H; Turkkan, E | 1 |
| Cai, Y; Ding, X; Huang, C; Qiu, H; Song, X; Sun, X; Tong, Y; Wan, L; Xu, X; Yang, J; Zhou, K | 1 |
| Carter, NM; Pomerantz, JL | 1 |
| Atilla, H; Bingöl Kızıltunç, P; Büyüktepe, TÇ; Ertem, M; İleri, T; İnce, E; Yalçındağ, FN | 1 |
| Abgueguen, P; Cottin, L; Daniel, V; Dieu, X; François, S; Giltat, A; Hunault, M; Lacombe, V; Nunes Gomes, C; Orvain, C; Riou, J; Robin, JB; Schmidt, A; Thépot, S; Ugo, V | 1 |
| Afanasyev, BV; Bondarenko, SN; Burmina, EA; Darskaya, EI; Moiseev, IS; Muslimov, AR; Pirogova, OV; Senina, NG; Tarakanova, YA | 1 |
| Alyea, EP; Bashey, A; Deeg, HJ; Devine, SM; Fernandez, HF; Geller, NL; Giralt, S; Hamadani, M; Horowitz, MM; Horwitz, ME; Le-Rademacher, J; Leifer, E; Logan, BR; Maziarz, RT; Mendizabal, AM; Pasquini, MC; Porter, DL; Scott, BL; Warlick, ED; Wu, J | 1 |
| Corradini, P; Greco, R; Mussetti, A; Peccatori, J | 1 |
| Halfwassen, C; Scholz, SL; Steuhl, KP; Thomasen, H; Westekemper, H | 1 |
| Koba, Y; Tamekane, A; Watanabe, M | 1 |
| Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
| Bertz, H; Bethge, WA; Finke, J; Grishina, O; Heim, D; Ottinger, H; Schmoor, C; Socie, G; Stelljes, M; Volin, L | 1 |
| Blaise, D; Blancho, G; Chantepie, S; Chevallier, P; Gaugler, B; Guillaume, T; Labopin, M; Magro, L; Malard, F; Mohty, M; Moreau, P; Tabrizi, R; Vanhove, B; Yakoub-Agha, I | 1 |
| Chen, HC; Jiao, Z; Mao, JJ; Qiu, XY; Yun, HY; Zhao, CY; Zhong, MK | 1 |
| Chang, YC; Chao, YH; Peng, CT; Weng, TF; Wu, HP; Wu, KH | 1 |
| Juvonen, E; Nihtinen, A; Niittyvuopio, R; Ruutu, T; Volin, L | 1 |
| Dong, Y; Liu, H; Liu, W; Miao, S; Qin, C; Ren, H; Shi, Y; Tang, B; Wang, Z | 1 |
| Alessandrino, PE; Angelucci, E; Bacigalupo, A; Brune, M; Bug, G; Chiusolo, P; Di Grazia, C; Dominietto, A; Ferrara, F; Finizio, O; Gualandi, F; Mordini, N; Olivieri, A; Raiola, AM; Van Lint, MT | 1 |
| Han, Y; Qiu, H; Sun, A; Tang, X; Wu, D; Yang, S; Yang, X | 1 |
| Alimoghaddam, K; Khodabakhsh, A; Nafissi, S; Sinaei, F | 1 |
| Borel, C; Boulinguez, S; Bulai Livideanu, C; Dimeglio, C; Huynh, A; Lepage, B; Marguery, MC; Paul, C; Richet, C | 1 |
| Bari, S; Cheung, AMS; Fan, X; Goh, SE; Guo, D; Hwang, WYK; Li, H; Li, S; Lim, KH; Poon, ZY; Yap, CS | 1 |
| Endo, T; Fujimoto, K; Goto, H; Hashimoto, D; Hayase, E; Hidaka, D; Ishio, T; Kahata, K; Kondo, T; Nakagawa, M; Okada, K; Onozawa, M; Shiratori, S; Sugita, J; Tateno, T; Teshima, T | 1 |
| Akahane, D; Gotoh, M; Kobayashi, C; Ohyashiki, JH; Ohyashiki, K; Saitoh, Y; Umezu, T; Yoshizawa, S | 1 |
| Bacigalupo, A | 1 |
| Chen, S; Doyle, JJ; Gassas, A; Gibson, P; Lee Dupuis, L; Lewis, VA; Mitchell, D; Schechter, T; Schultz, KR; Seto, W; Sung, L; Teuffel, O | 1 |
| Antonios, JP; Ciacci, JD; Cleary, DR; Farah, GJ; Martin, JR; Pham, MH | 1 |
| Adaeva, R; Banet, A; Bastos, J; Battipaglia, G; Belhocine, R; Brissot, E; de Wyngaert, ZV; Duléry, R; Giannotti, F; Isnard, F; Lapusan, S; Ledraa, T; Legrand, O; Malard, F; Médiavilla, C; Mohty, M; Paviglianiti, A; Rubio, MT; Ruggeri, A; Sestili, S; Vekhoff, A | 1 |
| Blijlevens, NMA; Bremmers, MEJ; Brüggemann, RJM; de Kort, EA; de Lil, HS; Huls, G; van der Velden, WJFM; van Dorp, S; van Groningen, LFJ | 1 |
| Arranto, C; Baldomero, H; Gerull, S; Halter, JP; Heim, D; Kleber, M; Medinger, M; Passweg, JR; Soltermann, Y | 1 |
| Ames, NJ; Barb, JJ; Cashion, AK; Childs, R; Faller, LL; Kim, H; Mudra, SE; Paster, BJ; Ranucci, A; Townsley, DM; Wallen, GR | 1 |
| Battipaglia, G; Bazarbachi, A; Belhocine, R; Brissot, E; Duléry, R; Ledraa, T; Malard, F; Médiavilla, C; Mohty, M; Mohty, R; Paviglianiti, A; Ruggeri, A; Sestili, S; Stocker, N; Vekhoff, A | 1 |
| Flores, C; Fouquet, G; Hermine, O; Maciel, TT; Moura, IC | 1 |
| Fukushima, T; Hosaka, S; Imadome, KI; Imai-Saito, A; Iwabuchi, A; Jimbo, T; Kato, Y; Kobayashi, C; Kosaki, K; Masumoto, K; Nanmoku, T; Onodera, M; Saito, H; Sumazaki, R; Suzuki, R; Takada, H; Watanabe, N | 1 |
| Aui, PM; Bosco, JJ; Grigg, A; Pumar, M; Shuttleworth, P; Smart, JM; van Zelm, MC | 1 |
| Cevreska, L; Chadievski, L; Georgievski, B; Stavridis, IP; Stojanoski, Z; Trajkova, S; Veljanovska, AP | 1 |
| Aljurf, M; Alousi, A; Antin, JH; Arora, M; Bredeson, C; Cahn, JY; Cairo, M; Chhabra, S; Choi, SW; Costa, L; Couriel, DR; Dandoy, C; Gale, RP; Gergis, U; Hamilton, BK; Hematti, P; Hemmer, MT; Inamoto, Y; Kamble, RT; Kim, D; Liu, Y; MacMillan, M; Majhail, N; Marks, DI; Nemecek, E; Nishihori, T; Pidala, JA; Ringden, O; Saad, A; Savani, BN; Schriber, J; Seo, S; Socié, G; Spellman, SR; Stuart, R; Teshima, T; Verdonck, LF; Waller, EK; Wirk, M | 1 |
| Ruggeri, A | 1 |
| Appelbaum, FR; Bethge, WA; Chauncey, TR; Flowers, MED; Gutman, JA; Kornblit, B; Langston, AA; Maloney, DG; Maris, MB; Martin, PJ; Mielcarek, M; Olesen, G; Petersen, SL; Pulsipher, MA; Sandmaier, BM; Storb, R; Storer, BE; Woolfrey, AE | 1 |
| Chen, M; He, X; Huang, B; Lin, X; Zhang, Y; Zhang, Z; Zheng, Z; Zhong, C | 1 |
| Al-Ahmari, A; Al-Jefri, A; Al-Saedi, H; Al-Seraihi, A; Alanazi, A; Ayas, M; Ayas, MF; Ghemlas, I; Jafri, R; Siddiqui, K | 1 |
| Blazar, BR; DeFor, TE; Holtan, SG; MacMillan, ML; Rashidi, A; Weisdorf, DJ | 1 |
| Feng, WY; Hu, L; Huang, L; Li, TF; Liu, XM; Luo, XX; Ma, XL; Wu, CF | 1 |
| de Bree, GJ; Defoer, JM; Garcia Garrido, HM; Goorhuis, A; Grobusch, MP; Hazenberg, MD; Koen, G; Nur, E; Schinkel, J; van Aalst, M; Zeerleder, SS | 1 |
| Li, D; Li, ZY; Pan, X; Qiu, T; Wu, Q; Xu, K; Yan, Z | 1 |
| Fuyama, M; Ikeda, H; Isoyama, K | 1 |
| D'Ascenzo, G; Feci, L; Fimiani, M; Marotta, G; Murdaca, F; Poggiali, S; Rubegni, P | 1 |
| Beato Merino, MJ; Gómez-Fernández, C; Hernández-Maraver, D; Herranz Pinto, P; Maldonado Cid, P; Noguera Morel, L; Sendagorta Cudós, E | 1 |
| Dalton, JT; Devine, SM; Edwards, RB; Farag, SS; Grever, MR; Hofmeister, CC; Jansak, BS; Johnston, JS; Lucas, DM; Phelps, MA; Poi, MJ | 1 |
| Abdel-Rahman, F; Adil, SN; Ahmed, P; Alabdulaaly, A; Alimoghaddam, K; Aljurf, M; Alseraihy, A; Bazarbachi, A; Bekadja, MA; Ben Othman, T; Benchekroun, S; Dennison, D; Elhaddad, A; Ghavamzadeh, A; Hamidieh, A; Hamladji, R; Hussain, F; Ibrahim, A; Jarrar, M; Mohamed, SY; Ramzi, M; Rasheed, W | 1 |
| De Revel, T; Doghmi, K; Jennane, S; Konopacki, J; Mahtat, el M; Malfuson, JV; Mikdame, M | 1 |
| Childs, R; Merideth, MA; Pulanic, TK; Sri, T; Stratton, P | 1 |
| Andresen, S; Bolwell, B; Copelan, E; Dean, R; Duong, H; Hamilton, BK; Hanna, R; Hill, B; Kalaycio, M; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| Caballero, D; Caballero-Velázquez, T; Castilla-Llorente, C; Encinas, C; Heras, I; López-Corral, L; Martino, R; Pérez-Simón, JA; Rosiñol, L; Sampol, A; San Miguel, J; Serrano, D | 1 |
| McNeil, C | 1 |
| Barrett, J; Childs, RW; Cook, L; Donohue, T; Geller, N; Khuu, H; Kurlander, R; Leitman, S; Pantin, J; Ramos, C; Shah, AA; Stroncek, D; Tian, X; Young, NS | 1 |
| Cai, Z; He, J; Huang, H; Lai, X; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhang, J; Zheng, W; Zhu, X | 1 |
| Bartel, C; Grouven, U; Peinemann, F | 1 |
| Casco, F; Colmenero, I; Delmiro, A; Fiuza-Luces, C; González-Murillo, A; Lucia, A; Melén, GJ; Morán, M; Palacio, JM; Ramírez, M; Soares-Miranda, L | 1 |
| Arora, M; Blazar, BR; Brunstein, CG; DeFor, TE; Fargen, AD; Rogosheske, JR; Warlick, E; Weisdorf, DJ | 1 |
| Askar, M; Mossad, S; Rybicki, L; Sobecks, R; Taimur, S; Warshawsky, I | 1 |
| Ayvaz, DC; Bayrakci, B; Kesici, S; Kuskonmaz, B; Sag, E; Tezcan, I; Uckan, D; Unal, S; Yalnızoglu, D | 1 |
| Cairo, M; Camitta, BM; Carpenter, PA; Chan, KW; Diaz Perez, MA; Doyle, J; Eapen, M; Fraser, C; Gross, TG; He, W; Hitzler, JK; Horan, JT; Kennedy-Nasser, AA; Kitko, C; Kurtzberg, J; Lehmann, L; O'Brien, T; Pulsipher, MA; Smith, FO; Zhang, MJ | 1 |
| Durkin, S; Gilhotra, JS; Ng, SK | 1 |
| Bacigalupo, A; Del Bono, V; Di Grazia, C; Dominietto, A; Ghiso, A; Mikulska, M; Nicolini, L; Raiola, AM; Rivoli, G; Signori, A; Varaldo, R; Viscoli, C | 1 |
| Ichikawa, M; Kurokawa, M; Nannya, Y; Nasu, R; Shinohara, A | 1 |
| Bhattacharya, R; Biswas, A; Park, E | 1 |
| Barba, P; Briones, J; Brunet, S; Esquirol, A; García Cadenas, I; Garrido, A; Granell, M; Martino, R; Moreno, C; Novelli, S; Piñana, JL; Saavedra, S; Sierra, J; Valcarcel, D | 1 |
| Kambayashi, T; Nomura, S; Satake, A; Schmidt, AM | 1 |
| Derniame, S; Domogala, A; Lee, F; Madrigal, A; Saudemont, A | 1 |
| Lu, Y; Sun, R; Sun, Y; Wei, Z; Xiao, J; Zhang, J; Zhu, H | 1 |
| Ding, KY; Geng, LQ; Liu, HL; Song, KD; Sun, ZM; Tang, BL; Tong, J; Wang, XB; Wang, Y; Wei, W; Yao, W; Zheng, CC; Zhou, CY; Zhu, XY | 1 |
| Alnabhan, R; Cooper, N; Derniame, S; Domogala, A; Escobedo-Cousin, M; Lee, F; Luevano, M; Madrigal, A; Pedroza-Pacheco, I; Perazzo, J; Saudemont, A | 1 |
| Djulbegovic, B; Kharfan-Dabaja, M; Kumar, A; Mhaskar, R; Perkins, JB; Pidala, J; Reljic, T | 1 |
| Kanakry, CG; Luznik, L | 1 |
| Li, D; Wang, H; Wang, Z; Yan, H; Zheng, X | 1 |
| Chen, YH; Hou, J; Hu, DM; Huang, XJ; Jiang, M; Lai, YR; Li, QC; Liu, KY; Liu, L; Liu, QF; Schwarzenberger, P; Zhang, ZM | 1 |
| Kato, K; Kobayashi, R; Kojima, S; Kosaka, Y; Kudo, K; Morimoto, A; Muramatsu, H; Ohara, A; Ohga, S; Suzuki, R; Takahashi, Y; Watanabe, K; Yabe, H; Yagasaki, H; Yoshida, N | 1 |
| Choudhary, D; Dhamija, M; Gupta, N; Khandelwal, V; Sharma, SK | 1 |
| Adachi, S; Atsuta, Y; Azuma, E; Chin, M; Goto, H; Hatakeyama, N; Hyakuna, N; Igarashi, S; Inoue, M; Kato, K; Koh, K; Kudo, K; Murata, M; Ogawa, A; Ohshima, K; Sakata, N; Sawada, A; Takahashi, Y; Takami, A; Tanaka, S; Umeda, K | 1 |
| Chen, HR; Chen, P; Guo, Z; He, XP; Liu, XD; Lou, JX; Yang, K; Zhang, Y; Zhu, F | 1 |
| Chen, HR; Guo, Z; He, XP; Liu, XD; Lou, JX; Zhang, Y | 1 |
| Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
| Furukawa, S; Hayashi, K; Hirose, T; Kohguchi, K; Matsuhashi, Y; Sugihara, T; Tasaka, T; Tohyama, K; Wada, H | 1 |
| Charron, D; Couture, F; Filion, A; Guillemette, C; Lalancette, M; Laverdière, I; Lévesque, É; Loiseau, P; Peffault de Latour, R; Robin, M; Socié, G; Tamouza, R; Tourancheau, A | 1 |
| Avraham, GP; Brammer, JE; Curtin, P; Frires, R; Gajewski, J; Hayes-Lattin, B; Kovacsovics, T; Leis, JF; Maziarz, RT; Meyers, G; Nemecek, E; Palmbach, G; Slater, S; Stentz, A; Subbiah, N | 1 |
| Beck, J; Gruhn, B; Steinbach, D; Weiss, M; Zintl, F | 1 |
| Liu, W; Ren, HY; Shi, YJ; Yuan, J | 1 |
| Locatelli, F; Niemeyer, CM | 1 |
| Chen, F; Chen, S; Fu, Z; Han, Y; Jin, S; Jin, Z; Liu, L; Ma, X; Miao, M; Qiu, H; Sun, A; Tang, X; Wang, X; Wu, D; Zhang, X | 1 |
| Liu, H; Sun, Z; Tang, B; Wang, L; Yao, W; Zhang, L; Zheng, C; Zhu, X | 1 |
| Bäuerlein, CA; Beilhack, A; Berberich-Siebelt, F; Chopra, M; Findeis, J; Mottok, A; Pusch, T; Rosenwald, A; Vaeth, M | 1 |
| Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
| Bigley, V; Collin, M; Dickinson, A; Hale, G; Jackson, G; Jardine, L; Pearce, K; Publicover, A | 1 |
| Avgerinou, G; Efstathiou, E; Gamaletsou, MN; Giamouris, VJ; Goussetis, E; Graphakos, S; Kitra, V; Paisiou, A; Peristeri, I; Sipsas, NV; Vessalas, G; Zisaki, K | 1 |
| Gao, YT; Qian, LL; Shen, JP; Wen, XW; Ye, BD; Zhang, Y; Zhou, YH | 1 |
| Choi, B; Han, N; Kim, IW; Kim, MG; Oh, JM; Park, S; Yun, HY | 1 |
| Andersen, NS; Hovgaard, D; Nygaard, M; Schjødt, IM; Sengeløv, H; Vindeløv, L | 1 |
| Bierings, M; Boelens, JJ; Broers, AE; Cuijpers, ML; Huisman, C; Huls, G; Janssen, JJ; Kuball, J; Lindemans, CA; Mansilla, C; Petersen, EJ; Plantinga, M; Slaper-Cortenbach, IC; Spierings, E; Te Boome, LC; Thus, KA; van der Wagen, LE; van Imhoff, GW; Westinga, K; Wulffraat, NM; Zeerleder, S | 1 |
| Murata, M | 2 |
| Didsbury, MS; Kennedy, SE; Mackie, FE | 1 |
| Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, FR; Wang, JZ; Wang, Y; Xu, LP; Yan, CH | 1 |
| Akpek, G; Alousi, AM; Antin, JH; Arora, M; Cairo, MS; Chao, NJ; Couriel, DR; Cutler, CS; Flowers, ME; Gale, RP; Gupta, V; Hamilton, BK; Hayashi, RJ; Hemmer, MT; Inamoto, Y; Kharfan-Dabaja, MA; Marks, DI; Martin, PJ; Nishihori, T; Reshef, R; Ringdén, OT; Saad, A; Shah, A; Socié, G; Solh, MM; Spellman, SR; Tallman, MS; Teshima, T; Urbano-Ispizua, A; Wang, T; Wirk, B | 1 |
| Dreyer, J; Gruenewald, T; Herscovici, C; Israeli, M; Levy-Assaraf, M; Mechoulam, R; Peck, A; Raanani, P; Ram, R; Shargian, L; Shpilberg, O; Yeshurun, M | 1 |
| Chen, C; Fang, JP; Guo, HX; Huang, K; Huang, SL; Li, Y; Xu, HG; Xue, HM; Zhou, DH | 1 |
| Launois, B | 1 |
| Alarcón-Payer, C; García-Martín, P; Jurado, M; López-Fernández, E; Moratalla, L; Ríos, R; Romero, A; Sainz, J | 1 |
| Afanasyev, B; Al Seraihy, A; Aljurf, M; Ancliff, P; Bierings, M; Calvillo, M; de Wreede, L; Donadieu, J; Dufour, C; Fioredda, F; Fischer, A; Ganser, A; Gaspar, B; Iacobelli, S; Kalwak, K; Ljungman, P; Marsh, J; Matthes-Martin, S; Morreale, G; Or, R; Ozturk, G; Peffault de Latour, R; Peters, C; Sánchez de Toledo Codina, J; Smith, O; van 't Veer-Tazelaar, N; van Biezen, A; Veys, P; Wynn, R; Yesilipek, A | 1 |
| Al-Musa, A; Duran-Struuck, R; Hanekamp, I; Huang, CA; Matar, AJ; Patil, AR; Sachs, DH | 1 |
| Aljurf, MD; Amrolia, PJ; Bacigalupo, A; Bader, P; Bhatnagar, N; Carraro, E; de la Fuente, J; Dufour, C; Ewins, AM; Gibson, B; Hochsmann, B; Hough, RE; Kulasekararaj, A; Marsh, JC; Passweg, J; Peffault de Latour, R; Pillon, M; Risitano, AM; Rovo, A; Samarasinghe, S; Schrezenmeier, H; Skinner, R; Socie, G; Steward, CG; Tichelli, A; van Biezen, A; Velangi, M; Veys, P; Vora, AJ; Wynn, R | 1 |
| Abdel-Azim, H; Crooks, GM; Kapoor, N; Khazal, S; Kohn, DB; Mahadeo, KM; Shah, AJ; Zhao, Q | 1 |
| Chai, J; Galleu, A; Girdlestone, J; Leaver, N; Lombardi, G; Navarrete, CV; Pido-Lopez, J; Srivastava, S | 1 |
| Ai, HS; Dong, Z; Guo, M; Hu, KX; Huang, XM; Huang, YJ; Liu, ZQ; Qiao, JH; Sun, QY; Wang, SF; Wang, Y; Yu, CL; Zuo, HL | 1 |
| Alberbide, J; Basquiera, AL; Berro, M; Burgos, R; Foncuberta, MC; García, JJ; Jaimovich, G; Jarchum, G; Kusminsky, G; Martínez Rolón, J; Milone, J; Milovic, V; Prates, V; Remaggi, G; Rivas, MM; Rizzi, ML | 1 |
| Arora, M; Bejanyan, N; Blazar, BR; Brunstein, CG; DeFor, T; Holtan, S; Lazaryan, A; MacMillan, ML; Wagner, JE; Weisdorf, DJ | 1 |
| Arai, Y; Atsuta, Y; Eto, T; Fukuda, T; Hirokawa, M; Iwato, K; Kaida, K; Kanda, J; Kanda, Y; Kondo, T; Morishima, Y; Murata, M; Nagamura-Inoue, T; Nakamae, H; Nakasone, H; Ohashi, K; Uchida, N | 1 |
| Ashizawa, M; Doki, N; Kakihana, K; Kako, S; Kanamori, H; Kanda, Y; Kato, J; Kikuchi, M; Kimura, SI; Kobayashi, T; Mori, T; Nakaseko, C; Okamoto, S; Tanaka, M; Tanihara, A; Watanabe, R; Yokota, A | 1 |
| Hajifathali, A; Mehdizadeh, M; Tafazoli, A | 1 |
| Ding, K; Geng, L; Liu, H; Sun, G; Sun, Z; Tang, B; Wang, L; Wang, X; Zheng, C | 1 |
| Åhlin, A; Hagelberg, S; Olsson, RF; Ringdén, O; Schiller, B; Truedsson, L | 1 |
| Ariga, T; Cho, Y; Iguchi, A; Kobayashi, R; Ohshima, J; Sato, TZ; Sugiyama, M; Terashita, Y | 1 |
| Arcos-Machancoses, JV; Fernández-Navarro, JM; Fuentes-Socorro, C; García-Williams, S; Menor-Serrano, F; Verdeguer-Miralles, A | 1 |
| Daloglu, H; Dincer, Z; Karasu, G; Uygun, V; Yesilipek, MA | 1 |
| Goyal, RK; Howrie, D; Joshi, R; Kenkre, TS; Venkataramanan, R; Windreich, RM | 1 |
| Davies, SM; Filipovich, AH; Grimley, MS; Khandelwal, P; Lane, A; Marsh, RA; Mellor-Heineke, S; Rehman, N; Smiley, K; Villanueva, J | 1 |
| Du, H; Jing, Y; Lu, W; Luan, Z; Tang, X; Wu, N; Xu, S; Zhang, B | 1 |
| Liu, H; Sun, G; Sun, Z; Tang, B; Yan, J; Yao, W; Zhang, L; Zheng, C; Zhu, X | 1 |
| Chang, W; Chen, F; Fu, C; Jin, Z; Ma, X; Miao, M; Qiu, H; Ruan, C; Sun, A; Tang, X; Wu, D; Xue, S | 1 |
| Adachi, S; Ago, H; Atsuta, Y; Eto, T; Fukuda, T; Iwato, K; Kanamori, H; Kobayashi, N; Miyamura, K; Mori, T; Morishima, Y; Morita, S; Murata, M; Nagamura-Inoue, T; Ohashi, K; Oshima, K; Sakai, R; Sakamaki, H; Taguri, M; Taniguchi, S | 1 |
| Glass, Ä; Junghanss, C; Killian, D; Lange, S; Machka, C; Roolf, C; Schäfer, S; Steder, A; Werner, J; Wittmann, S | 1 |
| Bertrand, Y; Bleyzac, N; Cuzzubbo, D; Domenech, C; Dubois, V; Garnier, N; Goutagny, MP; Goutelle, S; Grardel, N; Janoly-Duménil, A; Plesa, A; Rénard, C | 1 |
| Cheng, MY; Fung, MA; Maverakis, E; Patel, F; Shi, VY; Sultani, H; Wilken, R | 1 |
| Jordá, E; Martín, JM; Mateo, E | 1 |
| Gao, ZY; Li, WD; Lu, DP; Lu, DY; Yu, XJ | 1 |
| Dong, Y; Liu, H; Liu, W; Miao, S; Ren, H; Shi, Y; Tang, B; Yin, Y | 1 |
| Ding, KY; Geng, LQ; Han, YS; Liu, HL; Liu, X; Sun, ZM; Tang, BL; Tong, J; Wan, X; Wang, XB; Wang, ZY; Wu, JS; Wu, Y; Yang, HZ; Yao, W; Zhang, L; Zhang, XH; Zheng, CC; Zhu, WW; Zhu, XY | 1 |
| Jang, JH; Jung, CW; Kim, K; Kim, SJ; Kim, WS; Park, S | 1 |
| Arora, M; Bejanyan, N; Blazar, BR; Brunstein, CG; DeFor, TE; Holtan, SG; Jacobson, PA; Lazaryan, A; MacMillan, ML; Rogosheske, J; Verneris, MR; Wagner, JE; Weisdorf, DJ | 1 |
| Bronson, RT; Crepeau, RL; Duran-Struuck, R; Fishman, JA; Horner, BM; Huang, CA; Matar, AJ; Pathiraja, V; Sachs, DH; Spitzer, TR; Teague, AGS | 1 |
| Eskazan, AE | 1 |
| Arai, T; Ishiwata, Y; Kohsaka, H; Makiishi, M; Nagata, M; Takahashi, H; Yasuhara, M; Yoshikawa, M | 1 |
| Garming-Legert, K; Itälä-Remes, M; Ljungman, P; Mattsson, J; Remberger, M; Remes, K; Ringdén, O; Törlén, J; Winiarski, J | 1 |
| Akashi, K; Eto, T; Henzan, H; Iwasaki, H; Kamimura, T; Kato, K; Miyamoto, T; Nagafuji, K; Osaki, K; Takase, K; Takashima, S; Teshima, T; Yoshida, S; Yoshimoto, G | 1 |
| Butts-Miwongtum, T; Chang, J; Graves, SS; Mathes, DW; Sale, GE; Storb, R | 1 |
| Atsuta, Y; Fukuda, T; Ichinohe, T; Inamoto, Y; Kanamori, H; Murata, M; Ohashi, K; Onishi, Y; Ozawa, Y; Sakai, R; Takahashi, S; Takanashi, M; Terakura, S; Teshima, T; Uchida, N; Wake, A; Yamaguchi, H; Yamaguchi, T | 1 |
| Andreoli, A; Boissel, N; de Latour, RP; Dhédin, N; Granier, C; Larghero, J; Lengliné, E; Masson, E; Robin, M; Schlageter, MH; Socié, G; Vignon, M | 1 |
| Coelho, R; Flagg, A; Gonzalez, BE; Hanna, R; Harrington, S; Kusick, K; Ondrejka, S; Procop, GW; Stempak, LM; Zembillas, A | 1 |
| Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Shouval, R; Yerushalmi, R | 1 |
| Adam, R; Akesbi, J; Moyal, L; Nordmann, JP; Rodallec, FT | 1 |
| Cantú-Rodríguez, O; Gamboa-Alonso, CM; García-Sepulveda, R; Gómez-Almaguer, D; Gómez-De León, A; González-Llano, O; Gutiérrez-Aguirre, CH; Herrera-Rojas, MA; Jaime-Pérez, JC; Mancías-Guerra, C; Villarreal-Martínez, L | 1 |
| Chen, X; Du, X; Gao, L; Kong, P; Li, H; Liu, H; Liu, J; Liu, Y; Peng, X; Su, Y; Sun, A; Zhang, C; Zhang, X; Zhang, Y; Zhong, J | 1 |
| Adil, S; Ahmed, P; Ansari, S; Farzana, T; Hashmi, K; Irfan, M; Khan, B; Panjwani, V; Shamsi, T | 1 |
| Geng, LQ; Liu, HL; Sun, ZM; Tong, J; Wang, ZY; Yao, W; Yuan, X | 1 |
| Amrolia, P; Ancliff, P; Bonanomi, S; Bonnanomi, S; Connor, P; Goulden, N; Hemmatpour, S; McCloskey, D; Rao, K; Veys, P; Webb, D | 1 |
| Kuo, ML; Lin, SJ | 1 |
| Doyle, J; Dupuis, LL; Jin, M; Saunders, EF; Seto, W; Taylor, T | 1 |
| Andree, H; Freund, M; Hilgendorf, I; Holzhueter, S; Junghanss, C; Leithaeuser, M; Loddenkemper, C; Steiner, B; Wolff, D | 1 |
| Cai, Z; Deng, D; Lai, Y; Li, Q; Li, W; Liang, J; Luo, J; Luo, L; Ma, J; Peng, Z; Schwarzenberger, P; Yang, J; Zhou, J; Zhou, Y | 1 |
| Arakida, Y; Ishikawa, J; Ohga, K; Shimizu, Y; Takezawa, R | 1 |
| Kanda, Y | 1 |
| Benninghoff, U; Friedrich, W; Hönig, M; Schulz, A; Schütz, C | 1 |
| Baker, KS; Biernacki, MA; Kharbanda, S; Krishnamurti, L; Wagner, JE; Wu, CJ; Zhang, W | 1 |
| Benjamin, R; Caballero, D; Delgado, J; Kottaridis, P; Lovell, R; Mackinnon, S; Martino, R; Milligan, D; Nathwani, A; Peggs, K; Perez-Simon, JA; Pillai, S; Sierra, J; Sureda, A; Thomson, K; Vazquez, L | 1 |
| Kersting, S; Verdonck, LF | 1 |
| Barkholt, L | 1 |
| Bleyzac, N | 2 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Xu, LP | 1 |
| Barba, P; Briones, J; Brunet, S; Delgado, J; Martino, R; Moreno, E; Piñana, JL; Sierra, J; Sureda, A; Valcárcel, D; Vega, M | 1 |
| Gronkowska, A; Lakomy, M; Michalewska, B; Pogorzala, M; Rokicka, M; Styczynski, J; Tomaszewska, A; Torosian, T; Wiktor-Jedrzejczak, W; Wysocki, M | 1 |
| Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Okamoto, S; Shimizu, T; Suzuki, N; Suzuki, S; Tsukada, Y | 1 |
| Goodman, S; Reddy, N; Savani, BN | 1 |
| Arai, S; Blume, KG; Heydari, K; Hoppe, RT; Johnston, LJ; Kohrt, HE; Laport, GG; Lavori, PW; Lowsky, R; Miklos, DB; Negrin, RS; Shizuru, JA; Strober, S; Turnbull, BB; Weng, WK | 1 |
| Bramsiepe, I; Danz, B; Eismann, R; Fiedler, E; Marsch, WC; Neid, T; Wohlrab, J | 1 |
| Balduzzi, A; Cesaro, S; Dini, G; Favre, C; Lanino, E; Locatelli, F; Messina, C; Pession, A; Pollichieni, S; Rabusin, M; Rondelli, R; Santarone, S | 1 |
| Anasetti, C; Appelbaum, FR; Carnevale-Schianca, F; Carpenter, PA; Deeg, HJ; Furlong, T; Kiem, HP; Leisenring, W; Martin, PJ; McDonald, GB; Nash, RA; Schoch, G; Storb, R | 1 |
| Austen, B; Hewamana, S; Johnson, S; Murray, J; Wilson, K | 1 |
| Chang, K; Forman, SJ; Nademanee, A; Nakamura, R; Palmer, JM; Parker, P; Patane, K; Pullarkat, V; Rodriguez, R; Sahebi, F; Senitzer, D; Smith, E; Snyder, D; Zain, J | 1 |
| Bahceci, E; Devetten, M; Herzig, R; Holland, K; Isola, L; Jansen, J; Kebriaei, P; McGuirk, J; Monroy, R; Rowley, S; Schuster, M; Uberti, J | 1 |
| Chan, KC; Cheng, FW; Lee, V; Li, CK; Shing, MK; To, KF | 1 |
| Fox, LP; Goddard, DS; Mathes, ED; Nixon, M; Ruben, BS; Wolf, J | 1 |
| Cho, GJ; Choi, YJ; Chung, JS; Kwon, BR; Seol, YM; Shin, HJ; Song, MK | 1 |
| Bertz, H; Bethge, WA; Bornhäuser, M; Egger, M; Einsele, H; Finke, J; Grishina, O; Heim, DA; Holler, E; Kolb, HJ; Kolbe, K; Koza, V; Linkesch, W; Maertens, JA; Mayer, J; Ottinger, HD; Ruutu, T; Schmoor, C; Schwerdtfeger, R; Socié, G; Stelljes, M; Volin, L; Zander, AR | 2 |
| Abe, Y; Arita, Y; Baba, E; Choi, I; Harada, M; Ito, T; Kawabe, K; Miyamoto, T; Nagafuji, K; Nakano, S; Teshima, T | 1 |
| Kako, S; Kanda, Y; Kimura, S; Okuda, S; Oshima, K; Sato, M; Terasako, K | 1 |
| Ayari, S; Blin, N; Brissot, E; Chevallier, P; Delaunay, J; Dubruille, V; Gastinne, T; Guillaume, T; Harousseau, JL; Le Gouill, S; Mahe, B; Mohty, M; Moreau, P; Saulquin, B | 1 |
| Al-Ghamdi, A; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Ayas, M; Chaudhri, N; Mohammed, SY; Nassar, A; Tabbara, KF | 1 |
| Dana, R; Dastjerdi, MH; Hamrah, P | 1 |
| Barba, P; Briones, J; Brunet, S; Delgado, J; Martino, R; Piñana, JL; Querol, L; Sierra, J; Sureda, A; Valcárcel, D | 1 |
| den Hartigh, J; Egeler, RM; Lankester, AC; Press, RR; Vossen, JM; Willemze, AJ | 1 |
| Kato, K; Kato, S; Kawase, T; Kigasawa, H; Kodera, Y; Kojima, S; Morishima, Y; Muramatsu, H; Sakamaki, H; Tsuchida, M; Yabe, H; Yagasaki, H | 1 |
| Higuchi, T; Kako, S; Kanda, Y; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sato, K; Sato, M; Tanaka, Y; Tanihara, A; Terasako, K; Yamazaki, R | 1 |
| Chang, YJ; Huang, XJ; Huo, MR; Liu, DH; Liu, KY; Xu, LP; Zhao, XY | 1 |
| Katayama, Y; Kawamori, Y; Kawano, H; Kawano, Y; Matsui, T; Minagawa, K; Nishikawa, S; Okamura, A; Ono, K; Shimoyama, M; Yamamori, M | 1 |
| Hassan, Z; Mattsson, J; Olsson, R; Omazic, B; Remberger, M; Ringdén, O | 1 |
| Ayari, S; Blin, N; Brissot, E; Chevallier, P; Delaunay, J; Dubruille, V; Gastinne, T; Guillaume, T; Harousseau, JL; Le Gouill, S; Mahe, B; Malard, F; Mohty, M; Moreau, P; Saulquin, B; Szydlo, RM | 1 |
| Grigg, AP; Hoyt, R; Ritchie, DS; Szer, J; Wirth, A | 1 |
| Charlanne, H; Hachulla, E; Hatron, PY; Lambert, M; Launay, D; Maillard-Lefebvre, H; Morell-Dubois, S; Yakoub-Agh, I | 1 |
| Barba, P; Brunet, S; Carreras, E; Fernández-Avilés, F; Martínez, C; Martino, R; Piñana, JL; Rovira, M; Sierra, J; Sureda, A; Valcárcel, D | 1 |
| Arnold, R; Dörken, B; Hemmati, PG; le Coutre, P; Massenkeil, G; Neuburger, S; Terwey, TH; Vuong, LG | 1 |
| Ashouri, A; Babaie, MH; Ghavamzadeh, A; Iravani, M; Khatami, F; Tavakoli, E | 1 |
| Dupuis, LL; Schechter, T | 1 |
| Han, DJ; Kim, HM; Kim, SC; Kim, Y; Koo, SK; Lim, DG; Park, CS; Park, YH | 1 |
| Braida, S; Defabianis, P; Guagnano, R | 1 |
| Cao, YB; Da, WM; Gao, CJ; Li, HH; Li, XH; Ma, J; Wu, XX; Yu, L | 1 |
| Fukuhara, N; Harigae, H; Ishizawa, K; Kameoka, J; Kohata, K; Ohba-Ohtsuka, R; Ohguchi, H; Ohnishi, Y; Okitsu, Y; Tohmiya, Y; Yamada, MF; Yamamoto, J; Yokoyama, H | 1 |
| Gulín Dávila, J; López Rodríguez, L | 1 |
| Abe, T; Aizawa, Y; Furukawa, T; Fuse, I; Higashimura, M; Karimata, K; Kurasaki-Ida, T; Kuroha, T; Masuko, M; Momoi, A; Moriyama, M; Narita, M; Okazuka, K; Sato, N; Shibasaki, Y; Takahashi, M; Takizawa, J; Toba, K; Tsukada, N; Yano, T | 1 |
| Galicier, L; Petropoulou, AD; Robin, M; Socié, G | 1 |
| Gooley, TA; Kiem, HP; Sale, G; Sandmaier, BM; Santos, EB; Storb, R; Thakar, MS | 1 |
| Bondada, S; Brandon, JA; Bryson, JS; Cohen, DA; Jennings, CD; Kaplan, AM; Perez, J; Sindhava, VJ | 1 |
| Elad, S; Gesundheit, B; Levovic, A; Miron, S; Or, R; Resnick, IB; Shapira, MY; Slavin, S; Tsirigotis, PD; Yoffe, L; Zilberman, I | 1 |
| Burroughs, LM; Carpenter, PA; Englund, J; Ochs, HD; Rawlings, DJ; Sanders, J; Scharenberg, AM; Skoda-Smith, S; Storb, R; Torgerson, TR; Woolfrey, AE | 1 |
| Appelbaum, FR; Deeg, HJ; Flowers, ME; Maloney, DG; Martin, PJ; Mielcarek, M; Peffer, A; Rotta, M; Sandmaier, BM; Storb, R; Storer, BE; Vernon, MS | 1 |
| Akpek, EK; Stern, M; Utine, CA | 1 |
| Ahmed, S; Al-Anazi, K; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Bakr, M; Chaudhri, N; Elhassan, T; Elkum, N; Hussain, F; Ibrahim, K; Mohamed, S; Nassar, A; Nurgat, Z; Patel, M; Rasheed, W; Saleh, AJ | 1 |
| Bertrand, Y; Bleyzac, N; Freyer, G; Gérard, C; Girard, P; Tod, M | 2 |
| Malta, JB; Mian, SI; Musch, DC; Rhoades, W; Shtein, RM; Soong, HK; Sugar, A | 1 |
| du Toit, C; McDonald, A; Novitzky, N; Thomas, V | 1 |
| Abdelqader, S; Abonour, R; Baute, J; Cornetta, K; Farag, SS; Fausel, CA; Kalsekar, I; Kiel, PJ; Nelson, RP; Robertson, MJ; Rosenbeck, LL; Schwartz, J; Srivastava, S; Sullivan, CK; Vargo, C; Wood, L | 1 |
| Arnold, R; Dokal, I; Dörken, B; Hemmati, PG; le Coutre, P; Neuburger, S; Terwey, TH; Vulliamy, T; Vuong, LG | 1 |
| Abderrahmane, A; Amel, L; Anis, K; Lamia, T; Mohamed, L; Nadia, BF; Saloua, L; Tarek, BO | 1 |
| Ando, K; Inoko, H; Kawada, H; Kunii, N; Machida, S; Ogawa, Y; Ohgiya, D; Onizuka, M; Toyosaki, M | 1 |
| Inoue, Y; Kato, M; Kosugi, S; Miura, I; Nishio, Y; Ogawa, K; Saito, T; Shibuya, Y; Suzuki, Y; Takahashi, M | 1 |
| Ge, C; You, Y; Zou, P | 1 |
| Chun, C; Fang, JP; Huang, K; Huang, SL; Xu, HG; Xue, HM; Zhou, DH | 1 |
| Bailey, M; Grigg, A; Kong, DC; Shuttleworth, P | 1 |
| Cai, Z; Han, X; He, J; Huang, H; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhao, Y; Zheng, Y | 1 |
| Jorge, S; Lopes, JA | 1 |
| Baran, J; Czogała, W; Goździk, J; Krasowska-Kwiecień, A; Pituch-Noworolska, A; Skoczeń, S; Wędrychowicz, A; Wiecha, O; Zembala, M | 1 |
| Andreoli, C; Barberi, W; Foà, R; Gualdi, G; Iori, AP; Mercanti, C; Natalino, F; Perrone, S; Torelli, GF; Valle, V | 1 |
| Appelbaum, FR; Carpenter, PA; Deeg, HJ; Flowers, ME; Furlong, T; Inamoto, Y; Kiem, HP; Martin, PJ; Mielcarek, M; Nash, RA; Storb, RF; Storer, BE; Witherspoon, RP | 1 |
| Akiyama, H; Kakihana, K; Kobayashi, T; Murata, Y; Ohashi, K; Sakamaki, H; Tsubokura, M; Yamashita, T | 1 |
| Ishigatsubo, Y; Kanamori, H; Maruta, A; Matsumoto, K; Numata, A; Tachibana, T; Takasaki, H; Tanaka, M | 1 |
| Inagaki, J; Nagatoshi, Y; Nomura, Y; Okamura, J; Sakiyama, M; Teranishi, H; Yanai, F | 1 |
| Antin, JH | 1 |
| Gómez-Almaguer, D; Gonzalez-Llano, O; Hernandez-Arizpe, A; Macias-Gallardo, J; Mancias-Guerra, C; Martinez-Cabriales, SA; Rodriguez-Romo, LN; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ | 1 |
| Bruijnen, CP; Cornelisse, PB; Cornelissen, JJ; Emmelot, M; Huisman, C; Huls, G; Janssen, JJ; Kersten, MJ; Kneppers, E; Lokhorst, HM; Meijer, E; Minnema, MC; Mutis, T; Sonneveld, P; van der Holt, B; Zweegman, S | 1 |
| Dahlke, MH; Eggenhofer, E; Geissler, EK; Hoogduijn, MJ; Popp, FC; Renner, P; Schlitt, HJ; Soeder, Y | 1 |
| Cheng, J; Ding, JH; Liu, J; Wang, J; Wu, F; Yu, ZP; Zhao, G | 1 |
| Chua, BK; Flowers, ME; Maloney, DG; Martin, PJ; Mielcarek, M; Ram, R; Rotta, M; Sandmaier, BM; Storb, R; Storer, B | 1 |
| Beutel, G; Buchholz, S; Dammann, E; Eder, M; Ganser, A; Krauter, J; Stadler, M; Trummer, A | 1 |
| Clifford, R; Danby, R; Ellis, A; Hatton, C; Littlewood, T; Malladi, R; Medd, P; Monk, I; Peniket, A; Roberts, D; Vyas, P | 1 |
| de Graaf, P; Huijgens, PC; Janssen, JJ; Swart, EL; Veldkamp, AI; Wilhelm, AJ | 1 |
| Alimoghaddam, K; Ghavamzadeh, A; Hadjibabaie, M; Iravani, M; Moosavi, SA; Rezaee, S; Vazirian, I | 1 |
| Bularda, A; Lanzetta, M; Lascar, I; Popescu, M; Popovicu, C; Stefanescu, A; Zamfirescu, D; Zegrea, I | 1 |
| Chen, B; Chen, G; Cheng, J; Ding, J; Gao, C; Jin, N; Li, W; Liu, Z; Miao, Y; Wang, J; Wang, X; Xia, G; Zhou, Y | 1 |
| Socié, G | 1 |
| Abbas, AA; Jastaniah, WA | 1 |
| Goto, T; Koike, K; Kurokawa, M; Yamamoto, G; Yoshimi, A | 1 |
| Kim, YJ; Yi, ES | 1 |
| Amrolia, P; Bonney, D; Carey, P; Connor, P; Gibson, B; Goulden, N; Hiwarkar, P; Hough, R; Keogh, S; Lawson, S; Meyer, S; Norton, A; Pelidis, M; Qureshi, A; Rao, K; Saif, MA; Samarasinghe, S; Skinner, R; Steward, C; Stewart, G; Stubbs, M; Veys, P; Vora, A; Webb, D; Wynn, R | 1 |
| Bertz, H; Christopoulos, P; Finke, J; Ihorst, G; Marks, R; Wäsch, R | 1 |
| Bachanova, V; Brunstein, CG; Burke, MJ; Cao, Q; Sandhu, K; Singleton, TP; Verneris, MR; Wagner, JE; Weisdorf, DJ; Yohe, S | 1 |
| Alimoghaddam, K; Ghavamzadeh, A; Hamidi, Z; Hamidieh, AA; Haralambous, H; Heshmat, R; Larijani, B; Mohajeri-Tehrani, MR; Nedaeifard, L | 1 |
| Kabbin, GM; Kulkarni, V; Naveen, KN; Pai, VV; Rao, R | 1 |
| Aglietta, M; Boccadoro, M; Bruno, B; Casini, M; Cavattoni, I; Console, G; Festuccia, M; Filippi, AR; Gallamini, A; Giaccone, L; Gigli, F; Irrera, G; Levis, A; Messina, G; Montanari, M; Mordini, N; Passera, R; Pastano, R; Pini, M; Ricardi, U; Risitano, AM; Schianca, FC; Scortechini, I; Selleri, C; Sorasio, R | 1 |
| Bardwell, PD; Chen, J; Cippà, PE; Fehr, T; Guimezanes, A; Kraus, AK; Lindenmeyer, MT; Wekerle, T; Wüthrich, RP | 1 |
| Eljebari, H; Fradj, NB; Gaies, E; Jebabli, N; Klouz, A; Lakhal, M; Salouage, I; Trabelsi, S | 1 |
| Burton, L; Chiuzan, C; Garrett-Mayer, E; Heath, TS; Hudspeth, MP; Nista, E; Ragucci, D | 1 |
| Aker, M; Dray, L; Grisariu, S; Kedmi, M; Or, R; Resnick, IB; Shapira, MY; Stepensky, P | 1 |
| Dahllöf, G; Garming-Legert, K; Karlsson, H; Mattsson, J; Remberger, M; Ringdén, O; Svenberg, P; Uhlin, M; Uzunel, M | 1 |
| Airaghi, L; Annaloro, C; Cortelezzi, A; Deliliers, GL; Onida, F; Saporiti, G | 1 |
| Caballero, D; Cabrero, M; Lopez-Corral, L; Márquez-Malaver, FJ; Martinez, C; Martino, R; Parody, R; Perez-Simón, JA; Sierra, J; Solano, C; Valcarcel, D; Vazquez, L | 1 |
| Doyle, JD; Dupuis, LL; Egeler, RM; Gassas, A; Gibson, P; Schechter, T; Schultz, KR; Seto, W; Sung, L; Teuffel, O | 1 |
| Choudhary, D; Gupta, N; Handoo, A; Katewa, S; Kharya, G; Pavecha, P; Setia, R; Sharma, SK | 1 |
| Davies, SM; Jodele, S; Lawrence, J; Marsh, RA; Myers, KC | 1 |
| Blijlevens, NM; Dolstra, H; Feuth, T; Leenders, MJ; van der Velden, WJ; van der Voort, R; van der Waart, AB; van Halteren, AG | 1 |
| Fujisawa, S; Fujita, H; Kanamori, H; Kanda, Y; Kobayashi, T; Mori, T; Nakaseko, C; Nannya, Y; Ohashi, K; Okamoto, S; Sakamaki, H; Sakura, T; Takahashi, S; Tanaka, M; Yokota, A | 1 |
| Adachi, S; Daifu, T; Heike, T; Hiramatsu, H; Kato, I; Matsubara, H; Nodomi, S; Umeda, K; Watanabe, K | 1 |
| Jin, J; Wei, J; Xu, H; Zhang, J; Zhang, Y | 1 |
| Allgood, JW; Bodensteiner, DM; Cook, JD; Deauna-Limayo, D; Ellis, RJ; Kahn, Q; Mayo, MS; Skikne, BS | 1 |
| Fu, J; Huang, H; Lin, M; Zhang, R; Zheng, W | 1 |
| Liu, H; Liu, X; Liu, Z; Pan, L; Sun, Z; Wang, N; Wang, Z; Wu, J; Wu, S; Zhu, W | 1 |
| Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W | 1 |
| Chen, Y; Gao, Z; Guo, N; Huang, X; Lu, D; Ren, H; Xu, L; Zhang, Y | 1 |
| Fayen, JD; Jacobberger, JW; Kadereit, S; Laughlin, MJ; Miller, RE; Mohammad, SF; Shurin, SB; Sramkoski, RM; Stein, K; Templeton, D; Woods, KD | 1 |
| Cheng, LL; Jon, HC; Kwok, AK; Lam, DS; Neoh, EL; Wat, NM | 1 |
| Ananth, SL; Babu, YS; Banti, S; Horn, LL; Miller, PJ; Parker, CD; Sandhu, JS | 1 |
| Benard, L; Boisserie, G; Boyer, O; Bruel, S; Cohen, JL; Klatzmann, D; Litvinova, E; Maury, S | 1 |
| Chen, Z; Fidler, JM; Jin, R; Ku, GY; Piazza, D; Xu, R | 1 |
| Murata, R; Sakai, K; Ueda, M; Yamaguchi, M | 1 |
| Anagnostopoulos, A; Beguelin, GZ; Champlin, R; Couriel, DR; De Lima, M; Giralt, S; Hosing, C; Kharfan-Dabaja, MA | 1 |
| Cavenagh, J; Chopra, R; Clark, FJ; Culligan, D; Davies, A; Fuller, S; Hunt, L; Hunter, A; Littlewood, T; Lush, R; Marks, DI; Marsh, J; Milligan, DW; Parker, A; Schey, S; Smith, GM; Towlson, K; Vandenberghe, E; Williams, CD; Yin, J | 1 |
| Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K | 1 |
| Blazar, BR; Campbell, MT; Ehrhardt, MJ; Lees, CJ; Noelle, RJ; Taylor, PA; Wilson, JM | 1 |
| Anasetti, C; Blume, KG; Chauncey, T; Deininger, M; Hegenbart, U; Lange, T; Little, MT; Maloney, DG; Maris, M; McSweeney, PA; Niederwieser, D; Petersdorf, E; Pönisch, W; Sandmaier, BM; Shizuru, JA; Storb, RF; Storer, B; Woolfrey, A | 1 |
| Aschan, J; Barkholt, L; Eriksson, B; Hentschke, P; Holmberg, K; Myrbäck, KE; Remberger, M; Ringdén, O; Svahn, BM | 1 |
| Hamaki, T; Kami, M; Kanda, Y; Kusumi, E; Mineishi, S; Miyakoshi, S; Momomura, S; Morinaga, S; Mutou, Y; Takaue, Y; Ueyama, J | 1 |
| Colao, A; De Rosa, G; Del Puente, A; Esposito, A; Lombardi, G; Risitano, AM; Rotoli, B; Selleri, C; Serio, B; Tauchmanovà, L | 1 |
| Bernaudin, F; Blatt, J; Brichard, B; Brochstein, JA; Ertem, M; Garnier, F; Giorgiani, G; Gluckman, E; Grafakos, S; Haut, PR; Ionescu, I; Kurtzberg, J; Li, X; Locatelli, F; Lubin, BH; Lutz, P; Miniero, R; Nagler, A; Nugent, DJ; Raja, T; Reed, W; Roberts, I; Rocha, V; Rubin, CM; Tannoia, N; Vermylen, C; Walters, MC; Will, AM; Woodard, P; Yaniv, I | 1 |
| Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Ayuk, F; Erttmann, R; Horstmann, M; Kabisch, H; Kordes, U; Kröger, N; Krüger, W; Renges, H; Rischewski, J; Schrum, J; Zabelina, T; Zander, AR | 1 |
| Chen, HR; Ji, SQ; Liu, J; Wang, HX; Xue, M; Xun, CQ; Yan, HM; Zhu, L | 1 |
| Calevo, MG; Castagnola, E; Dallorso, S; Dini, G; Faraci, M; Fondelli, MP; Gaggero, R; Haupt, R; Lanino, E; Manzitti, C; Morreale, G | 1 |
| Wu, D; Xu, Y; Zhong, J; Zhu, KE | 1 |
| Cottler-Fox, M; Meisenberg, B; Rapoport, AP; Ruehle, K; Sarkodee-Adoo, C; Sensenbrenner, L; Sotirescu, D; Tricot, G | 1 |
| Akaho, R; Akiyama, H; Hagiya, K; Mori, S; Nakagome, K; Sakamaki, H; Sasaki, T; Yoshino, M | 1 |
| Chiba, T; Fukai, K; Imazeki, F; Kojima, H; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Carpenter, PA; Sanders, JE | 1 |
| Aoki, K; Chiba, S; Goyama, S; Hirai, H; Kanda, Y; Kandabashi, K; Kawazu, M; Komeno, Y; Kurokawa, M; Motokura, T; Nakamoto, T; Nannya, Y; Niino, M; Ogawa, S; Takeshita, M; Tsujino, S | 1 |
| Bader, P; Beck, LF; Dückers, G; Greil, J; Hoelle, W; Kerst, G; Klingebiel, T; Kreyenberg, H; Lang, P; Niethammer, D | 1 |
| Adler, KR; Bisaccia, E; Goldberg, SL; Gonzalez, J; Palangio, M; Rowley, SD | 1 |
| Berger, M; Biasin, E; Fagioli, F; Martino, S; Miniero, R; Nesi, F; Saroglia, EH; Tovo, PA | 1 |
| Aguilera, C; Boqué, C; Grañena, A; Petit, J; Vicente, L | 1 |
| Daly, AS; Hasegawa, W; Jamal, H; Kiss, TL; Kotchetkova, N; Lipton, JH; Messner, HA; Yi, QL | 1 |
| Urbano-Ispìzua, A | 1 |
| Arcese, W; Cerilli, L; Cerretti, R; De Felice, L; De Propris, MS; Fenu, S; Girelli, G; Iori, AP; Mengarelli, A; Moleti, ML; Romano, A | 1 |
| Flowers, ME; Leisenring, W; Maloney, DG; Maris, MB; Martin, PJ; Mielcarek, M; Sandmaier, BM; Storb, R | 1 |
| Ansell, SM; Dispenzieri, A; Elliott, MA; Gastineau, DA; Gertz, MA; Inwards, DJ; Lacy, MQ; Litzow, M; Micallef, IN; Nichols, WL; Plumhoff, EA; Tefferi, A | 1 |
| D'Costa, S; Hurwitz, JL; Slobod, KS | 1 |
| Hamazaki, Y; Hiwatashi, K; Ohguchi, H; Sai, T | 1 |
| Ju, XP; Li, HM; Song, XM; Tong, SP; Wang, JM; Zhang, WP | 1 |
| Bader, P; Bamberg, M; Einsele, H; Faul, C; Hebart, H; Kanz, L; Liebisch, P; Meisner, C; Plasswilm, L; Schäfer, HJ | 1 |
| Barrett, AJ; Carter, C; Childs, R; Dunbar, CE; Leitman, SF; Nakamura, R; Read, EJ; Solomon, SR; Young, NS | 1 |
| Armstrong, CA; Doyle, JJ; Dror, Y; Freedman, MH; Leaker, M; Saunders, FE; Verbeek, J | 1 |
| Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Brundage, R; Green, KG; Jacobson, PA; Ng, J; Rogosheske, J | 1 |
| Atra, A; Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Meller, S; Ortin, M; Pinkerton, CR; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J | 1 |
| Kawano, Y; Koga, Y; Nagatoshi, Y; Okamura, J | 1 |
| Benner, A; Goerner, M; Ho, AD; Hoepfner, S; Luft, T; Weber-Nordt, R | 1 |
| Bermudez, M; Cañete, A; Castel, V; De la Rubia, J; Fernandez, J; Verdeguer, A | 1 |
| Fujisawa, Y; Hamaki, T; Heike, Y; Hori, A; Imataki, O; Kami, M; Kim, SW; Kishi, Y; Kojima, R; Makimoto, A; Masuo, S; Murashige, N; Sakiyama, M; Takaue, Y; Tanosaki, R | 1 |
| Chen, Y; Han, W; Hong, H; Huang, X; Lu, D | 1 |
| Nishimura, J; Ohshima, K; Shiokawa, S; Shiratsuchi, M; Suehiro, S; Suehiro, Y; Tani, K | 1 |
| Ackerstein, A; Bitan, M; Elad, S; Miron, S; Or, R; Resnick, IB; Samuel, S; Shapira, MY; Slavin, S; Zilberman, I | 1 |
| Ai, HS; Hou, CM; Li, X; Mao, N; Sun, WJ; Wu, Y; Zhang, MW; Zhang, Y | 1 |
| Gan, R; Liu, T; Song, Y; Tang, Y; Wang, L; Yin, Z | 1 |
| Adkins, D; Blum, W; Brown, R; Chohan, R; Devine, S; DiPersio, JF; Goodnough, LT; Graubert, T; Khoury, H; Tomasson, M; Vij, R | 1 |
| Aulagner, G; Bertrand, Y; Bleyzac, N; Galambrun, C; Jelliffe, RW; Maire, PH; Martin, P; Souillet, G | 2 |
| Hess, AD; Miura, Y; Nakao, S; Shiobara, S; Takami, A; Ueda, M | 1 |
| Aymerich, M; Carreras, E; Fernández-Avilés, F; Jiménez, M; Martínez, C; Montserrat, E; Rovira, M; Talarn, C; Urbano-Ispizua, A | 1 |
| Barama, A; Busque, S; Chen, H; Daloze, P; Johnson, S; Jolicoeur, M; Liu, D; Qi, S; Smeesters, C; Xu, D | 1 |
| Im, YH; Jung, CW; Kang, WK; Kim, K; Ko, YH; Lee, H; Lee, HR; Lee, KE; Lee, MH; Lee, SH; Park, J; Park, JO; Park, K; Park, SH | 1 |
| Butt, NM; Clark, RE; McGinnity, N | 1 |
| Liu, QF; Liu, XL; Meng, FY; Sun, J; Xu, B; Xu, D; Zhang, Y; Zhou, SY | 1 |
| Asano, S; Iseki, T; Nagamura, F; Ooi, J; Takahashi, S; Takahashi, T; Takeuchi, M; Tani, K; Tojo, A; Tomonari, A; Uchimaru, K | 1 |
| Chybicka, A; Gorczyñska, E; Kalwak, K; Rybka, B; Ryczan, R; Sajewicz, L; Toporski, J; Turkiewicz, D | 1 |
| Zakrzewski, JL | 1 |
| Gastl, G; Kircher, B; Lätzer, K; Nachbaur, D | 1 |
| Cetkovská, P; Pizinger, K; Skálová, A | 1 |
| Aoun, E; Chehal, A; Obeid, M; Shamseddine, A; Taher, A | 1 |
| Asano, S; Iseki, T; Nagamura, F; Ooi, J; Takahashi, S; Takahashi, T; Tojo, A; Tomonari, A; Uchimaru, K | 1 |
| Antin, JA; Laufer, MR; Soiffer, RJ; Spiryda, LB | 1 |
| Bryson, JS; Carlson, SL; Caywood, BE; Goes, SW; Jennings, CD; Kaplan, AM; Zhang, L | 1 |
| Höffken, K; Issa, MC; Kasper, C; Mügge, LO; Sayer, HG; Schilling, K; Scholl, S | 1 |
| Aoki, K; Asano, Y; Chiba, S; Hangaishi, A; Hirai, H; Imai, Y; Izutsu, K; Kanda, Y; Kandabashi, K; Kurokawa, M; Matsubara, M; Motokura, T; Nakagawa, M; Ogawa, N; Ogawa, S; Sakata-Yanagimoto, M; Tsujino, S | 1 |
| Amadori, S; Ballatore, G; Caravita, T; Catalano, G; Cristina Cox, M; Cudillo, L; Cupelli, L; Dentamaro, T; Fabritiis Pd, Pd; Picardi, A; Venditti, A | 1 |
| Cerno, M; Damiani, D; Fanin, R; Fili', C; Geromin, A; Patriarca, F; Prosdocimo, S; Skert, C; Sperotto, A; Stocchi, R; Zaja, F | 1 |
| Bargetzi, M; Chklovskaia, E; Gratwohl, A; Nissen, C; Nowbakht, P; Wodnar-Filipowicz, A | 1 |
| Abe, Y; Choi, I; Inaba, S; Matsushima, T; Muta, K; Nagasawa, E; Nawata, H; Nishimura, J; Ohtsuka, R; Tachikawa, Y | 1 |
| Chan, G; Foss, FM; Gorgun, G; Grodman, H; Lawrence, D; Mahajan, A; Miller, KB; Relias, V; Roberts, TF; Schenkein, DP; Sprague, K | 1 |
| Bright, EC; Hess, AD; Miura, Y; Thoburn, CJ | 1 |
| Cantisani, V; Glickman, J; Mortele, KJ; Ros, PR; Silverman, SG; Viscomi, SG | 1 |
| Atsuta, Y; Furukawa, T; Hamajima, N; Hirabayashi, N; Hirai, H; Hiraoka, A; Iseki, T; Iwato, K; Izutsu, K; Kanda, Y; Kasai, M; Kawa, K; Kodera, Y; Maruta, A; Mitsui, H; Okamoto, S; Sakamaki, H | 1 |
| Hogan, WJ; Storb, R | 1 |
| Ruan, CG; Sun, AN; Tang, XW; Wu, DP; Xia, XM; Zhu, ZL | 1 |
| Al-Kadhimi, Z; Angelopoulou, M; Cohen, S; Falk, PM; Forman, SJ; Fung, HC; Kogut, N; Krishnan, AY; Nademanee, A; O'Donnell, MR; Parker, P; Popplewell, L; Rodriguez, R; Sahebi, F; Schriber, J; Senitzer, D; Slovak, M; Smith, D; Snyder, DS; Somlo, G; Spielberger, R; Stein, A | 1 |
| Aschan, J; Larsson, K; Ljungman, P; Remberger, M; Ringdén, O; Winiarski, J | 1 |
| Bardy, P; Doherty, K; Grigg, A; Heatley, S; Hughes, T; Mullighan, C; Schwarer, A; Szabo, F; Szer, J; Tait, B; To, B | 1 |
| Hoyle, C; Kazmi, M; Radia, D; Schey, SA; Streetly, M | 1 |
| Fujioka, T; Ishida, Y; Numaoka, H; Omori, S; Ono, Y | 1 |
| Kojima, S | 1 |
| Bérard, F; Hequet, O; Kaiserlian, D; Nicolas, JF; Saint-Mézard, P; Vocanson, M | 1 |
| Baek, KH; Kang, MI; Kim, CC; Kim, SW; Lee, KW; Lee, WY; Oh, ES; Oh, KW; Rhee, EJ; Tae, HJ | 1 |
| Mackinnon, S; Peggs, KS | 1 |
| Hamaki, T; Hayashi, T; Kami, M; Kanemaru, M; Kim, SW; Kishi, Y; Kobayashi, K; Kusumi, E; Masuo, S; Miyakoshi, S; Mori, S; Morinaga, S; Murashige, N; Muto, Y; Takaue, Y; Taniguchi, S; Ueyama, J; Yuji, K | 1 |
| Hirokawa, M; Miura, I; Sawada, K | 1 |
| Liang, TB; Lu, AW; Meng, XQ; Shen, Y; Tang, XF; Wang, WL; Zhang, M; Zheng, SS | 1 |
| Baron, ED; Camouse, MM; Coyle, TS; Nam, TK; Stevens, SR | 1 |
| Atsuta, Y; Emi, N; Hamajima, N; Hirabayashi, N; Hiraoka, A; Iwato, K; Kanda, Y; Kato, S; Naoe, T; Okamoto, S; Sakamaki, H; Takahashi, S; Tanimoto, M; Tanosaki, R; Yanada, M | 1 |
| Hamaki, T; Hayashi, T; Ikeda, M; Kami, M; Kanemaru, M; Katayama, Y; Kato, D; Kim, SW; Kishi, Y; Kobayashi, K; Kusumi, E; Matsumura, T; Miyakoshi, S; Mori, S; Morinaga, S; Murashige, N; Takaue, Y; Taniguchi, S; Yuji, K | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, J; Ghetie, V; Gooley, T; Hansen, JA; Martin, PJ; Nash, RA; Pei, J; Petersdorf, EW; Schindler, J; Storb, R; Vitetta, ES | 1 |
| Bilger, K; Blaise, D; Coso, D; de Lavallade, H; Faucher, C; Gastaut, JA; Gravis, G; Mohty, M; Stoppa, AM; Vey, N; Viens, P | 1 |
| Berlanga, JJ; Ferrá, C; Gallardo, D; Grañena, A; Martín-Henao, G; Rodríguez-Luaces, M | 1 |
| Andresen, S; Bolwell, B; Kalaycio, M; Kuczkowski, E; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| Figlin, R; Malone, R; Schiller, GJ | 1 |
| Herzog, H; Stroszczynski, C; Zuber, J | 1 |
| Arnold, R; Dörken, B; Heine, F; Le Coutre, P; Massenkeil, G; Nagy, M; Rosen, O | 1 |
| Koyama, M; Kunisaki, Y; Matsue, K; Matsuoka, K; Takeuchi, M | 1 |
| Chen, H; Chen, YH; Dong, LJ; Han, W; Huang, XJ; Jiang, Q; Liu, DH; Liu, KY; Lu, DP; Lu, J; Ren, HY; Wang, JB; Wu, T; Xu, LP | 1 |
| Childs, RW; Leppert, MF; Otterud, BE; Riddell, SR; Sandmaier, BM; Storb, R; Thompson, JA; Tykodi, SS; Warren, EH | 1 |
| Chen, PM; Hsiao, LT; Lin, PC | 1 |
| Bungay, PM; Csaky, KG; de Monasterio, F; Dunn, JP; Gilger, BC; Kim, H; Lee, SS; Lutz, RJ; Robinson, MR; Tansey, G; Tremblay, M; Yuan, P | 1 |
| Choi, SJ; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Ryu, SG; Seol, M | 1 |
| Bogunia-Kubik, K; Lange, A; Mlynarczewska, A; Wysoczanska, B | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Homma, CI; Hori, A; Kami, M; Katori, H; Kim, SW; Kishi, Y; Kojima, R; Kusumi, E; Masuo, S; Mitamura, T; Murashige, N; Sakiyama, M; Takaue, Y; Takeuchi, K | 1 |
| Du, B; Li, DP; Pan, XY; Xu, KL | 1 |
| Hamaki, T; Kami, M; Kishi, Y; Miyakoshi, S; Murashige, N; Shibagaki, Y; Takaue, Y; Taniguchi, S | 1 |
| Balon, J; Bieniaszewska, M; Bieniaszewski, L; Hałaburda, K; Hellmann, A; Pawłowski, R; Piekarska, A; Reichert, M | 1 |
| Fenk, R; Germing, U; Graef, T; Haas, R; Hinke, A; Kobbe, G; Neumann, F; Steidl, U; Tapprich, C; Vaupel, M | 1 |
| Ashouri, A; Bahar, B; Eghbal, L; Ghavamzadeh, A; Gholibeikian, S; Iravani, M; Mousavi, A; Samiee, S | 1 |
| Reiter, A; Schrappe, M; Schrauder, A; Sykora, KW; Teuffel, O; Welte, K; Zimmermann, M | 1 |
| Filipovich, AH; Gadner, H; Henter, JI; Horne, A; Imashuku, S; Janka, G; Ladisch, S; Locatelli, F; Maarten Egeler, R; Montgomery, SM; Webb, D; Winiarski, J | 1 |
| Cesaro, S; D'Amore, E; Gazzola, MV; Messina, C; Pillon, M; Putti, MC; Rosolen, A; Scarzello, G; Visintin, G; Zanesco, L | 1 |
| Chuhjo, T; Shiobara, S | 1 |
| Anasetti, C; Appelbaum, FR; Blume, KG; Deeg, HJ; Forman, SJ; Furlong, T; Johnston, L; Kiem, HP; Lloid, ME; Martin, PJ; McCune, JS; Nash, RA; Parker, P; Schubert, MM; Slattery, JT; Storb, R; Storer, B; Witherspoon, RP | 1 |
| Deeg, HJ; Leisenring, W; Martin, PJ; Sorror, ML; Storb, R | 2 |
| Hori, A; Kami, M; Kojima, R; Murashige, N; Ohnishi, M; Takaue, Y | 1 |
| Brunet, S; Caballero, MD; Carreras, E; de León, A; del Cañizo, MC; Díez-Campelo, M; López-Fidalgo, J; Martino, R; Pérez-Simón, JA; San Miguel, JF; Sierra, J; Urbano, A; Valcárcel, D | 1 |
| Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE | 1 |
| Adam, RL; Alborghetti, MR; Cintra, ML; Coracin, FL; Corrêa, ME; de Souza, CA; Metze, K | 1 |
| Chauncey, TR; Deeg, HJ; Flowers, ME; Kahl, C; Leisenring, W; Martin, PJ; Sanders, JE; Storb, R | 1 |
| Kujawa, A; Rózycki, R | 1 |
| Ai, HS; Bian, L; Fan, CB; Guo, M; Hu, KX; Huang, YJ; Liu, LH; Sun, QY; Xiao, XB; Yao, B; Yu, CL | 1 |
| Ai, HS; Li, X; Mao, N; Sun, WJ; Yuan, Y | 1 |
| Bartynski, WS; Lister, J; Shadduck, RK; Zeigler, ZR | 1 |
| Han, SB; Kang, JS; Kim, HM; Kim, YK; Lee, CW; Lee, K; Lee, KH; Park, SK; Yoon, WK; Yoon, YD | 1 |
| Brazzola, P; Champagne, J; Champagne, MA; Dalle, JH; Duval, M; Fournet, JC; Gauvin, F | 1 |
| Fischer, G; Fritsch, G; Gadner, H; Lawitschka, A; Lion, T; Matthes-Martin, S; Peters, C; Pötschger, U; Rosenmayr, A; Seidel, MG | 1 |
| Bader, P; Boppana, S; Dormann, S; Fisch, P; Goebel, H; Jung, A; Kontny, U; Niemeyer, C; Peters, A; Strahm, B; Werner, M | 1 |
| Aisa, Y; Ikeda, Y; Mori, T; Nakazato, T; Okamoto, S; Shimizu, T; Yamazaki, R | 1 |
| Aplenc, R; Bunin, N; Grupp, S; Monos, D; Pierson, G | 1 |
| Ahmed, P; Altaf, C; Anwar, M; Hashmi, K; Hussain, I; Iqbal, H; Kamal, K; Khan, B; Khan, MA; Malik, HS; Naeem, M; Raza, S | 1 |
| Hashmi, K | 1 |
| Barker, JN; Green, K; Jacobson, P; Long, J; McGlave, P; Ng, J; Remmel, R; Rogosheske, J; Sawchuk, R; Tan, Y; Weisdorf, D | 1 |
| Cometa, A; Comoli, P; Frassoni, F; Locatelli, F; Maccario, R; Montagna, D; Moretta, A; Podestà, M | 1 |
| Agura, E; Al-Ali, H; Bruno, B; Chauncey, T; Cordonnier, C; Gratwohl, A; Greinix, H; Hegenbart, U; Lange, T; Maloney, D; Maris, MB; Maziarz, RT; McSweeney, P; Niederwieser, D; Petersen, F; Rio, B; Sandmaier, BM; Shizuru, JA; Storb, R; Storer, B | 1 |
| Kiss, JE; Qu, L | 1 |
| Bélanger, R; Busque, L; Chamakhi, I; Dhédin, N; Ducruet, T; Fish, D; Perreault, C; Roy, DC; Roy, J; Sauvageau, G | 1 |
| Fujimori, Y; Hara, H; Itoi, H; Itsukuma, T; Kai, S; Misawa, M; Nakajima, T; Nishioka, K; Nomura, K; Ogawa, H; Okada, M; Takatsuka, H; Toda, A; Wakae, T | 1 |
| Eguchi, M; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Okuya, M; Sato, Y; Shimaoka, H; Sugita, K; Tsuboi, T | 1 |
| Chim, CS; Ooi, GC | 1 |
| Cantú-Rodríguez, OG; Gómez-Almaguer, D; Gómez-Rangel, JD; Gutiérrez-Aguirre, CH; Jaime-Pérez, JC; Rivas-Vera, S; Ruiz-Argüelles, GJ; Sobrevilla-Calvo, P; Vela-Ojeda, J | 1 |
| Hara, M; Kozuka, T; Maeda, Y; Nakase, K; Nawa, Y; Tanimoto, K | 1 |
| Agura, E; Blume, KG; Bruno, B; Chauncey, TR; Kliem, C; Langston, AA; Maloney, DG; Maris, MB; Maziarz, RT; McSweeney, PA; Pulsipher, M; Sandmaier, BM; Shizuru, JA; Storb, R; Storer, BE; Wade, J | 1 |
| Bradstock, KF; Gottlieb, D; Grigg, A; Hertzberg, M; Hoyt, R; Huang, G; Roberts, A; Szer, J | 1 |
| Baron, F; Bruno, B; Burroughs, L; Chauncey, TR; Flowers, ME; Forman, SJ; Leisenring, W; Maloney, DG; Martin, PJ; Mielcarek, M; Sandmaier, BM; Storb, R | 1 |
| Chi-Burris, K; Chu, AH; David, KM; Meier-Kriesche, HU; Steffen, BJ | 1 |
| Kupatawintu, P; O-Charoen, R; Seksarn, P; Vanichsetakul, P | 1 |
| Hess, AD; Thoburn, CJ | 1 |
| Alessandrino, PE; Bacigalupo, A; Barisione, G; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; van Lint, MT | 1 |
| Fujimi, A; Iyama, S; Kawanishi, J; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Sato, T; Takada, K; Takimoto, R | 1 |
| Fang, J; Guo, T; Jiang, H; Liu, F; Xia, L; You, Y; Zhang, C; Zou, P | 1 |
| Choi, JS; Chung, SJ; Koo, HH; Lee, SH; Sung, KW; Yoo, KH | 1 |
| Atanackovic, D; Ayuk, F; Kröger, N; Renges, H; Schieder, H; Zabelina, T; Zander, A | 1 |
| Chapman, JR; Nankivell, BJ | 1 |
| Furst, DE; Georges, GE; Henstorf, G; Langston, AA; Lee, J; McSweeney, PA; Nash, RA; Nelson, JL; Shulman, H; Storb, R; Sullivan, KM; Wener, M | 1 |
| Antonenas, V; Bradstock, KF; Gottlieb, DJ; Hertzberg, MS; Huang, G; Kerridge, IH; McGurgan, M; Svennilson, J | 1 |
| Le Blanc, K; Ringdén, O | 1 |
| Craddock, C; Duncan, N | 1 |
| Agarwal, R; Callard, E; Dvorak, CC | 1 |
| Aoyama, K; Fujii, N; Hiraki, A; Ikeda, K; Ishimaru, F; Kondo, E; Koyama, M; Masunari, T; Matsuzaki, T; Mizobuchi, S; Shinagawa, K; Tanimoto, M; Teshima, T | 1 |
| Blanche, S; Casanova, JL; Cavazzana-Calvo, M; Fischer, A; Le Deist, F; Neven, B; Ouachée-Chardin, M; Picard, C; Renella, R | 1 |
| Bambach, B; Benekli, M; Cooper, M; Hahn, T; McCarthy, PL; Roy, HN; Stewart, C; Wallace, P; Williams, BT | 1 |
| Iida, H; Kitaori, K; Kohno, A; Matsuo, K; Morishita, Y; Ozeki, K; Sakamaki, H; Sao, H; Yokozawa, T | 1 |
| Fujimaki, K; Hyo, R; Kanda, Y; Kurakawa, M; Maruta, A; Mori, T; Okamoto, S; Onoda, M; Oshima, K; Sakai, M; Sakamaki, H; Sakura, T; Taguchi, J; Tanaka, M; Yamashita, T | 1 |
| Fujii, H; Goto, H; Ikuta, K; Isaki, S; Kajiwara, R; Kuroki, F; Takahashi, H; Yanagimachi, M; Yokota, S | 1 |
| Jiang, XF; Sheng, BJ | 1 |
| Chen, SN; Fu, ZZ; Han, Y; He, GS; Jin, ZM; Ma, X; Miao, M; Qiu, HY; Sun, AN; Tang, XW; Wang, Y; Wu, DP; Xue, SL; Zhao, Y | 1 |
| Fujiwara, S; Kawano-Yamamoto, C; Kikuchi, S; Matsuyama, T; Meguro, A; Miyoshi, T; Mori, M; Muroi, K; Nagai, T; Nagashima, T; Obara, Y; Oh, I; Ohmine, K; Ozaki, K; Ozawa, K; Sato, K; Takatoku, M; Tatara, R; Toshima, M | 1 |
| Blijlevens, NM; Burger, DM; Donnelly, JP; Hendriks, MP; Schattenberg, AV | 1 |
| Bolderson, I; Clark, B; Cook, G; Gooi, HC; Kinsey, S; Stephens, E | 1 |
| Barkholt, L; Hassan, Z; Mattsson, J; Omazic, B; Remberger, M; Ringdén, O; Sairafi, D; Uzunel, M | 1 |
| Formánková, R; Hubácek, P; Keslová, P; Król, L; Kulich, M; Sedlácek, P; Srámková, L; Starý, J | 1 |
| Akiyama, H; Kamata, N; Kisida, S; Ohashi, K; Ohta, K; Sakai, M; Sakamaki, H; Yamashita, T | 1 |
| Farjo, QA; Gupta, A; Lelli, GJ; Mian, SI; Musch, DC; Nairus, TM | 1 |
| Rao, RD; Rao, SN | 1 |
| Altuntas, F; Cetin, M; Eser, B; Fen, T; Ferahbas, A; Kocyigit, I; Ozturk, A; Sari, I; Sisman, Y; Unal, A | 1 |
| Hamaguchi, M; Iida, H; Kohno, A; Matsuo, K; Miyamura, K; Morishita, Y; Murata, M; Narimatsu, H; Oba, T; Sawa, M; Terakura, S; Uchida, T; Watanabe, M | 1 |
| Arce, JA; Bollard, CM; Brenner, MK; Carrum, G; Gottschalk, S; Heslop, HE; Kennedy-Nasser, AA; Khan, SP; Krance, RA; Leung, KS; Mahajan, A; Weiss, HL | 1 |
| Doyle, J; Somech, R | 1 |
| Hayashi, N; Hino, M; Kanashima, H; Koh, H; Koh, KR; Mochizuki, K; Nakamae, H; Nakamae, M; Nakane, T; Sakamoto, E; Takeoka, Y; Yamane, T | 1 |
| Buzyn, A; Combe, C; Delmas, Y; Fakhouri, F; Glowacki, F; Hummel, A; Knebelmann, B; Lesavre, P; Maillard, N; Noël, LH; Nusbaum, S; Patey-Mariaud de Serre, N; Presne, C; Radford, I; Terrier, B | 1 |
| Kinjo, S; Nagasaki, A; Nakachi, S; Takasu, N; Yamanoha, A | 1 |
| Boon, L; Coenen, JJ; Hilbrands, LB; Joosten, I; Kasran, A; Koenen, HJ; van Rijssen, E | 1 |
| Altmaier, EM; Carter, S; Davies, SM; Henslee-Downey, J; Hochhausen, N; McQuellon, R; Papadopolous, E | 1 |
| Jiang, ZX; Liu, LX; Sun, H; Sun, L; Wan, DM; Xie, XS | 1 |
| Goto, H; Kajiwara, R; Kuroki, F; Tanoshima, R; Yanagimachi, M; Yokota, S | 1 |
| Holler, E | 1 |
| Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE | 1 |
| Gawlicka, G; Giebel, S; Holowiecki, J; Markiewicz, M; Miszczyk, L; Tomaszewska, R; Wojnar, J; Wyleioł, I | 1 |
| Blazar, BR; Cao, Q; Cornfield, DN; Grzywacz, B; Lee, AB; McCullar, V; Miller, JS; Sukovich, D; Verneris, MR; Wang, H | 1 |
| Bassan, R; Castellino, C; Del Grosso, F; Ferraris, AM; Gallamini, A; Mattei, D; Mordini, N; Peretti, C; Rambaldi, A; Rapezzi, D; Strola, G | 1 |
| Jurgutis, M; Kriukelyte, I; Priluckiene, J; Trociukas, I | 1 |
| Cantú-Rodríguez, OG; Gómez-Almaguer, D; Gonzalez-Llano, O; Gutierrez-Aguirre, CH; Jaime-Pérez, JC; Martinez-González, O; Morales-Toquero, A; Ruiz-Argüelles, GJ; Salazar-Riojas, R; Tarín-Arzaga, LC | 1 |
| Hara, M; Hino, M; Hori, A; Kami, M; Kanda, Y; Kim, SW; Mineishi, S; Mori, S; Ohashi, Y; Saito, AM; Suzuki, R; Takami, A; Takaue, Y; Takemoto, Y; Taniguchi, S; Yamaguchi, M; Yoshida, T | 1 |
| Hamaki, T; Hori, A; Kami, M; Kanda, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Tanaka, Y; Taniguchi, S; Uchida, N; Wake, A; Yuji, K | 1 |
| Bahlis, NJ; Balogh, A; Brown, CB; Chaudhry, MA; Geddes, M; Larratt, L; Quinlan, D; Russell, JA; Savoie, ML; Stewart, DA; Storek, J; Turner, AR | 1 |
| Alapat, D; Brandon, JA; Bryson, JS; Caywood, B; Jennings, CD; Kaplan, AM; Perez, J | 1 |
| Lu, DP; Yan, CH | 1 |
| Bo, J; DA, WM; Gao, CJ; Han, XP; Huang, WR; Jin, HJ; Jing, Y; Li, HH; Wang, SH; Yu, L; Zhang, BL; Zhang, YZ; Zhu, HY | 1 |
| Bolton-Maggs, PH; Caswell, M; Keenan, R; Pizer, B; Thachil, J | 1 |
| Barkholt, L; Bodegård, H; Böttiger, Y; Remberger, M; Ringdén, O | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
| Baron, F; Bethge, W; Chauncey, TR; Lange, T; Langston, AA; Maloney, DG; Maris, MB; Maziarz, RT; McSweeney, PA; Petersdorf, E; Pulsipher, MA; Sandmaier, BM; Shizuru, JA; Sorror, ML; Storb, R; Storer, BE; Wade, JC; Woolfrey, AE | 1 |
| Kami, M; Kato, D; Kishi, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Narimatsu, H; Takagi, S; Taniguchi, S; Tanimoto, T; Uchida, N; Wake, A; Yamaguchi, T; Yuji, K | 1 |
| Bureo, E; Diaz de Heredia, C; Gonzalez-Vicent, M; Maldonado, MS; Martinez, A; Muñoz, A; Olivé, T; Sastre, A | 1 |
| Remberger, M; Ringdén, O | 1 |
| Abe, T; Aizawa, Y; Furukawa, T; Izumi, N; Kurasaki, T; Masuko, M; Okazuka, K; Sato, N; Takahashi, M; Toba, K; Tsukada, N; Yano, T | 1 |
| Alvarez, I; Arranz, R; Caballero, D; Canales, M; Cavet, J; Garcia-Conde, J; Goldstone, AH; Hunter, A; Linch, DC; Mackinnon, S; Mahendra, P; Milligan, D; Parker, A; Peggs, KS; Qian, W; Ribera, JM; Sanz, G; Sierra, J; Sureda, A; Thomson, K; Urbano-Ispizua, A | 1 |
| Arai, S; Asai, T; Chiba, S; Hangaishi, A; Hosoya, N; Izutsu, K; Kanda, Y; Kurokawa, M; Motokura, T; Nakasone, H; Nishimoto, N; Oshima, K; Sato, H; Watanabe, T | 1 |
| Alonso, A; Arias, M; González Molina, M; Sánchez-Plumed, JA | 1 |
| Dogru, M; Fujishima, H; Igarashi, A; Kawai, M; Kujira, A; Ogawa, Y; Okada, N; Okamoto, S; Shimazaki, J; Tatematsu, Y; Tsubota, K; Uchino, M; Wang, Y | 1 |
| Cheng, PJ; Hsiao, SS; Kuo, ML; Lin, SJ | 1 |
| Carter, SL; Freifeld, AG; Godder, KT; High, KP; Kernan, NA; Mendizabal, AM; Papanicolaou, GA; van Burik, JA; Wagner, JE; Yanovich, S | 1 |
| Kline, J; Lazarus, HM; Subbiah, S; van Besien, K | 1 |
| Choi, G; Hong, W; Kim, YC; Shin, J; Song, H | 1 |
| Das, P; Diezi, M; Doyle, J; Dupuis, LL; Price, V; Punnett, A; Sung, L | 1 |
| Curtis, DJ; Grigg, AP; Hoyt, R; Macgregor, L; Ritchie, DS; Roberts, AW; Szer, J | 1 |
| Boeri, E; Cappelli, B; Cohen, A; Dallorso, S; Dini, G; Faraci, M; Lanino, E; Morreale, G; Scuderi, F | 1 |
| Aghdaie, MH; Azarpira, N; Daraie, M; Geramizadeh, B; Ramzi, M | 1 |
| Bertz, H; Finke, J; Grüllich, C; Müller, CI; Spyridonidis, A | 1 |
| Baron, F; Beguin, Y; Castermans, E; Cheynier, R; Geenen, V; Gothot, A; Herens, C; Meuris, N; Schaaf-Lafontaine, N; Seidel, L; Vanbellighen, JF; Willems, E | 1 |
| Hatakeyama, N; Hori, T; Imai, K; Kokai, Y; Mizue, Y; Naishiro, Y; Sohma, H; Sonoda, T; Suzuki, N; Tsutsumi, H; Yamamoto, M | 1 |
| Chen, H; Chen, Y; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Lu, DP; Shi, HX; Wang, JZ; Wang, Y; Xu, LP; Zhang, XU; Zhang, YC | 1 |
| Alimoghaddam, K; Ashouri, A; Ghaffari, H; Ghavamzadeh, A; Hadjibabaie, M; Iravani, M; Mahdavi, N; Mousavi, SA; Namdar, R; Nedaeifard, L; Shamshiri, A | 1 |
| Fan, ZP; Liu, QF; Luo, XD; Ning, J; Wei, YQ; Xu, D | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Shi, HX; Wang, Y; Xu, LP | 1 |
| Appelbaum, FR; Carpenter, PA; Deeg, HJ; Doney, K; Flowers, ME; Furlong, T; Kiem, HP; Martin, PJ; Mielcarek, M; Nash, RA; Storb, R | 1 |
| Ayuk, F; Bacher, U; Binder, T; Diyachenko, G; Eiermann, T; Erttmann, R; Fehse, B; Kabisch, H; Kröger, N; Panse, J; Wolschke, C; Zabelina, T; Zander, AR | 1 |
| Boos, J; Grigull, L; Hempel, G; Hoy, H; Saleh, S; Schrauder, A; Sykora, KW; Welte, K | 1 |
| Al-Hazzouri, A; Burns, LJ; Cao, Q; Majhail, NS; Weisdorf, DJ | 1 |
| Caballero, D; Calvo, MV; de la Cámara, R; de Oteiza, JP; Heras, I; Martino, R; Pérez-Simón, JA; Rebollo, N; San Miguel, JF; Sierra, J; Valcarcel, D | 1 |
| Burggraaf, J; Cremers, SC; den Hartigh, J; Lankester, AC; Schoemaker, RC; Vossen, JM; Willemze, AJ | 1 |
| Ikawa, Y; Kagaya, T; Koizumi, S; Saikawa, Y | 1 |
| Bordigoni, P; Brion, A; Burdach, S; Cahn, JY; Kolb, HJ; Lioure, B; Michel, G; Milpied, N; Tiberghien, P; Widjenes, J | 1 |
| Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I | 1 |
| Panis, Y; Valleur, P | 1 |
| Blazar, BR; Fitzsimmons, WE; Taylor, PA; Vallera, DA | 1 |
| Bekersky, I; Benedetti, E; Dunn, DL; Fasola, C; Fryer, JP; Gruessner, AC; Gruessner, RW; Kim, S; Nakhleh, RE; Pirenne, J | 1 |
| Grigg, AP; Lickliter, JD; Roberts, AW | 1 |
| Barnett, MJ; Chan, KW; Klingemann, HG; Meharchand, JM; Nantel, SH; Nevill, TJ; Phillips, GL; Shepherd, JD; Spinelli, JJ; Sutherland, HJ | 1 |
| Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J | 1 |
| Bloomer, MM; Colony, PC; Kauffman, GL; Koltun, WA; Ruggiero, FM | 1 |
| Bourinbaiar, AS; Lee-Huang, S | 1 |
| Blume, KG; Chao, N; Forman, SJ; Kashyap, A; Long, GD; Margolin, K; Molina, A; Nademanee, A; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Planas, I; Schmidt, GM; Smith, EP; Snyder, DS; Somlo, G; Spielberger, R; Stein, AS; Stepan, DE; Wilsman, K; Zwingenberger, K | 1 |
| Hemenway, C | 1 |
| Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
| Baruchel, A; Devergie, A; Esperou Bourdeau, H; Hirsch, I; Moussalem, M; Parquet, N; Ribaud, P; Schaison, G; Socie, G; Traineau, R | 1 |
| Bloom, EJ; Przepiorka, D; Rosenfeld, CS; Schwinghammer, TL; Shadduck, RK; Wilson, JW | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Hampl, W; Heimpel, H; Hertenstein, B; Koszinowski, U; Mertens, T; Wiesneth, M | 1 |
| Brandt, SA; Edwards, JR; Goodman, S; Greer, JP; Leelasiri, A; Stein, RS; Wolff, SN | 1 |
| Pearson, DA; Sykes, M; Szot, GL | 1 |
| Carreras, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Dagis, AC; Molina, A; Nademanee, A; O'Donnell, M; Parker, P; Schmidt, GM; Smith, EP; Snyder, DS; Stein, A; Stepan, DE | 1 |
| Anasetti, C; Beach, K; Deeg, HJ; Doney, KC; Hansen, JA; Martin, PJ; Nash, RA; Schubert, MM; Storb, R; Sullivan, KM | 1 |
| Colombani, P; Hess, AD; Horwitz, L; Ruvolo, P; Zhang, H | 1 |
| Betker, R; Hoffknecht, M; Horstmann, M; Kabisch, H; Krüger, W; Stockschläder, M; Zander, A | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Heimpel, H; Heit, W; Hertenstein, B; Novotny, J; Stefanic, M; Wiesneth, M | 1 |
| Hardy, MA; James, T; Ohajekwe, OA; Oluwole, SF | 1 |
| Ash, RC; Auerbach, AD; Bortin, MM; Butturini, A; Camitta, BM; Champlin, RE; Friedrich, W; Gale, RP; Gluckman, E; Good, RA; Gordon-Smith, EC; Harris, RE; Horowitz, MM; Klein, JP; Ortega, JJ; Pasquini, R; Ramsay, NK; Sobocinski, KA; Speck, B; Vowels, MR; Zhang, MJ | 1 |
| De Witte, T; Dompeling, EC; Schattenberg, A; Swaak, AJ; Vreugdenhil, G | 1 |
| Morris, LE; Vogelsang, GB | 1 |
| Fuchs, E; Hess, AD; Horwitz, LR; Laulis, MK | 1 |
| Baelde, HJ; Bergijk, EC; Bruijn, JA; de Heer, E | 1 |
| Beschorner, WE; Bright, EC; Burt, R; Fischer, AC; Hess, AD; Hess, JM; Horwitz, LR; Ruvolo, PP | 1 |
| Blaise, D; Leblond, V; Maraninchi, D; Marit, G; Michallet, M; Olive, D | 1 |
| Borel, JF; Feurer, C; Gubler, HU; Stähelin, H | 1 |
| Baxter-Lowe, LA; Bunin, N; Camitta, B; Casper, J; Garbrecht, F; Hunter, J; Lawton, C; Murray, K; Pietryga, D; Truitt, R | 1 |
| Eibl, B; Nachbaur, D; Niederwieser, D | 1 |
| Lee, L; Maxymiw, WG; Messner, HA; Miller, PA; Rotstein, LE | 1 |
| Clark, RE; Pettitt, AR | 1 |
| Bellazzi, R; Quaglini, S | 1 |
| Benedetti, E; Dunn, DL; Fryer, J; Gruessner, RW; Hakim, NS; Kim, S; Médot, M; Najarian, JS; Pirenne, J; Williams, JG | 1 |
| Bright, E; Fischer, A; Hess, A; Jones, R; Kennedy, MJ; Morris, L; Ruvolo, P; Vogelsang, G | 1 |
| Hardy, MA; Ohajekwe, OA; Oluwole, SF | 1 |
| Gratwohl, A; Marbet, GA; Speck, B; Tichelli, A; Tsakiris, DA | 1 |
| He, X; Liu, T; Wang, P; Zhu, L; Zhu, W | 1 |
| Bassetti, D; Ferrea, G; Fioredda, F; Loy, A; Mangraviti, S; Rossi, G | 1 |
| Fujita, S; Hato, T; Ishii, Y; Shinozaki, F; Shiobara, S; Takada, K; Takamatsu, H; Tamai, T; Yasukawa, M; Yoshizaki, K | 1 |
| Chan, TK; Chiu, EK; Yuen, P | 1 |
| Fullard, L; Hale, G; Jacobs, P; Waldmann, H; Wood, L | 1 |
| Abla, O; Arcese, W; Boni, L; Di Bartolomeo, P; Dini, G; Iori, AP; Locatelli, F; Polchi, P; Rossetti, F; Uderzo, C | 1 |
| Adams, GB; Jamal, N; Lipton, JH; Messner, HA | 1 |
| Biffi, R; DeFranchis, R; Faccioli, AM; Fagiuoli, S; Fassina, A; Frezza, EE; Gerunda, GE; Gurakar, A; Van Thiel, DH | 1 |
| Aschan, J; Lönnqvist, B; Lungman, P; Markling, L; Remberger, M; Ringdén, O | 1 |
| Demetris, AJ; Fontes, P; Murase, N; Rao, AS; Starzl, TE; Thomson, AW; Trucco, M; Zeevi, A | 1 |
| Antin, JH; Bierer, BE; Fruman, DA; Leong, T; McGarigle, C; Neuberg, D; Pai, SY; Rosano, TG | 1 |
| Gondo, H; Harada, M; Nakamura, M; Niho, Y; Okamura, S; Otsuka, T; Sano, T; Shimoda, K | 1 |
| Andström, E; Aschan, J; Ljungman, P; Lönnqvist, B; Remberger, M; Ringdén, O | 1 |
| Bulengo-Ransby, SM; Maize, JC; Metcalf, JS; Sahn, EE | 1 |
| Beelen, DW; Liedtke, W; Quabeck, K; Schaefer, UW; Straeten, V | 1 |
| Higa, T; Kasai, M; Kiyama, Y; Masauzi, N; Matsuura, A; Morii, K; Naohara, T; Ohizumi, H; Tanaka, J; Watanabe, M | 1 |
| Jones, AR; Poon, MC; Ruether, BA; Russell, JA; Woodman, RC | 1 |
| Habertheuer, KH; Hinterberger-Fischer, M; Kalhs, P; Kier, P; Lechner, K; Ruckser, R; Schmid, A; Sebesta, C; Spona, J; Tiefengraber, E | 1 |
| Catovsky, D; Horton, C; Mehta, J; Milan, S; Powles, R; Tait, D; Treleaven, J | 1 |
| Epstein, JB; Reece, DE | 1 |
| D'Alessandro, AM; Rankin, MA | 1 |
| Boström, L; Hägglund, H; Nilsson, B; Remberger, M; Ringdén, O | 1 |
| Andström, E; Aschan, J; Ljungman, P; Remberger, M; Ringdén, O | 1 |
| Aschan, J; Ljungman, P; Lönnqvist, B; Markling, L; Remberger, M; Ringden, O | 1 |
| Hale, G; Waldmann, H | 1 |
| Abella, E; Dan, ME; Hussein, M; Karanes, C; Lum, LG; Ratanatharathorn, V; Sensenbrenner, LL; Uberti, J | 1 |
| Aschan, J; Ringdén, O | 1 |
| Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H | 1 |
| Chandanayingyong, D; Issaragrisil, S; Piankijagum, A; Suvatte, V; Visuthisakchai, S | 1 |
| Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
| DeLaat, C; Desantes, K; Friedman, DJ; Kohli-Kumar, M; Masterson, M; Morris, C; Mueller, R; Sambrano, J; Shahidi, NT; Yanik, G | 1 |
| Huss, R | 1 |
| Johnsson, C; Tufveson, G | 1 |
| Bryson, JS; Caywood, BE; Jennings, CD; Kaplan, AM | 1 |
| Berkman, E; Comenzo, R; Erban, JK; Fogaren, T; Hirsch, CA; Miller, KB; Rabson, A; Schenkein, DP | 1 |
| Altomonte, V; Davidson, NE; Farmer, ER; Hess, AD; Huelskamp, AM; Jones, RJ; Kennedy, MJ; Vogelsang, GB | 1 |
| Gratwohl, A; Nissen, C; Speck, B; Stebler, C; Tichelli, A | 1 |
| Hess, AD; Jones, RC; Santos, GW | 1 |
| Majoor, GD; Van Breda Vriesman, PJ; Wodzig, KW | 1 |
| Andolina, M; Arcese, W; Dini, G; Locatelli, F; Messina, C; Miniero, R; Porta, F; Rovelli, A; Uderzo, C; Zecca, M | 1 |
| Cooley, MA; Donnellan, M; Farrell, C; Fussell, ST | 1 |
| Anasetti, C; Appelbaum, F; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Hansen, J; Leisenring, W; Storb, R | 1 |
| Coleman, DN; Dan, ME; LeVeque, FG; Orville, B; Ratanatharathorn, V; Turner, S | 1 |
| Euchenhofer, B; Fauser, AA; Finke, J; Heinz, J; Mertelsmann, R; Schreiner, T; Zeller, C | 1 |
| Fitzsimmons, WE; Ghalie, R; Kaizer, H; Manson, S; Weinstein, A | 1 |
| Bacigalupo, A; Clavio, M; Fagioli, F; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Sogno, G; Van Lint, MT; Vitale, V | 1 |
| Fujita, H; Hashimoto, Y; Hataoka, K; Kanamori, H; Maeda, K; Ohtsuka, M; Okamoto, R; Tamura, T; Tanabe, J; Yamazaki, E | 1 |
| Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M | 1 |
| Bright, EC; Fischer, AC; Hess, AD; Horwitz, L; Laulis, MK | 1 |
| Fischer, AC; Hess, AD; Horwitz, LR; Laulis, MK | 1 |
| Kumar, L | 1 |
| Anasetti, C; Bianco, JA; Hasen, J; Nemunaitis, J; Singer, JW | 1 |
| Blazar, BR; Sehgal, SN; Snover, DC; Taylor, PA; Vallera, DA | 1 |
| Parkman, R | 1 |
| Bloom, EJ; Schwinghammer, TL | 1 |
| Farmer, ER; Hess, AD; Jones, RJ; Santos, GW; Vogelsang, GB; Yeager, AM | 1 |
| Kennedy, MJ | 1 |
| Buser, U; Gengenbacher, D; Gimmi, C; Gratwohl, A; Haberthür, C; Passweg, J; Pless, M; Signer, E; Stauffer, G; Tichelli, A | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Arcese, W; Bandini, G; Bosi, A; Carreras, E; Frassoni, F; Gahrton, G; Gratwohl, A; Hermans, J; Niederwieser, D; Vernant, JP | 1 |
| Blazar, B; Filipovich, A; Kersey, J; McGlave, P; Miller, W; Ramsay, N; Weisdorf, D | 1 |
| Davis, SK; Ninno, MA | 1 |
| Goldschneider, I; Zadeh, HH | 1 |
| Aschan, J; Klaesson, S; Ljungman, P; Lönnqvist, B; Ringdén, O; Sundberg, B | 1 |
| Bafundi, P; Chan, CK; Fyles, G; Hyland, RH; Messner, H; Payne, L; Yeung, M | 1 |
| Ambinder, R; Burns, WH; Carroll, MP; Griffin, CA; Jones, RJ; May, WS; Mellits, ED; Miller, CB; Sensenbrenner, LL; Vogelsang, GB | 1 |
| Bucy, RP; Huang, G; Li, J; Xu, XY | 1 |
| Bungey, J; Cross, NC; Feng, L; Ferrant, A; Goldman, JM; Hughes, TP; Marks, DI; Martiat, P; O'Shea, P | 1 |
| Chen, RL; Lin, DT; Lin, KH; Lin, KS; Lui, LT | 1 |
| Bader, A; Christians, U; Linck, A; Link, H; Schottmann, R; Sewing, KF; Spiekermann, K; Wonigeit, K | 1 |
| Buckley, JD; Feig, SA; Hammond, GD; Kim, T; Lampkin, B; Nesbit, ME; Versteeg, CM; Woods, WG | 1 |
| Dörries, K; Schneider, EM | 1 |
| Appelbaum, FR; Bakke, L; Bensinger, WI; Bianco, JA; Bowden, RA; Buckner, CD; Clift, RA; McDonald, GB; Schubert, M; Singer, JW | 1 |
| Jones, RJ; Kennedy, MJ | 1 |
| Amylon, MD; Chao, NJ; Dagis, AC; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Schmidt, GM | 1 |
| Ford, D; Lam-Po-Tang, R; Shing, MM; Trickett, AE; Vowels, MR | 1 |
| Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
| Biggs, JC; Champlin, RE; Deeg, HJ; Dicke, K; Gale, RP; Horowitz, MM; Masaoka, T; Powles, RL; Ringdén, O; Sondel, P | 1 |
| Greenstein, SM; Schechner, RS; Senitzer, D; Sun, SC; Tellis, VA | 1 |
| Hess, AD; Horwitz, LR; Laulis, MK; Severino, ME | 1 |
| Hess, AD; Vogelsang, GB | 1 |
| Hess, AD; Horwitz, LR; Laulis, MK | 1 |
| Anasetti, C; Choo, SY; Hansen, JA; Longton, GM; Martin, PJ; Mickelson, EM; Petersdorf, EW; Smith, AG | 1 |
| Ringdén, O | 2 |
| Aurer, I; Bogdanić, V; Kovacević-Metelko, J; Labar, B; Maravić, N; Mrsić, M; Nemet, D; Radman, I; Zupancić-Salek, S | 1 |
| Altomonte, V; Beveridge, RA; Davidson, NE; Farmer, ER; Huelskamp, AM; Kennedy, MJ; Vogelsang, GB | 1 |
| Akpolat, T; Arik, N; Arinsoy, T; Ataman, M; Caglar, S; Sungur, C; Turgan, C; Yasavul, U | 1 |
| Alessandrino, EP; Aversa, F; Calori, E; Dini, G; Garbarino, L; Lamparelli, T; Lanino, E; Locatelli, F; Marenco, P; Medugno, D | 1 |
| Appleton, AL; Eastham, EJ; Green, MA; Malcolm, AJ; Pearson, AD; Sviland, L | 1 |
| Aotuka, N; Asai, T; Hashimoto, S; Hirasawa, A; Ishii, G; Kawano, E; Morio, S; Nakamura, H; Oh, H; Yoshida, S | 1 |
| de Bruin, RW; Heineman, E; Jeekel, J; Marquet, RL; Saat, RE | 1 |
| Belanger, C; Bordigoni, P; Esperou-Bourdeau, H; Herve, P; Jouet, JP; Kuentz, M; Milpied, N; Reiffers, J; Souillet, G; Troussard, X | 1 |
| Kohno, M; Matsuyama, R; Ohomoto, A | 1 |
| Hunter, A; Rogers, S; Russell, N | 1 |
| Ezaki, K; Hirano, M; Kojima, H; Maruyama, F; Tsuzuki, M | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Hess, AD; Jones, RJ; Kennedy, MJ; Ruvolo, PP; Vogelsang, GB | 1 |
| Brugger, SA; Dieckmann, KU; Fischer, G; Geissler, K; Greinix, HT; Haas, O; Hinterberger, W; Hocker, P; Jager, U; Kalhs, P; Keil, F; Lechner, K; Linkesch, W; Mannhalter, C; Reiter, E; Schneider, B; Schwarzinger, I | 1 |
| Arseniev, L; Diedrich, H; Link, H | 1 |
| Bernaud, J; Garin, L; Mérieux, Y; Philippe, N; Rigal, D; Souillet, G | 1 |
| Altomonte, V; Horn, TD; Kennedy, MJ; Vogelsang, G | 1 |
| Chou, TC; Kahan, BD; Qu, X; Stepkowski, SM; Wang, M | 1 |
| Edwards, LL; Normand, MM; Wszolek, ZK | 1 |
| Blazar, BR; Panoskaltsis-Mortari, A; Sehgal, S; Taylor, PA; Vallera, DA | 1 |
| Aker, M; Kapelushnik, J; Nagler, A; Or, R; Shapira, J | 1 |
| Issaragrisil, S; Piankijakum, A; Suvatte, V; Tang-naitrisorana, Y; Visuthisakchai, S | 1 |
| Okumura, H; Takamatsu, H; Yoshida, T | 1 |
| Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H | 1 |
| Cremer, PD; Forsyth, CJ; Iland, HJ; Torzillo, P; Young, GA | 1 |
| Hardy, MA; Oluwole, SF; Yaron, I; Yaron, R | 1 |
| Asaka, M; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Noto, S; Sakurada, K; Tanaka, J | 1 |
| Benedetti, E; Fryer, JP; Gruessner, A; Gruessner, RW; Hakim, N; Moon, C; Nakhleh, RE; Pirenne, J; Troppmann, C | 1 |
| Akard, LP; Burns, S; Chang, Q; English, D; Garrett, P; Hanks, S; Jansen, J; Thompson, JM | 1 |
| Aker, SN; Bruemmer, B; Chesnut, CH; Lenssen, PS; Sanders, J; Stern, JM; Sullivan, KM | 1 |
| Bacigalupo, A; Brinch, L; Cook, G; Domingo-Albos, A; Finke, J; Garcia-Conde, J; Gratwohl, A; Labopin, M; Lambertenghi-Deliliers, G; Lange, A; Laporte, JP; Majolino, I; Rozman, C; Schmitz, N | 1 |
| Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
| Asaka, M; Hashino, S; Higa, T; Imamura, M; Kasai, M; Tanaka, J | 1 |
| Beebe, D; Fasola, C; Fryer, J; Gruessner, AC; Gruessner, RW; Kim, S; Moon, C; Najarian, JS; Nakhleh, RE; Troppmann, C | 1 |
| Cruz, OA; Fogg, SG; Roper-Hall, G | 1 |
| Beams, F; Gilman, AL; Mazumder, A; Tefft, M | 1 |
| Abhyankar, SH; Gee, AP; Godder, KT; Henslee-Downey, PJ; Pati, AR | 1 |
| Alegre, A; Benet, I; Besalduch, J; Brunet, S; Carreras, E; de la Rubia, J; Díaz, MA; Domingo-Albós, A; García-Conde, J; Hernández, F; Moraleda, JM; Ojeda, E; Petit, J; Rozman, C; Sanz, G; Solano, C; Urbano-Ispizua, A; Vivancos, P | 1 |
| Goulmy, E; Liem, LM; van Noort, JT | 1 |
| Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Maiello, A; Polchi, P | 1 |
| Hamai, K; Imai, H; Komatsuda, A; Miura, AB; Nakamoto, Y; Ohtani, H; Oyama, Y; Wakui, H | 1 |
| Ahmed, T; Beer, M; Easaw, SJ; Feldman, EJ; Lake, DE; Seiter, K | 1 |
| Bader, S; Nelson, D; Schultz, KR | 1 |
| Abboud, MR; Barredo, JC; Hahn, A; Laver, J; Yusuf, U | 1 |
| Eisen, T; Horton, C; Mehta, J; Meller, S; Middleton, G; Pinkerton, CR; Powles, R; Singhal, S; Tait, D; Treleaven, J | 1 |
| Bernis, C; Fernández-Rañada, JM; Gruss, E; Rodriguez, F; Tomás, JF; Traver, JA | 1 |
| Kelley, SE; Squiers, EC | 1 |
| Bacigalupo, A; Fiere, D; Frassoni, F; Gluckman, E; Gorin, NC; Harrousseau, JL; Jouet, JP; Labopin, M; Reiffers, J; Ringdén, O; Vernant, JP | 1 |
| Epstein, JB; Truelove, EL | 1 |
| Appelbaum, FR; Bensinger, WI; Benyunes, M; Buckner, CD; Clift, R; Demirer, T; Lee, M; Martin, P; Rowley, S; Schiller, G; Shannon-Dorcy, K; Storb, R | 1 |
| Blay, JY; Bonnotte, B; Bourhis, JH; Burdiles, AM; Caignard, A; Carayol, G; Chehimi, J; Chouaib, S; Dietrich, PY; Hayat, M; Ibrahim, A; Kubin, M; Pardoux, C; Pico, JL; Robinet, E | 1 |
| Ali, II; Egan, TM; Lackner, RP; Messenheimer, JA; Olivier, KN; Paradowski, LJ; Robertson, KR; Vaughn, BV | 1 |
| Beijleveld, LJ; Damoiseaux, JG; Roglic, M; Theofilopoulos, AN; van Breda Vriesman, PJ | 1 |
| Alonso, E; Banda, ED; Berlanga, JJ; Espanñol, I; Ferrà, C; Gallardo, D; Grañena, A; Ponce, C; Riu, C; Salar, A | 1 |
| Johnson, FL | 1 |
| Chiba, S; Haseyama, K; Katoh, S; Kudoh, T; Oda, T; Suzuki, N; Watanabe, J | 1 |
| Openshaw, H; Slatkin, NE; Smith, E | 1 |
| Gerber, M; Gmeinhart, B; Greinix, H; Kalhs, P; Knobler, R; Volc-Platzer, B | 1 |
| Alexanian, R; Andersson, B; Champlin, R; Colome, M; Delasalle, K; Dimopoulos, M; Gajewski, J; Giralt, S; Khouri, I; Korbling, M; Mehra, R; Przepiorka, D; Seong, D; Van Besien, K; von Wolff, B; Weber, D | 1 |
| Karasuno, T | 1 |
| Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM | 1 |
| Deeg, HJ; Kiem, HP; Leisenring, W; Nash, RA; Shulman, H; Storb, R; Wagner, JL; Yu, C | 1 |
| Apperley, JF; Gratwohl, A; Niederwieser, D; Ruutu, T | 1 |
| Abhyankar, SH; Armstrong, W; Godder, K; Henslee-Downey, PJ; Lamb, LS; Pati, AR | 1 |
| Gilman, AL; Schultz, KR | 1 |
| Baker, KS; DeLaat, CA; Filipovich, AH; Gross, TG; Harris, R; Loechelt, B; Shapiro, RS; Steinbuch, M | 1 |
| Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Ho, CH; Hsu, HC; Lin, JS; Tsai, WH; Tzeng, CH; Wang, SY | 1 |
| Bertz, H; Finke, J; Mertelsmann, R; Potthoff, K | 1 |
| De'Arce, M; Gardiner, N; Lawler, M; McCann, SR; O'Riordan, J | 1 |
| Boulad, F; Brochstein, JA; Castro-Malaspina, H; Childs, BH; Gillio, AP; Kernan, NA; Laver, J; O'Reilly, RJ; Reyes, B; Small, TN | 1 |
| Fink, FM; Greinix, H; Heitger, A; Kern, H; Nachbaur, D; Neu, N; Niederwieser, D; Panzer-Grümayer, ER | 1 |
| Booth, M; Bull, A; Coleman, S; Evely, R; Lim, SH; O'Callaghan, U | 1 |
| Hof, A; Hof, RP; Joergensen, J; Rudin, M; Wehr, S | 1 |
| Kulkarni, S; Mehta, J; Powles, R; Singhal, S; Treleaven, J | 1 |
| Grigg, A; Harun, MH; Szer, J | 1 |
| Erttmann, R; Hassan, HT; Krog, C; Krüger, W; Stockschläder, M; Zander, AR; Zeller, W | 1 |
| Cerezo, L; Domínguez, P; López, M; Marín, A; Martín De Vidales, C; Pérez Torrubia, A; Zapatero, A | 1 |
| Haberal, M; Karakayali, H; Moray, G; Senel, FM; Yildirim, S | 1 |
| Berger, A; Gerlach, J; Jörres, A; Neuhaus, P; Nohr, R; Schön, M; Smith, MD; Spatkowski, G | 1 |
| Yasukawa, M | 1 |
| Harano, H; Kanamori, H; Matsuzaki, M; Mohri, H; Ogawa, K; Okubo, T; Sasaki, S; Tamura, T; Ueda, S; Yamazaki, E | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Chauncey, T; Clift, R; Deeg, HJ; Doney, K; Flowers, ME; Hansen, JA; Leisenring, W; Martin, P; Pepe, M; Pettinger, M; Sanders, J; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R | 1 |
| Akan, H; Arslan, O; Beksaç, M; Dilek, I; Gürman, G; Ilhan, O; Koç, H; Konuk, N; Ozcan, M; Uysal, A | 1 |
| Bader, S; HayGlass, KT; Nelson, D; Schultz, KR; Wang, MD | 1 |
| Abraham, R; Bardy, P; Grigg, A; Szer, J | 1 |
| Madan, B; Schey, SA | 1 |
| Haridas, V; Kamat, RS | 1 |
| Asano, S; Kikuchi, A; Nishikawa, T; Okamoto, S; Takahashi, S | 1 |
| Bellazzi, R; Magni, P | 1 |
| Amill, B; Berlanga, JJ; Boqué, C; Brunet, S; Canals, C; Cancelas, JA; Domingo-Albós, A; Ferra, C; Gallardo, D; García-López, J; Grañena, A; Martín-Henao, G; Martínez, C; Martino, R; Picón, M; Sureda, A; Torrico, C | 1 |
| Gilbert, MJ; Korngold, R; Townsend, RM | 1 |
| Matsuda, T; Miura, Y; Nakao, S; Shiobara, S; Sugimori, N; Takami, A; Yachie, A; Yamazaki, H; Zeng, W | 1 |
| Beelen, DW; Elmaagacli, AH; Schaefer, UW | 1 |
| Gooley, T; Hackman, RC; Ko, CW; Lee, SP; McDonald, GB; Myerson, D; Sale, GE; Schoch, HG; Shulman, HM | 1 |
| Aspeslet, LJ; Gallant, HL; Yatscoff, RW | 1 |
| Herzig, S; Schröder, F | 1 |
| Bunin, N; Darbyshire, PJ; Davies, SC; Dinndorf, P; Kurtzberg, J; Leisenring, W; Mentzer, WC; Patience, M; Roberts, IA; Rogers, ZR; Scott, JP; Smith, FO; Sullivan, KM; Wall, DA; Walters, MC; Wayne, AS; Wiley, J; Yeager, A | 1 |
| Colony, P; Koltun, WA; Olt, GJ; Poritz, LS; Ruggiero, FM; Tilberg, AF | 1 |
| Barsoukov, A; Deeg, HJ; Nash, RA; Sandmaier, BM; Santos, E; Seidel, K; Storb, R; Yu, C | 1 |
| Choi, KS; Chung, IJ; Hwang, TJ; Kim, HJ; Kook, H; Lee, JJ; Park, MR; Seo, JS | 1 |
| Hess, AD; Horwitz, L; Thoburn, C | 1 |
| Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
| Amend, WJ; Criswell, LA; Millward, CL; Olson, JL; Stone, JH | 1 |
| Dinndorf, PA; Jubran, RF | 1 |
| Bacigalupo, A; Berisso, G; Bregante, S; De Stefano, F; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Occhini, D; Soracco, M; Van Lint, MT; Vitale, V; Zikos, P | 1 |
| Amemiya, H; Chiba, K; Hoshino, Y; Kakefuda, T; Kataoka, H; Kawaguchi, T; Rahman, F; Suzuki, S | 1 |
| Imai, Y; Moizumi, Y; Sakurai, M; Tabayashi, K; Uchida, S | 1 |
| Fuchs, D; Gruhn, B; Häfer, R; Kosmehl, H; Zintl, F | 1 |
| Bonetti, F; Locatelli, F; Paolucci, G; Pession, A; Prete, A; Rondelli, R; Zecca, M | 1 |
| Gadner, H; Klingebiel, T; Minkov, M; Niethammer, D; Peters, C | 1 |
| Bandini, G; Bonini, A; Campanini, E; Mangianti, S; Motta, MR; Remiddi, C; Rizzi, S; Rondelli, D; Rosti, G; Testoni, N; Tura, S; Zuffa, E | 1 |
| Akan, H; Anadolu, R; Arat, M; Beksaç, M; Demirer, T; Dilek, I; Erdi, H; Ilhan, O; Koç, H; Ozcan, M; Ustün, C | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kirsten, D; Römer, E; Rudolphi, M; Sanchez, H | 1 |
| Flowers, ME; Longton, G; Schubert, M; Storb, R; Sullivan, KM; Wagner, JL | 1 |
| Kellaway, J; Kiang, E; Przepiorka, D; Tesavibul, N; Yee, R | 1 |
| Gorin, NC; Landman, J; Laporte, JP; Lesage, S; Najman, A; Portnoï, MF; Rubinstein, P | 1 |
| Beksac, M; Bernaudin, F; Brichard, B; Gluckman, E; Locatelli, F; Miniero, R; Nagler, A; Roberts, I; Rocha, V; Saracco, P; Yaniv, I | 1 |
| Landaw, EM; Paquette, RL; Tran, L | 1 |
| Corr, T; Currie, C; Keown, PA; Nevill, TJ; Schultz, KR; Strong, DK; Toze, CL | 1 |
| Boccadoro, M; Caracciolo, D; Cavallaro, AM; Corradini, P; Indovina, A; Majolino, I; Marcenò, R; Palumbo, A; Pileri, A; Santoro, A; Scimè, R; Tarella, C | 1 |
| Antin, JH; Avalos, B; Buell, DN; Christiansen, NP; Devine, SM; Fay, JW; Fitzsimmons, WE; Herzig, RH; Karanes, C; Klein, JL; Litzow, MR; Longo, WL; Maher, RM; Nademanee, A; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; van der Jagt, R; Weisdorf, D; Wingard, JR; Wolff, SN | 1 |
| Hayakawa, M; Kamiya, Y; Kasai, M; Kato, C; Kato, H; Kitaori, K; Morishima, Y; Sao, H; Shimokawa, T; Yamaguchi, T; Yanada, M | 1 |
| Bessell, EM; Byrne, JL; Haynes, AP; Hyde, H; Miflin, G; Russell, NH; Stainer, C | 1 |
| Anasetti, C; Leisenring, W; Sanders, J; Sandmaier, BM; Storb, R; Stucki, A | 1 |
| Hazzan, M; Jouet, JP; Noël, C; Noël-Walter, MP | 1 |
| Banerjee, D; Fyles, G; Lipton, JH; Lowsky, R; Messner, HA; Ng, CM; Spaner, D; Wade, JA | 1 |
| Aschan, J; Carlens, S; Hägglund, H; Klaesson, S; Ljungman, P; Lönnqvist, B; Mattsson, J; Remberger, M; Ringdén, O; Svahn, BM; Winiarski, J | 1 |
| Barrett, AJ; Bunjes, D; Hale, G; Horowitz, MM; Prentice, HG; Spence, D; Waldmann, H; Zhang, MJ | 1 |
| Abrams, R; Ambinder, RF; Braine, HG; Flinn, I; Grever, M; Griffin, C; Hess, AD; Jones, RJ; Marcellus, DC; Miller, C; Noga, SJ; O'Donnell, PV; Piantadosi, S; Seber, A; Vogelsang, GB | 1 |
| Chen, W; Hess, AD; Thoburn, C | 1 |
| Gregory, CR; Hou, SM; Jeng, CR; Lai, YC; Lui, LT; Yeh, LS | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Rudolphi, M; Sanchez, H | 1 |
| Baczkowska, T; Cieciura, T; Gaciong, Z; Kukuła, K; Lao, M; Serafinowicz, A | 1 |
| Angonin, R; Bittencourt, M; Cahn, JY; Contassot, E; Hervé, P; Laithier, V; Pavy, JJ; Robinet, E; Tiberghien, P | 1 |
| Hatsumi, N; Karasawa, M; Kim, K; Matsushima, T; Murakami, H; Naruse, T; Saito, T; Sakuraya, M; Sato, M; Takada, S; Tamura, J | 1 |
| Dieckman, K; Fischer, G; Greinix, HT; Kalhs, P; Keil, F; Lechner, K; Leitner, G; Malzer, R; Rabitsch, W; Reiter, E | 1 |
| Bátorová, A; Bojtárová, E; Buc, M; Demecková, E; Fehérvízyová, E; Holománová, D; Hrubisko, M; Kusiková, M; Mistrík, M; Sakalová, A | 1 |
| Cukrová, V; Dolezalová, L; Gasová, Z; Hrabánek, J; Hrubá, A; Kobylka, P; Korínková, P; Loudová, M; Marinov, J; Sajdová, J; Sieglová, Z; Vítek, A | 1 |
| Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
| Bradstock, K; Brandenburg, U; Gottlieb, D | 1 |
| Fay, JW; Fitzsimmons, WE; Klein, JL; Maher, RM; Nash, RA; Przepiorka, D; Ratanatharathorn, V; Weisdorf, DJ; Wingard, JR; Zhu, J | 1 |
| Ebeling, PR; Erbas, B; Grigg, AP; Hopper, JL; Szer, J; Thomas, DM | 1 |
| Bahia, D; Balda, C; Franco, M; Kerbauy, J; Oliveira, JS; Stella, S | 1 |
| Berger, C; Braumann, D; de Witt, M; Erttmann, R; Fiedler, W; Grimm, J; Horstmann, M; Hossfeld, KD; Illiger, HJ; Kabisch, H; Kröger, N; Krüger, W; Kuse, R; Schönrock, P; Stockshläder, M; Weh, HJ; Zander, AR; Zeller, W | 1 |
| Bornhäuser, M; Ehninger, G; Geissler, G; Naumann, R; Pörksen, G; Schuler, U; Schwerdtfeger, R; Thiede, C; Thiede, HM | 1 |
| Carreras, E; Marín, P; Martínez, C; Montfort, N; Montserrat, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Balguerie, X; Boullie, MC; Joly, P; Lauret, P; Tanasescu, S; Thomine, E; Tron, P; Vannier, JP | 1 |
| Archimbaud, E; Belhabri, A; Fière, D; Guyotat, D; Michallet, M; Molina, L; Nicolini, F; Perrin, MC; Sotto, JJ; Tigaud, JD | 1 |
| Glomstein, A; Gustafsson, G; Jonmundsson, G; Mellander, L; Nysom, K; Ringdén, O; Saarinen-Pihkala, UM; Schroeder, H | 1 |
| Afify, Z; Shaw, PJ | 1 |
| Beelen, DW; Elmaagacli, AH; Nahler, M; Schaefer, UW; Schmidt, O; Trenn, G | 1 |
| Bielack, S; de Wit, M; Dürken, M; Erttmann, R; Jaburg, N; Kabisch, H; Kröger, N; Krüger, W; Löliger, C; Renges, H; Rüssmann, B; Stockschläder, M; Wacker-Backhaus, G; Zabelina, T; Zander, AR | 1 |
| Goldschneider, I; Wu, DY | 2 |
| Ascensao, JL; Batinić, D; Grcević, D; Marusić, M | 1 |
| Bartels, P; Buell, DN; Erdman, J; Fitzsimmons, WE; Hodosh, E; Horowitz, MM; Huang, C; Maher, R; Przepiorka, D; Wingard, JR; Zhang, MJ | 1 |
| Billingham, M; Hoyt, EG; Morris, RE; Pollard, J; Poston, RS; Robbins, RC; Shorthouse, R | 1 |
| Drobyski, WR; Hessner, MJ; Kabler-Babbitt, C; Keever-Taylor, CA; Klein, JP; Margolis, DA; Vesole, DH | 1 |
| Bryson, JS; Flanagan, DL; Jennings, CD | 1 |
| Iberti, M; Odone, P | 1 |
| Arns da Cunha, C; Dantas da Cunha, A; de Medeiros, CR; Pasquini, R | 1 |
| Fujimori, Y; Kakishita, E; Kanamaru, A; Okada, M; Okamoto, T; Takatsuka, H; Takemoto, Y; Tamura, S; Wada, H | 1 |
| Bordone, J; Buschiazzo, H; Castelletto, R; Etchegogen, O; Marin, GH; Milone, J; Morales, V; Napal, J; Porto, A; Prates, V; Rubens, L | 1 |
| Fischer, J; Göbel, U; Kögler, G; Niehues, T; Nürnberger, W; Somville, T; Wernet, P | 1 |
| Abboud, C; Constine, L; DiPersio, J; Duerst, R; Liesveld, J; Linder, T; McKenna, B; Packman, C; Rapoport, A; Rowe, J; Silverman, W; Swift, S; Wedow, L; Zwetsch, L | 1 |
| Aschan, J; Carlens, S; Dilber, M; Remberger, M; Ringdén, O | 1 |
| Abrams, R; Altomonte, V; Bitton, R; Hess, A; Horn, T; Jones, R; Marcellus, D; Miller, C; Piantadosi, S; Vogelsang, G | 1 |
| Deeg, HJ; Georges, G; Kiem, HP; McSweeney, PA; Nash, RA; Storb, R; Wagner, JL; Yu, C; Zaucha, JM | 1 |
| Bergna, MI; Cánepa, C; Gardenal, L; Gil, MA; Italiano, C; Klein, G; Malacalza, J; Mansilla, E; Marin, GH; Mendez, MC; Menna, ME; Orlando, S; Perez, M; Piccinelli, G; Saba, S | 1 |
| Gooley, T; Hansen, JA; Lin, MT; Martin, EG; Martin, PJ; Pei, J; Petersdorf, EW; Smith, AG; Tseng, LH | 1 |
| Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
| Apperley, JF; Duell, T; Jacobsen, N; Kolb, HJ; Ljungman, P; Nekolla, E; Prentice, HG; Socié, G; Tichelli, A; Van Lint, MT; van Weel, M; Weiss, M; Wick, R | 1 |
| Ahmed, T; Baskind, P; Beer, M; Chiao, JW; Feldman, E; Goff, H; Seiter, K; Stein, M | 1 |
| Imaizumi, M; Maseki, T; Teranishi, K; Usui, A; Watanabe, T; Yasuura, K | 1 |
| De Maeseneer, M; Debaere, C; Osteaux, M; Stadnik, T | 1 |
| Boyd, AS | 1 |
| Kasai, M; Kato, C; Kitaori, K; Morishima, Y; Sao, H; Shimokawa, T; Ueda, R; Yamanishi, H | 1 |
| Bacigalupo, A; Barra, S; Berisso, G; Bregante, S; Corvò, R; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Van Lint, MT; Vitale, V | 1 |
| Bilbao, G; Cartner, S; Contreras, JL; Eckhoff, DE; Neville, DM; Ricordi, C; Thomas, FT; Thomas, JM | 1 |
| Goh, YT; How, GF; Hwang, WY; Tan, CH; Tan, HC | 1 |
| Hibi, S; Imashuku, S; Misawa, A; Sawada, T; Takeuchi, Y; Todo, S | 1 |
| Bonetti, F; Dini, G; Giorgiani, G; Giraldi, E; Locatelli, F; Messina, C; Pession, A; Porta, F; Prete, A; Ripaldi, M; Rondelli, R; Uderzo, C; Zecca, M | 1 |
| Deeg, HJ; Linsley, P; Nash, RA; Sale, G; Seidel, K; Storb, R; Yu, C | 1 |
| Chen, W; Hess, AD; Horwitz, LR; Thoburn, CJ | 1 |
| Fukuda, H; Hiraoka, A; Karasuno, T; Masaoka, T; Nakamura, H; Teshima, H | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Schmetzer, B | 1 |
| Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H | 1 |
| Haghshenas, M; Khojasteh, HN; Ramzi, M; Zakerinia, M | 1 |
| Hatsumi, N; Karasawa, M; Matsushima, T; Miyawaki, S; Saito, T; Sakura, T; Takada, S; Tamura, J | 1 |
| Busca, A; Lanino, E; Manfredini, L; Messina, C; Miniero, R; Nicolini, B; Rabusin, M; Saroglia, EM; Uderzo, C | 1 |
| Atkinson, KA; Barrett, AJ; Cahn, JY; Champlin, RE; Drobyski, WR; Gale, RP; Goldman, JM; Gordon-Smith, EC; Gratwohl, A; Henslee-Downey, PJ; Herzig, RH; Horowitz, MM; Klein, JP; Marmont, AM; O'Reilly, RJ; Passweg, JR; Pelz, CJ; Ringdén, O; Rowlings, PA; Slavin, S; Sobocinski, KA; Speck, B; Weiner, RS; Zhang, MJ | 1 |
| Albrechtsen, D; Brinch, L; Egeland, T; Evensen, SA; Heldal, D; Solheim, BG; Steen, R; Tjønnfjord, G | 1 |
| Amylon, MD; Bluzme, KG; Chao, NJ; Forman, SJ; Fung, H; Hu, WW; Jain, M; Johnston, LJ; Kashyap, A; Kohler, S; Krishnan, A; Long, GD; Molina, A; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, P; Rodriguez, R; Snyder, DS; Spielberger, R; Stein, A; Stockerl-Goldstein, KE; Tierney, DK; Wong, RM | 1 |
| McSweeney, P; Sandmaier, BM; Storb, R; Yu, C | 1 |
| Arroyo, JL; Caballero, D; Cañizo, C; García, R; González, M; González, MI; Hernández, R; Izarra, A; López, C; San Miguel, JF; Vázquez, L | 1 |
| Kawamura, Y; Miura, Y; Nakao, S; Shiobara, S; Takami, A; Ueda, M; Wang, H; Yamazaki, H; Zeng, W | 1 |
| Andrews, D; Colby, C; Cox, B; Foley, A; McAfee, S; Multani, P; Poliquin, C; Preffer, F; Sachs, DH; Sackstein, R; Saidman, S; Spitzer, TR; Sykes, M; Toh, HC; Weyouth, DW | 1 |
| Hirabayashi, N | 1 |
| Appelbaum, FR; Deeg, HJ; Flowers, ME; Leisenring, W; Martin, PJ; Storb, RF | 1 |
| Arcese, W; Bacigalupo, A; Bruno, B; Dallorso, S; Di Bartolomeo, P; Fagioli, F; Lawler, M; Locasciulli, A; Locatelli, F; McCann, S; Van-Lint, MT; Zecca, M | 1 |
| Bertz, H; Engelhardt, M; Finke, J; Hahn, J; Holler, E; Kunzmann, R; Reisser, S; Veelken, H; Wäsch, R | 1 |
| Anasetti, C; Antin, JH; Avalos, BR; Bartels, P; Buell, D; Davies, S; Fay, JW; Fitzsimmons, W; Karanes, C; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; Yeager, AM | 1 |
| Bekasi, A; Cornish, J; Gadner, H; Klingebiel, T; Locatelli, F; Minkov, M; Niethammer, D; Ortega, J; Peters, C; Souillet, G; Stary, J; Vossen, J | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Chakrabarti, S; Chakraverty, RK; Chopra, R; de Elvira, MC; Devereux, S; Goldstone, AH; Hale, G; Kottaridis, PD; Linch, DC; Mackinnon, S; Mahendra, P; Marsh, JC; Milligan, DW; Morgan, GJ; Peggs, K; Pettengell, R; Robinson, S; Schey, S; Verfuerth, S; Waldmann, H; Williams, CD | 1 |
| Battermann, JJ; Kal, HB; Mourits, MP; Schipper, J; Struikmans, H; van der Tweel, I; van Kempen-Harteveld, ML; Verdonck, LF | 1 |
| Gondo, H; Kamimura, T; Miyake, K; Niho, Y; Okamura, T | 1 |
| Altomonte, V; Armstrong, DK; Bond, S; Bright, E; Clarke, B; Davidson, NE; Davis, JM; Fetting, J; Hess, AD; Horn, T; Kennedy, MJ; Lee, SM; McIntyre, K; Noga, SJ; Ohly, KV; Passos-Coehlo, JL; Thomassen, J; van der Wall, E; Vogelsang, G | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Flowers, ME; Koc, S; Leisenring, W; Martin, PJ; Nash, RA; Sanders, JE; Storb, R; Witherspoon, RP | 2 |
| Attal, M; Blaise, D; Bordigoni, P; Buzyn, A; Fegueux, N; Garban, F; Gluckman, E; Guardiola, P; Kuentz, M; Lioure, B; Reiffers, J; Socié, G; Tanguy, ML; Vernant, JP | 1 |
| Horibe, K; Inaba, J; Kato, K; Kojima, S; Kudo, K; Matsuyama, T; Takahashi, Y; Yoshimi, A | 1 |
| Flowers, ME; Margolis, DA; McDonald, GB; Prumbaum, M; Reddy, R; Seropian, SE; Shulman, HM; Strasser, SI | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Doney, K; Furlong, T; Martin, P; Nash, RA; Storb, R; Sullivan, K; Witherspoon, R | 1 |
| Anasetti, C; Carnevale-Schianca, F; Deeg, J; Flowers, M; Furlong, T; Gooley, T; Martin, P; McSweeney, P; Nash, RA; Storb, R; Sullivan, K | 1 |
| Boeckh, M; Seidel, K; Storb, R; Wagner, JL | 1 |
| de Soria, VG; Fernández-Rañada, JM; Figuera, A; Font, P; Gruss, E; Sánchez, S; Sanz-Rodriguez, C; Tomis, JF | 1 |
| McKerlie, C; Sheng-Tanner, X; Spaner, D | 1 |
| Almeida, A; Daly, P; Dokal, I; McCloy, M; Roberts, IA; Vulliamy, T | 1 |
| Cheng, TO | 1 |
| Barbui, T; Caruso, R; Dotti, G; Gaspari, F; Perico, N; Rambaldi, A; Remuzzi, G | 1 |
| Hinterberger-Fischer, M | 1 |
| Cantú, OG; Gómez-Almaguer, D; González-Llano, O; Jaime-Pérez, JC; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ | 1 |
| McDonald, GB; Shulman, HM; Strasser, SI | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Kanai, S; Kanda, Y; Makimoto, A; Mineishi, S; Miyawaki, S; Nakai, K; Niiya, H; Ohnishi, M; Ohnishi, T; Saito, A; Saito, T; Suenaga, K; Takaue, Y; Takeuchi, T; Tanosaki, R; Tobinai, K | 1 |
| Basara, N; Bischoff, M; Blau, W; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Schmetzer, B | 1 |
| Baan, CC; Balk, AH; de Groot-Kruseman, HA; Maat, AP; Mol, WM; Niesters, HG; Weimar, W | 1 |
| Bornhäuser, M; Ehninger, G; Freiberg-Richter, J; Helwig, A; Jenke, A; Platzbecker, U; Renner, U; Richte, M; Schäfer-Eckart, K; Thiede, HM | 1 |
| Arora, M; Blazar, BR; Davies, SM; Defor, T; Enright, H; Miller, WJ; Wagner, JE; Weisdorf, DF | 1 |
| Chandy, M; Danda, D; George, B; Mathews, V; Srivastava, A | 1 |
| Baldwin, W; Chen, W; Hess, AD; Hruban, R; Miura, Y; Qian, Z; Sommer, M; Thoburn, CJ | 1 |
| Buzio, C; Cardarelli, F; Olivetti, G; Rossi, L; Vampa, ML | 1 |
| Eom, KS; Kim, CC; Kim, DW; Lee, JW; Lee, S; Min, CK; Min, WS | 1 |
| Ilan, Y; Menachem, Y; Nagler, A | 1 |
| Blume, KG; Chauncey, T; Feinstein, L; Flowers, C; Georges, G; Kiem, HP; Little, MT; Maloney, D; Maris, M; McSweeney, PA; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, B; Shizuru, J; Storb, R; Woolfrey, A; Zaucha, JM | 1 |
| Bright, EC; Hess, AD; Lefell, S; Miura, Y; Nakao, S; Sommer, M; Thoburn, CJ; Ueda, M | 1 |
| Bryon, RJ; Chakrabarti, S; Griffiths, MJ; Handa, SK; Milligan, DW | 1 |
| Pakkala, I; Pakkala, S; Räisänen-Sokolowski, A; Taskinen, E | 1 |
| Ancín, I; Berlanga, J; Ferrá, C; Gallardo, D; Gonzalez, JR; Grañena, A; Peris, J; Virgili, N | 1 |
| Arnold, D; Brunner, T; Frutschi, C; Green, DR; Lin, T; Mueller, C; Vallan, C; Wasem, C | 1 |
| Dohy, H; Hiraoka, A; Kanamaru, A; Kodera, Y; Masaoka, T; Moriyama, Y; Nagao, T; Ohashi, Y; Okamoto, S | 1 |
| Antin, JH; Bierer, BE; Cowan, MJ; Ho, WG; Jiao, J; Kaizer, H; Lazarus, HM; Linker, C; Miller, KB; Petersen, FB; Petrarca, MA; Schiller, GJ; Small, T; Territo, MC; Tonetta, SA; Wingard, JR; Winston, DJ; Wolff, SN | 1 |
| Gao, ZH; Garcia, B; Grant, DR; Kellersmann, A; Kellersmann, R; Kiyochi, H; Zhong, R | 1 |
| Durrant, S; Gillett, EA; Lockwood, L; Mollee, P; Morton, J; Rowell, J; Woodward, N | 1 |
| Chen, MG; Gastineau, DA; Gertz, MA; Harmsen, WS; Inwards, DJ; Kumar, S; Lacy, MQ; Litzow, MR; Tefferi, A | 1 |
| Domingues-Martins, M; França, CM; Pallotta Filho, RS; Soares de Araújo, N; Volpe, A | 1 |
| Simpson, D | 1 |
| Bittencourt, MA; Bonfim, CM; Brandi, IV; Camargo, CH; de Medeiros, CR; Friedrich, ML; Pasquini, R; Teive, HA; Werneck, LC | 1 |
| Chiba, T; Fujii, S; Nakase, H; Nishi, T; Nishihara, T; Ohana, M; Okazaki, K; Uchida, K; Uose, S | 1 |
| Aotsuka, N; Fujimaki, K; Fujisawa, S; Kanamori, H; Maruta, A; Matsuzaki, M; Okamoto, S; Saito, K; Sakamaki, H; Takahashi, S | 1 |
| Alessandrino, PE; Bacigalupo, A; Barbanti, M; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; Van Lint, MT | 1 |
| Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A | 1 |
| Ashihara, E; Fujita, N; Hatsuse, M; Inaba, T; Nakagawa, M; Noda, Y; Ochiai, N; Okano, A; Shimazaki, C; Takahashi, R | 1 |
| Asaka, M; Chiba, K; Hashino, S; Izumiyama, K; Suzuki, S; Takahata, M | 1 |
| Carmagnat, M; Charron, D; Devergie, A; Esperou, H; Gluckman, E; Guardiola, P; Mary, JY; Maury, S; Rabian, C; Ribaud, P; Schwarzinger, M; Scieux, C; Socié, G; Toubert, A; Vexiau, P | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Flowers, ME; Gooley, T; Kansu, E; Martin, PJ; Nash, RA; Sanders, JE; Storb, R; Witherspoon, RP | 1 |
| Bryson, JS; Caywood, BE; Flanagan, DL; Goes, S; Gross, R; Jennings, CD; Kaplan, AM | 1 |
| Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
| Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF | 1 |
| Kinsey, SE; Pratt, G | 1 |
| Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B | 1 |
| Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H | 1 |
| Arcese, W; Cerretti, R; De Felice, L; Donato, V; Fenu, S; Guglielmi, C; Iori, A; Laurenti, L; Mengarelli, A; Micozzi, A; Romano, A; Torromeo, C | 1 |
| Denney, J; Espino, G; Fitzsimmons, W; Furlong, T; Nash, RA | 1 |
| Crilley, P; Styler, M; Teruya, J; Topolsky, D; Verde, S | 1 |
| Arranz, R; Brunet, S; Bueno, J; Cabrera, R; Carreras, E; Conde, E; Conde, JG; Fernández-Rañada, JM; Iriondo, A; Maldonado, J; Marín, P; Odriozola, J; Pajuelo, FJ; Petit, J; Rodriguez-Salvanés, F; Sanz, MA | 1 |
| Benard, L; Boyer, O; Bruel, S; Cohen, JL; Klatzmann, D; Litvinova, E; Maury, S | 1 |
| Huang, H; Huang, J; Jin, J; Lin, M; Luo, Y; Meng, H; Qian, W | 1 |
| Antinori, A; Chiusolo, P; Cingolani, A; De Luca, A; Laurenti, L; Leone, G; Ortona, L; Piccirillo, N; Rutella, S; Sica, S; Sorà, F | 1 |
| Zelunka, EJ | 1 |
| Baker, KS; Nagarajan, R; Neglia, J; Ramsay, N | 1 |
| Corey, L; Geisler, WM | 1 |
| Jacobsohn, DA; Vogelsang, GB | 1 |
| Chen, H; Ji, S; Wang, H | 1 |
| Claviez, A; Dreger, P; Glass, B; Suttorp, M | 1 |
| Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
| Eibl, M; Greinix, HT; Gritsch, B; Hinterberger, W; Kalhs, P; Knöbl, P; Krieger, O; Lechner, K; Linkesch, W; Lutz, D; Nachbaur, D; Niederwieser, D; Rosenmayr, A | 1 |
| Baron, F; Baudoux, E; Beguin, Y; Fillet, G; Matus, G; Sautois, B | 1 |
| Boström, L; Forsgren, M; Ringdén, O | 1 |
| Kersey, JH; Ringdén, O | 1 |
| Clark, CL; Crane, PW; Fabre, JW; Lear, PA; Price, BA; Smith, GJ; Wood, RF | 1 |
| Masaoka, T | 1 |
| Gress, RE; Hiruma, K | 1 |
| Apperley, J; Barrett, AJ; Cullis, JO; Hows, JM; Hughes, TP; Kelly, S; Mackinnon, S; Marks, DI; Schwarer, AP; Szydlo, R | 1 |
| Anasetti, C; Appelbaum, FR; Bowden, RA; Deeg, HJ; Doney, K; Longton, G; Nash, RA; Pepe, MS; Pettinger, M; Storb, R | 1 |
| Darmstadt, GL; Donnenberg, AD; Farmer, ER; Horn, TD; Vogelsang, GB | 1 |
| Hiller, E; Holler, E; Kolb, HJ; Seeber, C | 1 |
| Beelen, DW; Brandt, H; Graeven, U; Haralambie, E; Linzenmeier, G; Mahmoud, HK; Müller, KD; Quabeck, K; Sayer, HG; Schaefer, UW | 1 |
| Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L | 1 |
| Bennett, M; Collins, RH; Fay, JW; Kumar, V; Nikein, A; Rogers, ZR | 1 |
| Beyer, J; Schwerdtfeger, R; Siegert, W | 1 |
| Blaise, D; Bordigoni, P; Esperou-Bourdeau, H; Gluckman, E; Kuentz, M; Michel, G; Milpied, N; Rubie, H; Thuret, I; Vernant, JP | 1 |
| Bessell, EM; Hunter, AE; Russell, NH | 1 |
| Fujioka, M; Makabe, M; Orita, K; Orita, T; Tanaka, S; Uda, K | 1 |
| Gratwohl, A; Nissen, C; Speck, B; Tichelli, A | 1 |
| Dahllöf, G; Heimdahl, A; Lönnquist, B; Mattsson, T; Ringdén, O | 1 |
| Hess, AD; Jones, RJ; Morris, LE; Noga, SJ; Santos, GW; Vogelsang, GB; Yeager, AM | 1 |
| Ballardie, FW; Edwards, BD; Hows, J; Jones, L; Peters, AM | 1 |
| Brown, R; Stevens, M; Tiedemann, K; Vowels, M | 1 |
| Klaesson, S; Ljungman, P; Lönnqvist, B; Persson, U; Ringdén, O; Sundberg, B | 1 |
| Albrechtsen, D; Brinch, L; Evensen, S; Sinding-Larsen, B | 1 |
| Wagner, JE | 1 |
| Barbara, JA; Gillis, D; Ho, JO; Smith, PS; Thomas, AC; Woodroffe, AJ | 1 |
| Geller, RB; Griffin, C; Piantadosi, S; Saral, R; Shah, N; Vogelsang, GB; Wagner, JE; Wingard, JR; Zahurak, M; Zehnbauer, BA | 1 |
| Bruckner-Tuderman, L; Burger, J; Gmür, J | 1 |
| Goldman, JM | 1 |
| Altomonte, V; Farmer, ER; Hess, AD; Jones, RJ; Santos, GW; Vogelsang, GB; Yeager, AM | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Martin, P; Pepe, M; Sanders, JE; Singer, J; Stewart, P; Storb, R; Sullivan, KM | 1 |
| Carlin, J; Emerson, S; Gmur, DJ; McGuire, TR; Yee, GC | 1 |
| Clark, CL; Crane, PW; Cunningham, AJ; Lear, PA; Wood, RF | 1 |
| Banner, B; Langrehr, JM; Lee, KK; Lee, TK; Markus, PM; Müller, AR; Schraut, WH | 1 |
| Fecteau, A; Guttman, FM; Rosenmann, E; Tchervenkov, J | 1 |
| Foster, PF; Kociss, K; Sankary, HN; Templeton, AC; Williams, JW; Xiao, F | 2 |
| Alsina, AE; Nagashima, I; Schweizer, RT | 1 |
| Corry, RJ; Murr, MM | 1 |
| Dietze, O; Habringer, C; Klima, G; Königsrainer, A; Krausler, R; Margreiter, R | 1 |
| Agah, R; Charak, BS; Mazumder, A | 1 |
| Baba, M; Hatta, Y; Horie, T; Itoh, T; Kawamura, M; Tomura, K | 1 |
| Akiyama, H; Kiuchi, C; Noguchi, M; Onozawa, Y; Sakamaki, H | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Deeg, HJ; Doney, K; Hansen, J; Pepe, M; Storb, R | 1 |
| Coutinho, A; Gaspar, ML; Marcos, MA; Martinez, C; Pereira, P; Toribio, ML | 1 |
| Bäckman, L; Dati, F; Duraj, FF; Ringdén, O | 1 |
| Kakishita, E; Kanamaru, A; Masaoka, T; Moriyama, Y; Shibata, H; Takemoto, Y | 1 |
| Cai, X; Cooper, M; Fung, JJ; Harnaha, J; Markus, PM; Selvaggi, G; Starzl, TE | 1 |
| de Bruin, RW; Heineman, E; HogenEsch, H; Jeekel, J; Marquet, RL | 1 |
| Bacigalupo, A; Biggs, JC; Camitta, BM; Champlin, RE; Gale, RP; Gluckman, E; Gordon-Smith, EC; Horowitz, MM; Hows, JM; Marmont, AM | 1 |
| Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC | 1 |
| Hidaka, S; Hiraoka, A; Kobayashi, M; Matsunashi, T; Nakamura, H; Tejima, H; Tominaga, N; Yoshida, H; Yoshida, S; Yoshimura, M | 1 |
| Speck, B | 1 |
| Capra, C; Frisoni, R; Gualandi, F; Malfanti, L; Occhini, D; Valbonesi, M | 1 |
| Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
| Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H | 1 |
| Bourdeau-Esperou, H; Cosset, JM; Devergie, A; Gluckman, E; Socie, G; Traineau, R | 1 |
| Chandrasekar, PH; Cronin, SM | 1 |
| Bernauer, W; Daicker, B; Gratwohl, A; Keller, A | 1 |
| Parfrey, NA; Prud'homme, GJ; Vanier, LE | 1 |
74 review(s) available for cyclosporine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Defibrotide combined with triple therapy including posttransplant cyclophosphamide, low dose rabbit anti-t-lymphocyte globulin and cyclosporine is effective in prevention of graft versus host disease after allogeneic peripheral blood stem cell transplanta
Topics: Adult; Aged; Animals; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polydeoxyribonucleotides; Rabbits; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2022 |
Occurrence and influencing factors of cyclosporine A on the kidney injury following allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Topics: Acute Kidney Injury; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney | 2023 |
Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis.
Topics: Antilymphocyte Serum; Bortezomib; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2020 |
Secondary skin neoplasms in patients after autologous and allogeneic hematopoietic stem cell transplantation procedures.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Skin Neoplasms; Transplantation, Homologous | 2020 |
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
Topics: Age Factors; Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Methotrexate; Risk Factors; Transplantation Conditioning; Unrelated Donors; Vidarabine | 2021 |
Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?
Topics: Acute Disease; Allografts; Antilymphocyte Serum; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Sirolimus | 2017 |
[Ocular graft versus host disease : Corneal complications].
Topics: Adrenal Cortex Hormones; Chronic Disease; Combined Modality Therapy; Corneal Diseases; Corneal Ulcer; Cyclosporine; Diagnosis, Differential; Eye Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Interdisciplinary Communication; Intersectoral Collaboration; Keratoplasty, Penetrating; Limbus Corneae; Ophthalmic Solutions; Tacrolimus | 2017 |
Alternative donor transplants for severe aplastic anemia.
Topics: Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Severity of Illness Index; Unrelated Donors | 2018 |
Immunosuppressive mechanisms for stem cell transplant survival in spinal cord injury.
Topics: Adjuvants, Immunologic; Allografts; Animals; Basiliximab; Cells, Cultured; Clinical Trials as Topic; Cyclosporine; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Human Embryonic Stem Cells; Humans; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Male; Mice; Mycophenolic Acid; Oligodendrocyte Precursor Cells; Rats; Spinal Cord Injuries; Tacrolimus; Transplantation, Autologous | 2019 |
Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications.
Topics: Autoimmune Diseases; CD8-Positive T-Lymphocytes; Cyclosporine; Graft vs Host Disease; Humans; Immunomodulation; Immunosuppressive Agents; Lymphocyte Activation; Neoplasms; Organ Transplantation | 2019 |
Comparison of Tacrolimus and Cyclosporine Combined With Methotrexate for Graft Versus Host Disease Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.
Topics: Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Global Health; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Methotrexate; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous; Unrelated Donors | 2020 |
[A case of focal segmental glomerulosclerosis with nephrotic syndrome after hematopoietic stem cell transplantatation for aplastic anemia].
Topics: Anemia, Aplastic; Biopsy; Child; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Glomerulus; Microscopy, Electron; Mycophenolic Acid; Nephrotic Syndrome; Proteinuria; Treatment Outcome | 2013 |
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Mendelian Randomization Analysis; Siblings; T-Lymphocytes; Transplantation, Homologous | 2013 |
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Topics: Allografts; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus | 2014 |
How I treat juvenile myelomonocytic leukemia.
Topics: Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Genetic Testing; Graft vs Host Disease; Humans; Leukemia, Myelomonocytic, Juvenile; Male; Transplantation Conditioning; Transplantation, Homologous | 2015 |
Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.
Topics: Acute Disease; Bone Marrow Transplantation; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Japan; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2015 |
A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients.
Topics: Acute Kidney Injury; Adolescent; Amphotericin B; Biomarkers; Child; Cyclosporine; Foscarnet; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Prognosis; Risk Factors; Transplantation, Homologous; Treatment Outcome | 2015 |
[Treatment of Gaucher disease with allogeneic hematopoietic stem cell transplantation: report of three cases and review of literatures].
Topics: Antilymphocyte Serum; Busulfan; Child; Child, Preschool; China; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Gaucher Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Retrospective Studies; Transplantation Conditioning; Vidarabine | 2015 |
Mycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature.
Topics: Abdomen; Adolescent; Alemtuzumab; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Antibodies, Monoclonal, Humanized; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Cyclosporine; Diabetes Mellitus, Type 1; Diarrhea; Genetic Diseases, X-Linked; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytes; Humans; Immune System Diseases; Immunosuppressive Agents; Lymph Nodes; Male; Melphalan; Mycobacterium Infections, Nontuberculous; Mycophenolic Acid; Nontuberculous Mycobacteria; Photopheresis; Polymerase Chain Reaction; Transplantation Conditioning; Vidarabine | 2017 |
[Graft-versus-host disease: friend or foe?].
Topics: Acute Disease; Cell Separation; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; T-Lymphocytes; Tacrolimus; Transplantation, Homologous | 2008 |
Clinical review: topical ophthalmic use of cyclosporin A.
Topics: Acute Disease; Blepharitis; Conjunctival Diseases; Conjunctivitis, Allergic; Corneal Transplantation; Cyclosporine; Dry Eye Syndromes; Emulsions; Eye Diseases; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Rosacea | 2010 |
Acute kidney injury following HCT: incidence, risk factors and outcome.
Topics: Acute Kidney Injury; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Incidence; Myeloablative Agonists; Risk Factors; Transplantation Conditioning; Treatment Outcome | 2011 |
Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Cyclosporine; Embolization, Therapeutic; Esophageal and Gastric Varices; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Postoperative Complications; Prednisolone | 2012 |
Metabolic syndrome in patients with hematological diseases.
Topics: Adrenal Cortex Hormones; Cyclosporine; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Insulin Resistance; Metabolic Syndrome; Risk Factors | 2012 |
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Polymyositis; Tacrolimus; Transplantation, Homologous | 2002 |
Steroid-refractory graft-vs.-host disease: past, present and future.
Topics: Acute Disease; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Chronic Disease; Cyclosporine; Daclizumab; Glucocorticoids; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Mycophenolic Acid; Photopheresis; Prednisone; Prodrugs; Sirolimus; Tacrolimus | 2003 |
Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Histocompatibility Testing; HLA Antigens; Host vs Graft Reaction; Humans; Infections; Male; Methotrexate; Middle Aged; Parents; Risk; Siblings; Survival Analysis; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita.
Topics: Adrenal Cortex Hormones; Adult; Child, Preschool; Cyclosporine; Dyskeratosis Congenita; Female; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Male; Stem Cell Transplantation | 2003 |
Use of cyclosporine in hematopoietic cell transplantation.
Topics: Animals; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Models, Animal; Stem Cell Transplantation; Transplantation, Homologous | 2004 |
[Treatment of acquired a plastic anemia: an update].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Prognosis; Transplantation Conditioning; Transplantation, Homologous | 2004 |
[GVHD].
Topics: Antilymphocyte Serum; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Muromonab-CD3; Photopheresis; Prednisolone; Prognosis; Tacrolimus | 2004 |
[Chronic graft-versus-host disease].
Topics: Animals; Autoimmunity; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; HLA Antigens; Humans; Immunosuppressive Agents; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prognosis; PUVA Therapy; Risk Factors; Severity of Illness Index; Th2 Cells; Tissue Donors | 2005 |
Thrombotic microangiopathy in transplantation and malignancy.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Neoplasms; Plasma Exchange; Prognosis; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Tacrolimus; Treatment Outcome | 2005 |
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Topics: Acute Disease; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Postoperative Complications; Sirolimus; Tacrolimus | 2006 |
Optimizing the use of cyclosporin in allogeneic stem cell transplantation.
Topics: Cyclosporine; Drug Monitoring; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Transplantation, Homologous; Treatment Outcome | 2006 |
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
Topics: Acute Disease; Adrenal Cortex Hormones; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Risk Assessment; T-Lymphocytes; Tacrolimus | 2007 |
Sirolimus, the first mTOR inhibitor.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Atherosclerosis; Bone Marrow Diseases; Cell Division; Clinical Trials as Topic; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Lymphocyte Subsets; Mice; Multicenter Studies as Topic; Muscle, Smooth, Vascular; Neoplasms; Postoperative Complications; Sirolimus; TOR Serine-Threonine Kinases; Wound Healing | 2006 |
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Topics: Animals; Antiviral Agents; Autoimmune Diseases; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Mice; Models, Animal; Self Tolerance; Transplantation, Autologous | 2008 |
[Small intestine transplantation. Experimental and clinical results].
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Cyclosporine; Dogs; Female; Graft Rejection; Graft vs Host Disease; Humans; Infant; Intestine, Small; Liver Transplantation; Male; Middle Aged; Rats; Tacrolimus | 1993 |
Rational problems associated with the development of cellular approaches in controlling HIV spread.
Topics: Acquired Immunodeficiency Syndrome; Animals; Cell Communication; Combined Modality Therapy; Cyclosporine; Graft vs Host Disease; HIV Infections; Humans; Immunity, Cellular; T-Lymphocytes, Cytotoxic | 1995 |
Prevention and management of graft-versus-host disease. Practical recommendations.
Topics: Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Graft vs Host Disease; Humans; T-Lymphocytes | 1993 |
Graft-versus-host disease after autologous bone marrow transplantation: a realistic expectation?
Topics: Animals; Bone Marrow Transplantation; CD8-Positive T-Lymphocytes; Cyclosporine; Graft vs Host Disease; Histocompatibility Antigens Class II; Humans; Prognosis; Rats; T-Lymphocyte Subsets; Transplantation, Autologous | 1995 |
Thrombotic microangiopathy following bone marrow transplantation.
Topics: Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Purpura, Thrombotic Thrombocytopenic | 1994 |
Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients.
Topics: Animals; Chemotaxis, Leukocyte; Chimera; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Iatrogenic Disease; Immunosuppressive Agents; Kidney Transplantation; Leukocytes; Tissue Donors; Transplantation; Transplantation Immunology | 1994 |
Autologous graft-vs-host disease: mechanisms and potential therapeutic effect.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Histocompatibility Antigens Class II; Humans; Rats; T-Lymphocytes; Transplantation, Autologous | 1993 |
Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Graft Enhancement, Immunologic; Graft vs Host Disease; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Remission Induction; Reoperation; Risk Factors; Salvage Therapy; Survival Rate; Treatment Outcome | 1993 |
Is chronic graft versus host disease an autoimmune disease?
Topics: Animals; Autoimmune Diseases; Autoimmunity; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Humans; Mice | 1993 |
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Risk Factors | 1993 |
Induced autologous graft-versus-host disease for the treatment of cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy; Interferon-gamma; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Rats; Transplantation, Autologous | 1994 |
Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunotherapy; Interferon-gamma | 1993 |
Antitumor activity of syngeneic/autologous graft-versus-host disease.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility Antigens Class II; Humans; Immunotherapy; Neoplasms; Transplantation, Autologous | 1995 |
Neurophysiologic evaluation of cyclosporine toxicity associated with bone marrow transplantation.
Topics: Adult; Blindness; Bone Marrow Transplantation; Brain Diseases; Cerebral Cortex; Cyclosporine; Electroencephalography; Evoked Potentials, Auditory, Brain Stem; Evoked Potentials, Visual; Female; Graft vs Host Disease; Humans; Magnetic Resonance Imaging; Male | 1995 |
Late onset bone marrow transplant nephropathy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Leukemia, Myeloid, Acute; Male; Proteinuria; Radiation Injuries; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1996 |
What is the most effective treatment of children with severe aplastic anemia who lack a matched sibling donor?
Topics: Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Fetal Blood; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Interleukin-3; Methylprednisolone; Nuclear Family; Recombinant Fusion Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
[Nephrotic syndrome related to chronic graft versus host disease after allogeneic bone marrow transplantation in a patient with malignant lymphoma].
Topics: Adolescent; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Lymphoma, T-Cell; Male; Nephrotic Syndrome | 1996 |
Autologous graft-versus-host disease.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Transplantation, Autologous | 1997 |
The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease.
Topics: Animals; Antigen Presentation; Bone Marrow Transplantation; Chloroquine; Clinical Trials as Topic; Cyclosporine; Drug Synergism; Graft vs Host Disease; H-2 Antigens; Histocompatibility Antigens Class II; HLA Antigens; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoantigens; Lysosomes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes, Cytotoxic | 1997 |
[Treatment of transfusion-associated graft-versus-host disease].
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Methylprednisolone; Muromonab-CD3; Transfusion Reaction | 1997 |
Renal failure and bone marrow transplantation.
Topics: Acute Kidney Injury; Bone Marrow Transplantation; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents | 1998 |
New and emerging therapies for lichenoid dermatoses.
Topics: Cyclosporine; Female; Graft vs Host Disease; Humans; Interferons; Levamisole; Lichenoid Eruptions; PUVA Therapy | 2000 |
[Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease].
Topics: Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Purpura, Thrombotic Thrombocytopenic; Syndrome | 2000 |
Cholestasis after hematopoietic cell transplantation.
Topics: Cholestasis; Cyclosporine; Cytomegalovirus Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Parenteral Nutrition, Total; Sepsis | 1999 |
Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma.
Topics: Cyclosporine; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Nephrotic Syndrome | 2001 |
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Topics: Adult; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Disease Progression; Dogs; Forecasting; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Methotrexate; Middle Aged; Mycophenolic Acid; Neoplasms; Prednisone; Radiation Chimera; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2001 |
New developments in the prophylaxis and treatment of graft versus host disease.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Differentiation; Antimetabolites; Bone Marrow Transplantation; CD40 Ligand; Clinical Trials as Topic; CTLA-4 Antigen; Cyclosporine; Drug Design; Graft vs Host Disease; Guanidines; Guidelines as Topic; Humans; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Methotrexate; Mycophenolic Acid; Sirolimus; T-Lymphocytes; Tacrolimus | 2001 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2001 |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debridement; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Skin Ulcer; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Contraindications; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Multiple Organ Failure; Plasma Exchange; Platelet Transfusion; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure | 2001 |
Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation.
Topics: Bone Marrow; Cladribine; Combined Modality Therapy; Cyclosporine; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Remission Induction; Transplantation, Homologous; Vinblastine | 2001 |
Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
Topics: Acute Disease; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carbamates; Chronic Disease; Combined Modality Therapy; Cyclosporine; Daclizumab; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interleukin-11; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; T-Lymphocytes; Tacrolimus | 2002 |
Autologous graft-versus-host disease: a new frontier in immunotherapy.
Topics: Animals; Autoimmunity; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunotherapy; Neoplasms; T-Lymphocyte Subsets; Transplantation, Autologous | 1992 |
Bone marrow transplantation for chronic myeloid leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous | 1992 |
Allogeneic bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Survival Analysis; Transplantation, Homologous | 1991 |
Cyclosporine-induced autoimmunity and immune hyperreactivity.
Topics: Adjuvants, Immunologic; Animals; Autoimmunity; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Hypersensitivity, Delayed; Immune Tolerance; Lymphocyte Activation; T-Lymphocytes | 1991 |
217 trial(s) available for cyclosporine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Neoplasm Recurrence, Local; Prospective Studies | 2022 |
High Response Rate and Corticosteroid Sparing with Arsenic Trioxide-Based First-Line Therapy in Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adrenal Cortex Hormones; Adult; Arsenic Trioxide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Prospective Studies | 2022 |
Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycophenolic Acid; Recurrence; Sirolimus; Tacrolimus; Unrelated Donors | 2023 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patient Reported Outcome Measures; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2020 |
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
Topics: Aged; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Sirolimus; Tissue Donors; Transplantation, Homologous | 2020 |
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Siblings; Tissue Donors; Transplantation Conditioning | 2020 |
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Topics: Adult; Allografts; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Pentostatin; Photopheresis; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Prospective Studies; Stem Cell Transplantation; Treatment Outcome | 2021 |
Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study.
Topics: Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate | 2020 |
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Sirolimus; Stomatitis; Tacrolimus | 2021 |
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Placebo Effect; Transplantation, Homologous; Treatment Outcome | 2021 |
Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Cyclosporine; Cytokine Release Syndrome; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Transplantation, Haploidentical; Young Adult | 2021 |
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Recurrence; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2017 |
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Male; Methotrexate; Middle Aged; T-Lymphocytes; Time Factors; Treatment Outcome; Young Adult | 2017 |
Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study.
Topics: Adrenal Cortex Hormones; Adult; B-Lymphocytes; B7-H1 Antigen; Chronic Disease; Cyclosporine; Drug Combinations; Graft vs Host Disease; Humans; Lymphocyte Count; Middle Aged; Rituximab; Stem Cell Transplantation; Survival Rate; T-Lymphocytes, Helper-Inducer; Transplantation, Homologous; Young Adult | 2017 |
A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Transplantation, Homologous; Young Adult | 2018 |
Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources.
Topics: Adolescent; Adult; Aged; Allografts; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Predictive Value of Tests; Remission Induction; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning | 2018 |
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Busulfan; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Rate; T-Lymphocytes; Thiotepa; Transplantation Conditioning; Vidarabine | 2019 |
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Topics: Aged; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Sirolimus; Survival Rate; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2019 |
Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
Topics: Adolescent; Allografts; Antilymphocyte Serum; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Depletion; Male; Mycophenolic Acid; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Vidarabine | 2019 |
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.
Topics: Adenosine Deaminase Inhibitors; Adult; Antibodies, Monoclonal; Area Under Curve; Blood Transfusion, Autologous; Creatinine; Cyclosporine; Drug Resistance; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infliximab; Lymphocyte Transfusion; Male; Methotrexate; Methylprednisolone; Middle Aged; Pentostatin; Renal Insufficiency; Stem Cell Transplantation; Tacrolimus; Young Adult | 2013 |
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation.
Topics: Adult; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Siblings; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2013 |
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Remission Induction; Reoperation; Salvage Therapy; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine | 2013 |
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Risk Factors; Salvage Therapy; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2013 |
Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies.
Topics: Adolescent; Adult; Allografts; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Living Donors; Male; Middle Aged; Mycophenolic Acid; Quality of Life; Siblings; Survival Rate; Transplantation Conditioning; Unrelated Donors | 2014 |
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Risk Factors; Transplantation Conditioning; Young Adult | 2014 |
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population.
Topics: Aged; Antineoplastic Agents; Busulfan; Cyclosporine; Female; Frail Elderly; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine; Whole-Body Irradiation | 2015 |
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells.
Topics: Acute Disease; Adolescent; Adult; Aged; Antigens, Neoplasm; Biomarkers; Child; Child, Preschool; Cyclosporine; Cytokines; Drug Resistance; Female; Graft vs Host Disease; Humans; Immunophenotyping; Immunosuppressive Agents; Infant; Lymphocytes; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Prednisone; Prognosis; Steroids; Treatment Outcome; Young Adult | 2015 |
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Topics: Adult; Aged; Allografts; Anti-Inflammatory Agents; Cannabidiol; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Young Adult | 2015 |
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.
Topics: Acute Disease; Adolescent; Adult; Allografts; Child; Child, Preschool; Cyclosporine; Europe; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Incidence; Male; Methotrexate; Middle East; Neutropenia; Retrospective Studies; Societies, Medical; Unrelated Donors | 2015 |
Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Allografts; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Registries; Risk Factors; Survival Rate | 2016 |
A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation.
Topics: Acute Disease; Adult; Allografts; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Middle Aged; Survival Rate; Tacrolimus; Unrelated Donors | 2016 |
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
Topics: Adult; Aged; Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Infections; Male; Middle Aged; Mycophenolic Acid; Premedication; Sirolimus; Survival Analysis; Time Factors; Transplantation Conditioning; Young Adult | 2016 |
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Premedication; Sirolimus; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2016 |
Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphocyte Subsets; Male; Middle Aged; Premedication; Recurrence; Survival Rate; Tacrolimus; Young Adult | 2017 |
Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Child; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Living Donors; Male; Mycophenolic Acid; Myeloablative Agonists; Siblings; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2008 |
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.
Topics: Adult; Aged; Anti-Infective Agents; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Living Donors; Lymphatic Irradiation; Male; Middle Aged; Mycophenolic Acid; Premedication; Risk; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2009 |
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Topics: Adolescent; Child; Child, Preschool; Communicable Diseases; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Postoperative Complications; Prospective Studies; Recurrence; Transplantation, Homologous | 2009 |
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.
Topics: Adult; Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycophenolic Acid | 2010 |
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Mycophenolic Acid; Tacrolimus | 2009 |
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prospective Studies; Regression Analysis; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Biological Availability; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Pharmacokinetic and pharmacodynamic analysis of cyclosporine A (CsA) to find the best single time point for the monitoring and adjusting of CsA dose using twice-daily 3-h intravenous infusions in allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Cells, Cultured; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Middle Aged; Pharmacokinetics; T-Lymphocytes; Time Factors; Young Adult | 2010 |
Assessment of bioequivalence of a generic cyclosporine (Equoral) by a prospective randomized controlled trial on allogeneic stem cell transplant recipients.
Topics: Adolescent; Adult; Area Under Curve; Child; Cross-Over Studies; Cyclosporine; Drugs, Generic; Graft vs Host Disease; Humans; Immunosuppressive Agents; Middle Aged; Prospective Studies; Stem Cell Transplantation; Therapeutic Equivalency; Transplantation, Homologous; Treatment Outcome; Tunisia; Young Adult | 2010 |
Pharmacokinetics of cyclosporine A at a high-peak concentration of twice-daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation.
Topics: Administration, Oral; Adult; Area Under Curve; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Time Factors; Transplantation, Homologous | 2011 |
Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Cell Survival; Child; Child, Preschool; China; Combined Modality Therapy; Cyclosporine; Female; Filgrastim; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Histocompatibility Testing; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2011 |
CsA 2-h concentration correlates best with area under the concentration-time curve after allo-SCT compared with trough CsA.
Topics: Adolescent; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymorphism, Genetic; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Eruptions; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Lenalidomide; Lymphocyte Count; Male; Melphalan; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Prospective Studies; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 2011 |
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.
Topics: Adenine Nucleotides; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Development and validation of limited sampling strategies for estimation of cyclosporine area under the concentration-time curve in hematopoietic stem cell transplant patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Iran; Linear Models; Male; Models, Biological; Young Adult | 2011 |
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Humans; Infant; Male; Middle Aged; Mycophenolic Acid; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Secondary Prevention; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2012 |
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; Pilot Projects; Sirolimus; Tacrolimus; Transplantation, Homologous; Young Adult | 2011 |
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Survival Rate; Tacrolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2013 |
Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
Topics: Adult; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Prospective Studies; Risk; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Whole-Body Irradiation | 2013 |
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Topics: Adolescent; Adult; Analgesics; Cause of Death; Costs and Cost Analysis; Cyclosporine; Drug Utilization; Erythrocyte Transfusion; Female; Fever; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Home Nursing; Hospitalization; Humans; Immunosuppressive Agents; Infection Control; Male; Methotrexate; Middle Aged; Pancytopenia; Parenteral Nutrition, Total; Patient Care Team; Patient Isolation; Prednisolone; Quality of Life; Recurrence; Survival Rate; Sweden; Transplantation Conditioning; Treatment Outcome | 2002 |
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Longitudinal Studies; Male; Methotrexate; Mycoses; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation, Homologous | 2003 |
Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japa
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Humans; Infant; Japan; Male; Methotrexate; Siblings; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2003 |
Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; CD3 Complex; Cell Separation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation, Homologous | 2003 |
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
Topics: Adult; Busulfan; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasms; Patient Selection; Pilot Projects; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2003 |
Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.
Topics: Acute Disease; Adolescent; Bayes Theorem; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Severity of Illness Index; Siblings; Tissue Donors; Transplantation, Homologous | 2003 |
Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
Topics: Acute Disease; Adolescent; Area Under Curve; Bayes Theorem; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infant; Male; Methotrexate; Risk Factors; Tissue Donors | 2003 |
Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Interferon-gamma; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Survival Analysis; Transplantation, Autologous | 2003 |
Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Chimera; Transplantation, Autologous; Treatment Outcome | 2004 |
Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.
Topics: Administration, Topical; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Compounding; Estrogens; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Middle Aged; Treatment Outcome; Vaginal Diseases; Vulvar Diseases | 2003 |
Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors.
Topics: Adult; Blood Donors; Cyclosporine; Cytomegalovirus; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Virus Activation | 2004 |
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
Topics: Adult; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand.
Topics: Adolescent; Adult; Cell Lineage; Cyclosporine; Cytokines; Cytotoxicity, Immunologic; Dendritic Cells; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Killer Cells, Natural; Kinetics; Membrane Proteins; Middle Aged; Regeneration; Transplantation, Homologous | 2004 |
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Pentostatin; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2004 |
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Premedication; Prospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2004 |
Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Graft vs Host Reaction; Hodgkin Disease; Humans; Immunologic Factors; Interferon-alpha; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2004 |
Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Topics: Adoptive Transfer; Adult; Antigens, Viral; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Coculture Techniques; Complementarity Determining Regions; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytotoxicity Tests, Immunologic; Dendritic Cells; DNA, Viral; Female; Flow Cytometry; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Interleukin-4; Lymphocyte Activation; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Monocytes; Patient Selection; Phosphoproteins; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocyte Subsets; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Viral Matrix Proteins | 2004 |
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Topics: Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporine; Female; Flow Cytometry; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunoconjugates; Intestines; Leukemia; Liver; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Lymphoma; Male; Middle Aged; Patient Selection; Receptors, Interleukin-2; Ricin; Skin; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous | 2004 |
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantation.
Topics: Adult; Aged; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Middle Aged; Mycophenolic Acid; Neoplasm Staging; Siblings; Stem Cell Transplantation; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2004 |
Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.
Topics: Adolescent; Adult; Antigens, CD34; CD3 Complex; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunomagnetic Separation; Kinetics; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Siblings; T-Lymphocytes; Transplantation Chimera; Transplantation, Homologous; Treatment Outcome | 2004 |
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation.
Topics: Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Busulfan; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Transplantation, Homologous; Treatment Outcome | 2004 |
Re: allogenic transplantation after nonmyelosuppressive conditioning--the effect of single-agent pentostatin.
Topics: Carcinoma, Renal Cell; Cyclosporine; Graft Survival; Graft vs Host Disease; Humans; Leukocyte Transfusion; Pentostatin; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2004 |
Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
Topics: Adenocarcinoma, Clear Cell; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Renal Cell; Cells, Cultured; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Middle Aged; Minor Histocompatibility Antigens; Mycophenolic Acid; Myeloid Cells; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2004 |
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Topics: Adolescent; Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Transplantation Conditioning; Transplantation, Homologous | 2005 |
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate | 2005 |
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia; Methotrexate; Premedication; Prevalence; Survival Analysis | 2005 |
Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Calcineurin Inhibitors; Creatinine; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnesium; Male; Middle Aged; Tacrolimus; Transplantation, Homologous | 2005 |
Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias.
Topics: Adolescent; Adult; Antigens, CD34; CD3 Complex; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Donor Selection; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Transfusion; Male; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Thiotepa; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2006 |
Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors.
Topics: Adolescent; Adult; Alleles; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Pharmacokinetics; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2006 |
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Remission Induction; Survival Rate; Transplantation Conditioning; Vidarabine | 2006 |
Outcome of pediatric hematopoietic stem cell transplantations from Thai unrelated donors matched with high-resolution HLA typing.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; DNA Fingerprinting; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Premedication; Risk Factors; Survival Analysis; Thailand; Tissue Donors; Treatment Failure; Treatment Outcome | 2005 |
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity | 2006 |
Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients.
Topics: Administration, Oral; Adolescent; Age Factors; Anemia, Aplastic; Biological Availability; Body Weight; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infusions, Intravenous; Leukemia; Male; Metabolic Clearance Rate; Time Factors; Treatment Outcome | 2006 |
Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; CD3 Complex; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Herpes Zoster; Humans; Leukopenia; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Pyrazines; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Transplantation, Homologous | 2006 |
Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; CD3 Complex; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; T-Lymphocytes; Transplantation, Homologous | 2006 |
Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients.
Topics: Adolescent; Adult; Asian People; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Siblings; Transplantation, Homologous | 2006 |
Cyclosporine short infusion and C2 monitoring in haematopoietic stem cell transplant recipients.
Topics: Adult; Chi-Square Distribution; Cross-Over Studies; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Survival Analysis; Transplantation, Homologous | 2006 |
Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
Topics: Administration, Topical; Adult; Cyclosporine; Dry Eye Syndromes; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Muramidase; Prospective Studies; Surveys and Questionnaires; Tears; Treatment Outcome; Visual Acuity | 2006 |
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Topics: Adolescent; Adult; Aged; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2007 |
Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation.
Topics: Adolescent; Adult; Affect; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Physical Fitness; Psychology; Self Efficacy; Social Support | 2007 |
[Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2007 |
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
Topics: Active Transport, Cell Nucleus; Antigens, CD; Calcium Signaling; CD56 Antigen; Cell Differentiation; Cell Nucleus; Cell Proliferation; Coculture Techniques; Cyclosporine; Cytokines; GPI-Linked Proteins; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; K562 Cells; Killer Cells, Natural; Lymphocyte Subsets; Monomeric GTP-Binding Proteins; NFATC Transcription Factors; Receptors, IgG; Time Factors | 2007 |
Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mexico; Middle Aged; Recurrence; Salvage Therapy; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2007 |
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Topics: Adult; Aged; Busulfan; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Postoperative Complications; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2007 |
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Transplantation Conditioning; Treatment Failure | 2007 |
Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases.
Topics: Acute Disease; Adult; Aged; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Tacrolimus | 2007 |
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Melphalan; Methotrexate; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2007 |
Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Chronic Disease; Conjunctiva; Cornea; Cyclosporine; Dry Eye Syndromes; Female; Goblet Cells; Graft vs Host Disease; Humans; Male; Middle Aged; Mucin 5AC; Mucins; Ophthalmic Solutions; Patient Satisfaction; Pilot Projects; Tears; Treatment Outcome | 2008 |
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host
Topics: Adolescent; Adult; Aspergillosis; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Lymphocyte Depletion; Male; Methotrexate; Opportunistic Infections; Retrospective Studies; Survival Analysis; Transplantation, Homologous | 2007 |
Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Logistic Models; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors | 2007 |
Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
Topics: Adolescent; Adult; Bone Density; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2008 |
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vidarabine | 2008 |
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning.
Topics: Adult; Aged; Anesthesia Recovery Period; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Flow Cytometry; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neoplasms; Peripheral Blood Stem Cell Transplantation; Receptors, Antigen, T-Cell, alpha-beta; Thymus Gland; Time Factors; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2008 |
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Survival Rate; Transplantation Conditioning | 2008 |
Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2008 |
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.
Topics: Acute Disease; Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Placebos; Transplantation, Homologous | 1995 |
Phase II study of glycosylated recombinant human granulocyte colony-stimulating factor after HLA-identical sibling bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glycosylation; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Histocompatibility; HLA Antigens; Humans; Injections, Subcutaneous; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Recombinant Proteins; Tissue Donors | 1994 |
Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation | 1995 |
Thalidomide as salvage therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chronic Disease; Constipation; Cyclosporine; Drug Eruptions; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Neuritis; Neutropenia; Prednisone; Remission Induction; Salvage Therapy; Survival Rate; Thalidomide; Treatment Outcome | 1995 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infections; Male; Methotrexate; Methylprednisolone; Survival Rate | 1995 |
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; Humans; Middle Aged; Survival Analysis; Trimetrexate | 1995 |
Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Aspergillosis; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Female; Fungemia; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Male; Methotrexate; Polymorphism, Restriction Fragment Length | 1995 |
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate.
Topics: Acute Disease; Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome | 1995 |
Bone marrow transplantation for Fanconi anemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Male; Methotrexate; Survival Rate | 1995 |
Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Activation; Male; Methotrexate; Middle Aged; Prospective Studies; Receptors, Interleukin-2; T-Lymphocytes | 1995 |
T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
Topics: Adolescent; Adult; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Depletion; Male; Middle Aged; Multiple Myeloma; Transplantation, Homologous | 1994 |
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Multivariate Analysis; Recurrence; Remission Induction; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; T-Lymphocytes | 1994 |
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Male; Methotrexate; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors | 1994 |
Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
Topics: Administration, Topical; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Mouth Diseases; Mouthwashes; Myelodysplastic Syndromes | 1994 |
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Methotrexate; Recurrence; Survival Analysis; T-Lymphocytes; Time Factors | 1994 |
Phase I study of alpha-interferon augmentation of cyclosporine-induced graft versus host disease in recipients of autologous bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Transplantation, Autologous | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Topics: Adult; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; HLA-DR Antigens; Humans; Interferon-gamma; Middle Aged; Prospective Studies; Skin; Treatment Outcome | 1994 |
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Methotrexate; Prospective Studies | 1994 |
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Multivariate Analysis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous | 1994 |
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Prednisolone; Transplantation, Homologous | 1994 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Edema; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunotoxins; Infant; Male; Methotrexate; Prednisolone; Ricin; Tissue Donors; Weight Gain | 1993 |
Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Children's Cancer Group.
Topics: Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Prognosis | 1993 |
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Fever; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Pentoxifylline; Placebos; Probability; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Treatment Outcome | 1993 |
Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporin compared with either agent alone for prevention of graft-versus-host disease. Advisory Committee of the International
Topics: Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Probability; Proportional Hazards Models; Regression Analysis | 1993 |
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.
Topics: Adult; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Infusions, Intravenous; Middle Aged; Transplantation, Autologous | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Transplantation of allogeneic CD34+ blood cells.
Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
Immunomagnetic CD4+ and CD8+ cell depletion for patients at high risk for severe acute GVHD.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Cyclosporine; Female; Fever; Graft vs Host Disease; Humans; Immunomagnetic Separation; Incidence; Male; Middle Aged; Risk Factors; Syndrome; Transplantation, Homologous | 1996 |
Bone density loss during treatment of chronic GVHD.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Marrow Transplantation; Cyclosporine; Diet; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Transplantation, Homologous | 1996 |
Nephroprotective effect of cilastatin in allogeneic bone marrow transplantation. Results from a retrospective analysis.
Topics: Acute Kidney Injury; Adult; Bone Marrow Transplantation; Cilastatin; Cyclosporine; Female; Graft vs Host Disease; Humans; Imipenem; Immunosuppressive Agents; Kidney; Leukemia; Male; Protease Inhibitors; Retrospective Studies; Transplantation, Homologous | 1996 |
Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial.
Topics: Administration, Topical; Adult; Aged; Bone Marrow Transplantation; Cellulose; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Middle Aged; Mouth Diseases; Treatment Outcome | 1996 |
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Topics: Adult; Aged; Antigens, CD34; Blood Cells; Cell Count; Cell Separation; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Administration Schedule; Feasibility Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 1997 |
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome | 1997 |
Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; T-Lymphocytes; Time Factors; Transcription, Genetic; Transplantation Chimera | 1997 |
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy, Adoptive; Interferon alpha-2; Interferon-alpha; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction | 1997 |
Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey.
Topics: Adult; Body Weight; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Transplantation Conditioning | 1997 |
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Karnofsky Performance Status; Methotrexate; Multivariate Analysis; Recurrence; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Failure | 1997 |
Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?
Topics: Adult; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia; Male; Methotrexate; Middle Aged; Nuclear Family; Tissue Donors; Transplantation, Homologous | 1997 |
Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants.
Topics: Adolescent; Aged; Bone Marrow Transplantation; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Graft vs Host Reaction; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Living Donors; Male; Middle Aged; Nuclear Family; Treatment Outcome | 1997 |
Induction of autocytotoxic T cells with cyclosporine and interferon-gamma for patients with non-Hodgkin's lymphoma after transplantation of peripheral blood stem cells.
Topics: Adult; Autoimmunity; Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Interferon-gamma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recombinant Proteins; T-Lymphocytes, Cytotoxic | 1997 |
Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.
Topics: Adolescent; Anemia, Sickle Cell; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Methotrexate; Transplantation Chimera; Transplantation Conditioning | 1997 |
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Time Factors | 1998 |
Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
Topics: Adolescent; Adult; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Prospective Studies; Skin; Transplantation, Autologous | 1998 |
Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group.
Topics: Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 1998 |
Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Burkitt Lymphoma; Cyclosporine; Erythropoietin; Female; Fetal Blood; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male | 1998 |
Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord.
Topics: Anemia, Sickle Cell; Antineoplastic Agents, Alkylating; beta-Thalassemia; Child; Child, Preschool; Cyclosporine; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prospective Studies; Thiotepa; Treatment Outcome | 1998 |
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Nuclear Family; Recurrence; Survival Analysis; Tacrolimus; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1998 |
[Outcomes of 50 leukemia patients who received bone marrow transplants from unrelated donors].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Germ-Free Life; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Risk; Survival Rate; Tissue Donors; Treatment Outcome | 1998 |
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Methotrexate; Multivariate Analysis; Prognosis; Time Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Bone Marrow Transplantation; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Risk Factors; Survival Rate; Transplantation Chimera; Transplantation, Homologous | 1998 |
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
Topics: Acute Disease; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Mycophenolic Acid; Nuclear Family; Prednisolone | 1998 |
Higher exposure to cyclosporine A with unchanged tolerability in patients converted from Sandimmun to Sandimmun Neoral.
Topics: Adult; Biological Availability; Cyclosporine; Drug Delivery Systems; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pharmaceutical Solutions | 1997 |
Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus; Transplantation, Homologous | 1998 |
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Time Factors; Transplantation, Homologous | 1997 |
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Survival Rate; Transplantation, Homologous | 1999 |
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Topics: Adolescent; Adult; Anti-Infective Agents; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Histocompatibility Testing; Humans; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Infant; Male; Methotrexate; Metronidazole; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1999 |
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Survival; Tacrolimus | 1999 |
Graft versus host disease in autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Female; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon-alpha; Male; Middle Aged; Transplantation Conditioning; Transplantation, Autologous | 1999 |
Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Interferon-gamma; Middle Aged; Prospective Studies; Transplantation, Autologous | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Topics: Acute Disease; Adenoviridae Infections; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cystitis; Cytomegalovirus Infections; Female; Fungemia; Ganciclovir; Graft vs Host Disease; Histocompatibility; Humans; Immunomagnetic Separation; Immunosuppressive Agents; Leukemia; Lung Diseases, Interstitial; Lymphocyte Depletion; Male; Methotrexate; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Italy; Leukemia; Male; Neoplasm Recurrence, Local; Nuclear Family; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk; Tissue Donors; Transplantation Conditioning; Treatment Outcome | 2000 |
Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant, Newborn; Lymphocyte Count; Lymphocyte Subsets; Male; Middle Aged; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2000 |
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisolone; Safety; Survival Rate; Tissue Donors | 2000 |
Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Drug Resistance; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Opportunistic Infections; Prodrugs; PUVA Therapy; Safety; Transplantation, Homologous; Treatment Outcome | 2000 |
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
Topics: Adolescent; Adult; Bone Marrow Cells; Cyclosporine; Family; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Leukocyte Count; Living Donors; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Primary Myelofibrosis; Survival Analysis; Transplantation, Homologous | 2000 |
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2000 |
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
Topics: Adult; Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Genotype; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Heart Diseases; Hematologic Neoplasms; Histocompatibility; HLA Antigens; Humans; Leukocyte Transfusion; Male; Mice; Middle Aged; Models, Animal; Phenotype; Remission Induction; Reproducibility of Results; Salvage Therapy; Survival Analysis; T-Lymphocytes; Thymus Gland; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Middle Aged; Time Factors | 2000 |
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nuclear Family; Survival Analysis; Time Factors; Transplantation, Homologous; Treatment Outcome | 2000 |
Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukapheresis; Male; Melphalan; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Analysis; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Transplantation Tolerance; Vidarabine | 2000 |
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Microsatellite Repeats; Middle Aged; Nuclear Family; Polymerase Chain Reaction; Recurrence; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2000 |
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cyclophosphamide; Cyclosporine; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Interferon-gamma; Killer Cells, Natural; Lymphocytes; Middle Aged; Phytohemagglutinins; Survival Analysis; Thiotepa | 2000 |
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Topics: Actuarial Analysis; Chronic Disease; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Graft vs Host Disease; Humans; Hypesthesia; Neutropenia; Prednisone; Thalidomide | 2000 |
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Salvage Therapy; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
Topics: Adult; Aged; Area Under Curve; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Transplantation, Homologous | 2001 |
Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Mycophenolic Acid; Transplantation Conditioning | 2001 |
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.
Topics: Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infections; Prednisone; Prognosis; Risk Factors; Salvage Therapy; Survival Analysis; Thalidomide; Transplantation, Homologous; Treatment Outcome | 2001 |
Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Leukemia; Lymphocyte Depletion; Male; Nuclear Family; Recurrence; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous | 2001 |
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infections; Leukemia; Lymphocyte Depletion; Lymphoma; Male; Methotrexate; Middle Aged; Survival Analysis; Time Factors; Tissue Donors; Transplantation, Homologous | 2001 |
[Feasibility of early tapering and discontinuation of cyclosporine to intensify the graft-versus-leukemia effect in patients with advanced hematologic neoplasms].
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Feasibility Studies; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2001 |
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infection Control; Italy; Life Tables; Male; Methotrexate; Middle Aged; Rabbits; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Topics: Adult; Biopsy; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Prospective Studies; Risk Factors; Skin; Survival Rate; Time Factors; Transplantation, Homologous | 2001 |
Assessment of myocardial hypertrophy by echocardiography in adult patients receiving tacrolimus or cyclosporine therapy for prevention of acute GVHD.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Echocardiography; Female; Graft vs Host Disease; Humans; Hypertrophy, Left Ventricular; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus | 2001 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate as acute GVHD prophylaxis after unrelated donor allogeneic bone marrow transplantation].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Mycophenolic Acid; Transplantation, Heterologous; Young Adult | 2001 |
[A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haploidy; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Sibling Relations; Stem Cells; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation | 2001 |
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclosporine; Drug Administration Schedule; Erythropoietin; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Recombinant Proteins; Thrombocytosis; Transplantation, Homologous | 2002 |
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Survival Analysis; Thrombocytopenia; Transplantation, Homologous | 2002 |
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation | 1992 |
Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Melphalan; Methotrexate; Transplantation, Autologous; Transplantation, Homologous | 1992 |
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukemia; Methotrexate | 1992 |
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Time Factors | 1992 |
Phase II study of FK 506 for allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Diarrhea; Drug Evaluation; Female; Graft vs Host Disease; Humans; Male; Tacrolimus; Transplantation, Homologous | 1991 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1991 |
781 other study(ies) available for cyclosporine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay.
Topics: Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; False Positive Reactions; Graft vs Host Disease; Humans; Immunosuppressive Agents; Microbiological Techniques; Sirolimus; Tacrolimus; Triazoles | 2008 |
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Siblings; Transplantation Conditioning; United States | 2022 |
Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study.
Topics: Cohort Studies; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Unrelated Donors | 2022 |
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning; Transplantation, Homologous | 2022 |
The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment.
Topics: Acute Disease; Animals; Cyclosporine; Drugs, Chinese Herbal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Mice | 2022 |
The immunosuppressant drug Cyclosporin A aggravates irradiation effects in endothelial cells.
Topics: Cadherins; Cyclosporine; Endothelial Cells; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1 | 2022 |
Essential Roles of the Transcription Factor NR4A1 in Regulatory T Cell Differentiation under the Influence of Immunosuppressants.
Topics: Animals; Cell Differentiation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; T-Lymphocytes, Regulatory; Transcription Factors | 2022 |
Cyclosporine A regulates PMN-MDSCs viability and function through MPTP in acute GVHD: Old medication, new target.
Topics: Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mitochondrial Permeability Transition Pore; Myeloid-Derived Suppressor Cells | 2022 |
Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Monitoring; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid | 2022 |
Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell tran
Topics: Acute Disease; Adolescent; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2022 |
Risk factors for adverse outcomes following haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: a two-center analysis.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Risk Factors; Tacrolimus; Transplantation Conditioning | 2022 |
Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplant.
Topics: Acute Disease; Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning | 2022 |
Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft-versus-host disease prophylaxis following allogeneic haemopoietic cell transplantation.
Topics: Cyclosporine; Drug Tapering; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Retrospective Studies | 2023 |
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study
Topics: Antilymphocyte Serum; Bone Marrow; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mycophenolic Acid; Retrospective Studies; Transplantation, Haploidentical | 2022 |
Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHD.
Topics: Critical Illness; Cyclosporine; Feasibility Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Intensive Care Units | 2022 |
Optimizing the oral dose of cyclosporine with concomitant posaconazole post stem cell allograft.
Topics: Allografts; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Retrospective Studies | 2023 |
Age-Related Differences in the Clinical Patterns of Ocular Graft-Versus-Host Disease.
Topics: Adolescent; Adult; Cross-Sectional Studies; Cyclosporine; Dry Eye Syndromes; Graft vs Host Disease; Humans; Lubricant Eye Drops | 2022 |
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro.
Topics: Cyclophosphamide; Cyclosporine; Endothelial Cells; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Proto-Oncogene Proteins c-akt; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2023 |
Impact of Post-Transplantation Cyclophosphamide on Transfusion Requirements in HLA-Matched Sibling Peripheral Blood Stem Cell Transplantation.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Peripheral Blood Stem Cell Transplantation; Siblings | 2023 |
Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease.
Topics: Animals; Bendamustine Hydrochloride; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukocytes, Mononuclear; Mice | 2022 |
Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience.
Topics: 5-Aminolevulinate Synthetase; Anemia, Sideroblastic; Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Iran; Transplantation Conditioning | 2023 |
Successful Hematopoietic Stem Cell Transplant in a Patient with Omenn Syndrome: A Case Report.
Topics: Cyclosporine; Failure to Thrive; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Natural; Severe Combined Immunodeficiency; Transplantation Conditioning | 2023 |
Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis.
Topics: Allografts; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Retrospective Studies | 2023 |
A single-center experience of haploidentical stem cell transplantation in hematological malignancies.
Topics: Busulfan; Child; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Prospective Studies; Retrospective Studies | 2023 |
[Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy].
Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Prednisolone | 2023 |
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.
Topics: Animals; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immune Tolerance; Leukemia; Mice; Programmed Cell Death 1 Receptor; T-Lymphocytes | 2023 |
Cyclophosphamide with cyclosporine A for graft-versus-host disease prophylaxis in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation from human leucocyte antigen-matched donors.
Topics: Adult; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myeloid, Acute; Transplantation Conditioning | 2023 |
Post-transplantation Cyclophosphamide-based Graft-versus-host-disease Prophylaxis Compared to Methotrexate-cyclosporine a in Matched-related Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2023 |
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.
Topics: Bronchiolitis Obliterans Syndrome; Chronic Disease; Cross-Sectional Studies; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney | 2023 |
Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Unrelated Donors | 2023 |
Reaching the cyclosporine a level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantation.
Topics: Cyclosporine; East Asian People; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Prognosis; Retrospective Studies | 2023 |
Premature cyclosporine cessation and TBI-containing conditioning regimen increase the risk of acute GvHD in children undergoing unrelated donor hematopoietic stem cell transplantation.
Topics: Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies; Unrelated Donors | 2019 |
Correction of Severe Myelofibrosis, Impaired Platelet Functions and Abnormalities in a Patient with Gray Platelet Syndrome Successfully Treated by Stem Cell Transplantation.
Topics: Adult; Blood Platelets; Cyclosporine; Graft vs Host Disease; Gray Platelet Syndrome; Hematopoietic Stem Cell Transplantation; Humans; Male; Microscopy, Electron, Transmission; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Splenomegaly; Time Factors; Transplantation Conditioning | 2020 |
Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anemia, Hemolytic, Autoimmune; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Haploidentical; Transplantation, Homologous; Young Adult | 2019 |
Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible.
Topics: Cyclosporine; Eye; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Prospective Studies | 2020 |
TLI in pediatric patients.
Topics: Adolescent; Antibiotic Prophylaxis; Child; Child, Preschool; Cyclosporine; Dose Fractionation, Radiation; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Irradiation; Male; Myeloablative Agonists; Transplantation Conditioning; Transplantation, Haploidentical; Treatment Outcome | 2020 |
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.
Topics: Acetyl-CoA C-Acetyltransferase; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Japan; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Recurrence; Siblings; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2020 |
Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis.
Topics: Animals; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Mice | 2020 |
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Severity of Illness Index; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2019 |
Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
Topics: Adolescent; Anemia, Diamond-Blackfan; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Infusions, Intravenous; Male; Methotrexate; Prospective Studies; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2019 |
Effects of Immunosuppressive Medications on Mitochondrial Function.
Topics: Apoptosis; Cell Differentiation; Cyclosporine; Energy Metabolism; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Jurkat Cells; Membrane Potential, Mitochondrial; Mitochondria; Mycophenolic Acid; Reactive Oxygen Species; Sirolimus; T-Lymphocytes; Tacrolimus | 2020 |
Severity of mucositis during allogeneic transplantation impacts post-transplant cyclosporin absorption.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mucositis; Transplantation, Homologous | 2020 |
Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.
Topics: Anemia, Sickle Cell; Bayes Theorem; beta-Thalassemia; Child; Cyclosporine; Goals; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Transplantation Conditioning; Transplantation, Homologous | 2020 |
Berberine combined with cyclosporine A alleviates acute graft-versus-host disease in murine models.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Berberine; Bone Marrow Transplantation; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Signal Transduction | 2020 |
Severe Anaphylaxis During Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Aplastic Anemia: Case Report of Individualized Pharmaceutical Care and Literature Review.
Topics: Administration, Oral; Adult; Anaphylaxis; Anemia, Aplastic; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Transplantation, Homologous; Young Adult | 2020 |
Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Male; Middle Aged; Nervous System Diseases; Patient Safety; Retrospective Studies; Tacrolimus; Young Adult | 2021 |
Low cyclosporine concentrations in children and time to acute graft versus host disease.
Topics: Acute Disease; Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies | 2020 |
Evaluation of adherence and clinical outcomes in patients undergoing allogeneic haematopoietic stem cell transplantation.
Topics: Adult; Anti-Infective Agents; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Patient Compliance; Retrospective Studies; Treatment Outcome | 2020 |
Tolerance and Adherence to Cationic 0.1% Cyclosporine in Ocular Graft-versus-Host Disease.
Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Drug Tolerance; Dry Eye Syndromes; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Medication Adherence; Middle Aged; Prognosis; Retrospective Studies; Young Adult | 2021 |
Single-Agent Cyclosporine for Graft-versus-Host Disease Prophylaxis in Patients with Acquired Aplastic Anemia Receiving Fludarabine-Based Conditioning.
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Vidarabine; Young Adult | 2020 |
Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
Topics: Child; Child, Preschool; China; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Doxorubicin; Drug Therapy, Combination; Etoposide; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Prognosis; Remission Induction; Retrospective Studies; Transplantation Conditioning; Treatment Outcome | 2020 |
Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host disease.
Topics: Chromatography, Liquid; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Tacrolimus; Tandem Mass Spectrometry | 2021 |
Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Oligopeptides; Transplantation Conditioning; Unrelated Donors | 2021 |
Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pre-Exposure Prophylaxis; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Young Adult | 2021 |
Comparison of continuous versus intermittent infusion cyclosporine and impact on transplant related outcomes in allogeneic transplant recipients.
Topics: Adult; Allografts; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies | 2021 |
Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Retrospective Studies; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Haploidentical | 2021 |
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.
Topics: Agammaglobulinemia; Age of Onset; Anemia, Hemolytic, Autoimmune; Child; Cyclosporine; Cytochrome P-450 CYP3A; Female; Gain of Function Mutation; Germ-Line Mutation; Graft vs Host Disease; Growth Disorders; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphoproliferative Disorders; Mutation, Missense; Polymorphism, Single Nucleotide; Prednisolone; Retinal Hemorrhage; Spectrin; STAT3 Transcription Factor; Unrelated Donors | 2020 |
Drug delivery formulation impacts cyclosporine efficacy in a humanised mouse model of acute graft versus host disease.
Topics: Administration, Oral; Animals; Cyclosporine; Drug Delivery Systems; Graft vs Host Disease; Humans; Mice; Pharmaceutical Preparations | 2021 |
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Transplantation Conditioning; Unrelated Donors | 2022 |
Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy.
Topics: Adolescent; Brain Diseases; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Epilepsy; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Retrospective Studies | 2021 |
Impact of a Bayesian Individualization of Cyclosporine Dosage Regimen for Children Undergoing Allogeneic Hematopoietic Cell Transplantation: A Cost-Effectiveness Analysis.
Topics: Bayes Theorem; Child; Cost-Benefit Analysis; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Retrospective Studies | 2021 |
Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling.
Topics: Acute Disease; Animals; Calcineurin Inhibitors; CD8-Positive T-Lymphocytes; Cyclosporine; Graft vs Host Disease; Mice; Mice, Knockout; NFATC Transcription Factors; Receptors, Antigen, T-Cell; Signal Transduction | 2021 |
Successful Allogeneic Peripheral Blood Stem Cell Transplantation in 4 Wiskott-Aldrich Syndrome Patients.
Topics: Busulfan; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Wiskott-Aldrich Syndrome | 2022 |
Cyclosporine A and IFNγ licencing enhances human mesenchymal stromal cell potency in a humanised mouse model of acute graft versus host disease.
Topics: Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Activation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice | 2021 |
CD52/GPI- T-Cells Are Enriched for Alloreactive Specificity and Predict Acute Graft-Versus-Host-Disease After Stem Cell Transplantation.
Topics: Alemtuzumab; CD52 Antigen; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning | 2021 |
Analyzing the clinical outcomes of switching from cyclosporine to tacrolimus in pediatric hematopoietic stem cell transplantation.
Topics: Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Posterior Leukoencephalopathy Syndrome; Retrospective Studies; Tacrolimus | 2021 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
Ophthalmologic findings and complications before and after hematopoietic stem cell transplantation: single-center study.
Topics: Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Retrospective Studies; Transplantation Conditioning | 2021 |
Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation.
Topics: Antilymphocyte Serum; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mycophenolic Acid; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Unrelated Donors | 2021 |
Calcineurin inhibitors target Lck activation in graft-versus-host disease.
Topics: Calcineurin; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; NFATC Transcription Factors; Tacrolimus | 2021 |
Ocular Findings of Pediatric Dry Eye Related to Graft-Versus-Host Disease
Topics: Administration, Topical; Adolescent; Child; Child, Preschool; Conjunctiva; Cyclosporine; Dry Eye Syndromes; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Retrospective Studies; Tears; Transplantation, Homologous | 2021 |
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.
Topics: Aged; Bacterial Infections; Cyclosporine; Female; gamma-Globulins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Myelodysplastic Syndromes; Opportunistic Infections; Prognosis; ROC Curve; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2021 |
Pharmacokinetic comparison of cyclosporin A and tacrolimus in graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Risk Factors; Survival Analysis; Tacrolimus; Transplantation, Homologous; Young Adult | 2017 |
Successful treatment of calcineurin inhibitor-induced pain syndrome with acute graft versus host disease by switching calcineurin inhibitors followed by pregabalin.
Topics: Aged; Calcineurin Inhibitors; Combined Modality Therapy; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hip; Humans; Lower Extremity; Male; Myelodysplastic Syndromes; Pain; Pregabalin; Severity of Illness Index; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2017 |
External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.
Topics: Adult; Area Under Curve; Bayes Theorem; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Retrospective Studies; Transplant Recipients; Young Adult | 2018 |
Everolimus for pediatric patients with acute graft-versus-host disease after hematopoietic stem cell transplantation: A pilot study.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Everolimus; Feasibility Studies; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Infant; Male; Pilot Projects; Retrospective Studies; Steroids; Thrombotic Microangiopathies; Treatment Outcome; Young Adult | 2017 |
CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model.
Topics: Acute Disease; Animals; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CXCR3; T-Lymphocytes; Tissue Donors; Transplantation Conditioning | 2018 |
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Graft Survival; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Predictive Value of Tests; Survival Analysis; Transplantation, Haploidentical; Young Adult | 2018 |
Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; T-Lymphocytes; Transplantation Conditioning; Transplantation, Haploidentical; Transplantation, Homologous; Young Adult | 2018 |
Delayed-onset inflammatory polyneuropathy without graft versus host disease after bone marrow transplantation.
Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Demyelinating Diseases; Female; Graft vs Host Disease; Humans; Immunization, Passive; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Young Adult | 2018 |
Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease.
Topics: Adult; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Mycophenolic Acid; Photopheresis; Prednisone; Sclerosis; Skin; Tacrolimus | 2018 |
Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
Topics: Animals; Chemokine CCL24; Chemokine CXCL5; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Heterografts; Humans; Lymphocytes; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred ICR; Mice, Inbred NOD; Mice, SCID | 2018 |
Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Acute Disease; Adult; Aged; Area Under Curve; Biomarkers, Tumor; Calcineurin Inhibitors; Case-Control Studies; Cyclosporine; Exosomes; Female; Gene Expression Profiling; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; MicroRNAs; Middle Aged; Myeloablative Agonists; ROC Curve; Survival Analysis; Tacrolimus; Transplantation, Homologous | 2018 |
Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter study.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Transplantation Conditioning | 2018 |
Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adult; Aged; Calcineurin Inhibitors; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney; Liver; Male; Middle Aged; Netherlands; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Water-Electrolyte Imbalance; Young Adult | 2019 |
Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclophosphamide; Cyclosporine; Drug Evaluation; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Retrospective Studies; T-Lymphocytes; Tissue Donors | 2019 |
The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
Topics: Adult; Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antilymphocyte Serum; Benzoates; Biodiversity; Cyclosporine; Dental Health Surveys; DNA, Bacterial; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Immunocompromised Host; Immunosuppressive Agents; Male; Microbiota; Middle Aged; Mouth; Pilot Projects; Pyrazoles; Ribotyping; Sequence Analysis, DNA; Smoking; T-Lymphocytes; Tongue; Young Adult | 2019 |
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Risk Factors; Time-to-Treatment; Transplantation Conditioning; Transplantation, Haploidentical; Treatment Outcome; Young Adult | 2019 |
Establishment of immunity against Epstein-Barr virus infection in a patient with CHARGE/complete DiGeorge syndrome after peripheral blood lymphocyte transfusion.
Topics: CD3 Complex; Cell Proliferation; CHARGE Syndrome; Concanavalin A; Cyclosporine; Diarrhea; DiGeorge Syndrome; Epstein-Barr Virus Infections; Fatal Outcome; Graft vs Host Disease; Herpesvirus 4, Human; HLA Antigens; Humans; Infant, Newborn; Lymphocyte Transfusion; Male; Methotrexate; Mutation; Phenotype; Phytohemagglutinins; Siblings; T-Lymphocytes | 2019 |
Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for
Topics: Adult; Agammaglobulinemia; Cyclosporine; Genetic Diseases, X-Linked; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Transplantation Conditioning; Tumor Suppressor Protein p53 | 2019 |
Posterior Reversible Encephalopathy Syndrome (PRES) in Children Undergoing Allogeneic Stem Cell Transplantation.
Topics: Child; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Neurotoxicity Syndromes; Posterior Leukoencephalopathy Syndrome; Stem Cell Transplantation; Transplantation, Homologous | 2019 |
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Topics: Adolescent; Adult; Aged; Allografts; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycophenolic Acid; Survival Rate | 2019 |
Sirolimus-based graft-versus-host disease prophylaxis.
Topics: Cyclosporine; Graft vs Host Disease; Humans; Mycophenolic Acid; Sirolimus; Stem Cell Transplantation; Transplantation Conditioning | 2019 |
Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Dexamethasone; Disease-Free Survival; Drug Resistance; Etanercept; Female; Graft vs Host Disease; Humans; Infant; Male; Middle Aged; Mycophenolic Acid; Predictive Value of Tests; Prospective Studies; Survival Rate | 2019 |
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
Topics: Adolescent; Antifungal Agents; Asian People; Body Weight; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP3A; Drug Monitoring; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Models, Biological; Polymorphism, Genetic; Transplantation, Homologous; Triazoles | 2019 |
Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Allografts; Antibodies, Viral; Antibody Specificity; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Measles Vaccine; Measles virus; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Tacrolimus; Time Factors; Transplantation Conditioning | 2019 |
Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin A.
Topics: Acute Disease; Animals; Cyclosporine; Female; Forkhead Transcription Factors; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Plant Extracts; Random Allocation; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Tripterygium | 2013 |
Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Topics: Acute Disease; Adult; Allografts; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Photopheresis; Retrospective Studies; Stem Cell Transplantation; Steroids; Transplantation Conditioning | 2013 |
Acral erythema worsened by intravenous infusions of cyclosporin.
Topics: Adult; Antineoplastic Agents; Cyclosporine; Cytarabine; Drug Eruptions; Erythema; Graft vs Host Disease; Humans; Infusions, Intravenous; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2013 |
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Topics: Academies and Institutes; Anti-Infective Agents; Cyclosporine; Data Collection; Graft vs Host Disease; Growth Hormone; Hematopoietic Stem Cell Transplantation; Humans; Mediterranean Region; Methotrexate; Pulmonary Veno-Occlusive Disease; Transplantation, Autologous; Transplantation, Homologous; Ursodeoxycholic Acid | 2013 |
Cyclosporine-related posterior reversible encephalopathy syndrome after cord blood stem cell transplantation.
Topics: Adolescent; Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Radiography; Vidarabine; Whole-Body Irradiation | 2013 |
Human papillomavirus reactivation following treatment of genital graft-versus-host disease.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Papillomaviridae; Papillomavirus Infections; Uterine Cervicitis; Vaginal Diseases; Virus Activation | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Morbidity; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Transplantation, Homologous; Unrelated Donors; Young Adult | 2013 |
Exercise benefits in chronic graft versus host disease: a murine model study.
Topics: Adaptation, Physiological; Animals; Biomarkers; CD4 Lymphocyte Count; Chronic Disease; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Interleukin-4; Kaplan-Meier Estimate; Leukocyte Common Antigens; Lymphocytes; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Physical Conditioning, Animal; Physical Fitness; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2013 |
Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival.
Topics: Adolescent; Adult; Alleles; Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Risk Factors; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2014 |
Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Adult; Aged; Busulfan; Chimerism; Cohort Studies; Cyclophosphamide; Cyclosporine; Cytomegalovirus Infections; DNA; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; T-Lymphocytes; Tacrolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Viremia; Young Adult | 2014 |
Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Hearing Loss, Sensorineural; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Myasthenia Gravis; Mycophenolic Acid; Piebaldism; Pigmentation Disorders; Plasma Exchange; Remission Induction; Rituximab; Transplantation, Homologous; Treatment Outcome | 2014 |
Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Down Syndrome; Genetic Predisposition to Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Living Donors; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Registries; Remission Induction; Retrospective Studies; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2014 |
Rapid Resolution of Graft-versus-Host-Disease-Related Central Serous Chorioretinopathy.
Topics: Bone Marrow Transplantation; Central Serous Chorioretinopathy; Cyclosporine; Diarrhea; Exanthema; Female; Fluorescein Angiography; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2015 |
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Male; Middle Aged; Risk Factors; Rituximab; Survival Analysis; Transplant Recipients; Transplantation, Homologous; Treatment Outcome; Virus Activation; Young Adult | 2014 |
Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Survival Rate; Tacrolimus; Treatment Outcome; Young Adult | 2014 |
On a class of optimal covariate-adjusted response adaptive designs for survival outcomes.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Research Design; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Impact of cyclosporine levels on the development of acute graft versus host disease after reduced intensity conditioning allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Alleles; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2014 |
Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Melanoma, Experimental; Mice; Receptors, Antigen, T-Cell; T-Lymphocytes, Regulatory; Tissue Donors; TOR Serine-Threonine Kinases; Transplantation, Homologous | 2014 |
Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cell Death; Cell Proliferation; Cord Blood Stem Cell Transplantation; Cyclosporine; Cytokines; Fetal Blood; Graft vs Host Disease; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Leukocyte Common Antigens; Lymphocyte Activation; Mycophenolic Acid; T-Lymphocytes, Regulatory | 2014 |
[Allogeneic hematopoietic stem cell transplantation for hemophagocytic syndrome].
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Survival Rate; Tissue Donors; Transplantation Conditioning; Treatment Outcome | 2014 |
Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2.
Topics: Adult; Cells, Cultured; Cyclosporine; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant, Newborn; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Mycophenolic Acid; Pregnancy | 2014 |
Are alternative donors really still "alternative?".
Topics: Bone Marrow Transplantation; Cyclosporine; Gene Expression; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Recurrence; Siblings; Survival Analysis; Transplantation, Homologous; Unrelated Donors | 2014 |
Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Busulfan; Child; Child, Preschool; Cohort Studies; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutrophils; Salvage Therapy; Transplantation Conditioning; Treatment Outcome; Young Adult | 2014 |
First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Family; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Severity of Illness Index; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2014 |
Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY.
Topics: Allografts; Anemia, Aplastic; Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents | 2015 |
Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2015 |
[Therapeutic efficacy of second allo-HSCT for aplastic anemia after failure of first allo-HSCT].
Topics: Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies | 2014 |
[Retrospective analysis of therapeutic efficacy of haploidentical allogeneic hematopoietic stem cell transplantation for severe aplastic anemia].
Topics: Adolescent; Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Graft vs Host Disease; Haploidy; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies; Siblings; Survival Rate; Tissue Donors; Transplantation Conditioning; Vidarabine | 2014 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
Delayed false elevation of circulating tacrolimus concentrations after cord blood transplantation in a patient with myelodysplastic syndrome.
Topics: Behcet Syndrome; Cord Blood Stem Cell Transplantation; Cyclosporine; False Positive Reactions; Graft vs Host Disease; Humans; Immunoassay; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Tacrolimus | 2014 |
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
Topics: Acute Disease; Adult; Biomarkers, Tumor; Canada; Chronic Disease; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Young Adult | 2015 |
Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Germany; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Prevention; Retrospective Studies; Severity of Illness Index; Siblings; Treatment Outcome; Young Adult | 2015 |
Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model.
Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Cyclosporine; Cytokines; Disease Models, Animal; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Intestines; Liver; Male; Maraviroc; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; Receptors, CCR7; Receptors, CXCR3; Triazoles | 2015 |
[Efficacies of hematopoietic stem cell transplantation for severe aplastic anemia: a report of 43 patients].
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Siblings; Transplantation Conditioning; Vidarabine; Young Adult | 2014 |
[Allo-geneic hematopoietic stem cell transplantation in treatment with T315I mutation of chronic myelogenous leukemia].
Topics: Adult; Allografts; Benzamides; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mutation; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Piperazines; Pyrimidines; Retrospective Studies; Siblings | 2014 |
Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
Topics: Allografts; Animals; Calcineurin Inhibitors; CD8-Positive T-Lymphocytes; Cell Proliferation; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Mice; Mice, Knockout; NFATC Transcription Factors; T-Lymphocytes, Regulatory; Tacrolimus | 2015 |
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2015 |
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Retrospective Studies; Transplantation Chimera; Transplantation Conditioning; Unrelated Donors | 2015 |
Infectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathies.
Topics: Adolescent; Anemia, Sickle Cell; Antilymphocyte Serum; Bacteremia; beta-Thalassemia; Child; Cohort Studies; Cyclosporine; Cystitis; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Male; Pneumonia, Pneumocystis; Retrospective Studies; Toxoplasmosis; Transplantation Conditioning; Viremia | 2015 |
[Treatment of myelodysplastic syndrome by hematopoietic stem cell transplantation combined with Chinese medical syndrome typing: a clinical study].
Topics: Biomedical Research; Blood Platelets; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drugs, Chinese Herbal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Medicine, Chinese Traditional; Methotrexate; Myelodysplastic Syndromes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2015 |
Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
Topics: Adolescent; Adult; Biological Availability; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Models, Biological; Multidrug Resistance-Associated Protein 2; Polymorphism, Genetic; Prospective Studies; Young Adult | 2015 |
Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Young Adult | 2015 |
Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Transplantation, Homologous; Young Adult | 2015 |
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.
Topics: Age Factors; Anemia, Aplastic; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Proportional Hazards Models; Retrospective Studies; Tacrolimus; Transplantation Conditioning; Treatment Outcome | 2015 |
Allogeneic hematopoietic stem cell transplantation in children with aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; China; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Male; Rabbits; Transplantation, Homologous | 2015 |
[The 50th anniversary of the first liver transplantation: from myth to reality. Tributes to Thomas Starzl, 2012 Lasker Prize].
Topics: Awards and Prizes; Cyclosporine; Graft vs Host Disease; History, 20th Century; Humans; Immunosuppressive Agents; Liver Transplantation; Organ Preservation; United States | 2013 |
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
Topics: Acute Disease; Adult; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Recurrence; Retrospective Studies; Salvage Therapy; Sirolimus; Thrombotic Microangiopathies | 2015 |
Effect of Irradiation on Incidence of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation in Miniature Swine.
Topics: Animals; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 1, Suid; Histocompatibility; Humans; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lymphatic Irradiation; Lymphocyte Depletion; Lymphoproliferative Disorders; Swine; Swine Diseases; Swine, Miniature; T-Lymphocytes; Thymus Gland; Transplantation Conditioning; Tumor Virus Infections; Whole-Body Irradiation | 2015 |
Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working P
Topics: Adenoviridae Infections; Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Bone Marrow Transplantation; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Herpesviridae Infections; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Length of Stay; Living Donors; Male; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Primary Graft Dysfunction; Quality of Life; Retrospective Studies; Siblings; Survival Rate; T-Lymphocytes; Treatment Outcome; Virus Activation; Young Adult | 2015 |
Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Gene Expression; Genetic Diseases, Inborn; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Myeloablative Agonists; Pilot Projects; Survival Analysis; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine | 2015 |
Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs.
Topics: Animals; Antibodies, Neutralizing; Cell Proliferation; Coculture Techniques; Cyclosporine; Disease Models, Animal; Everolimus; Female; Graft vs Host Disease; Humans; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Sirolimus; T-Lymphocytes; Tacrolimus; Umbilical Cord | 2015 |
[Efficacy of Nonmyeloablative Allogeneic Hematopoietic Stem Cells for 14 Case of Severe Acquired Aplastic Anemia].
Topics: Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Mycophenolic Acid; Neutrophils; Siblings; Tissue Donors; Transplantation Conditioning; Vidarabine | 2015 |
Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality.
Topics: Age Factors; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors | 2015 |
Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mycophenolic Acid; Risk Factors; Siblings; Tissue Donors | 2016 |
Drug Utilization Evaluation of Cyclosporine in Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Cyclosporine; Drug Utilization Review; Graft vs Host Disease; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Medication Errors; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Time Factors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2015 |
[Prophylaxis of acute graft-versus-host disease].
Topics: Acute Disease; Allografts; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate | 2015 |
[Efficacy analysis of unrelated cord blood transplantation for 58 acute myelogenous leukemia patients].
Topics: Acute Disease; Adolescent; Cyclosporine; Disease-Free Survival; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia, Myeloid, Acute; Mycophenolic Acid; Quality of Life; Recurrence; Remission Induction; Retrospective Studies | 2015 |
Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience.
Topics: Adolescent; Adult; Child; Child, Preschool; Complement C1q; Cortisone; Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heterozygote; Humans; Infant; Iraq; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Rituximab; Sweden; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2016 |
Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation.
Topics: Adolescent; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Male; Methotrexate; Neoplasms; Neutrophils; Retrospective Studies; Tacrolimus; Time Factors; Transplantation Conditioning; Treatment Outcome | 2016 |
Headache, hypertension and seizures.
Topics: Central Nervous System Neoplasms; Child; Cyclosporine; Diagnosis, Differential; Female; Graft vs Host Disease; Headache; Hematopoietic Stem Cell Transplantation; Humans; Hypertension; Immunosuppressive Agents; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Seizures | 2015 |
Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study.
Topics: Adolescent; Blood Platelets; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Methylprednisolone; Mycophenolic Acid; Neutrophils; Retrospective Studies; Risk; Sepsis; Tacrolimus; Tissue Donors; Transplantation Conditioning | 2016 |
A Pilot Study of Continuous Infusion of Mycophenolate Mofetil for Prophylaxis of Graft-versus-Host-Disease in Pediatric Patients.
Topics: Adolescent; Adult; Area Under Curve; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Half-Life; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infusions, Intravenous; Mycophenolic Acid; Myeloablative Agonists; Pilot Projects; Prospective Studies; Survival Analysis; Transplantation Conditioning | 2016 |
Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.
Topics: Acute Disease; Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Cytokines; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Inflammasomes; Male; Myeloablative Agonists; Prospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2016 |
[Impacts of ABO incompatibility on early outcome after single unit unrelated cord blood transplantation: a retrospective single center experience].
Topics: ABO Blood-Group System; Blood Group Incompatibility; Cord Blood Stem Cell Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Mycophenolic Acid; Red-Cell Aplasia, Pure; Retrospective Studies; Tissue Donors; Transplantation, Homologous | 2015 |
[Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies; Siblings; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Vidarabine | 2015 |
A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.
Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Tacrolimus; Young Adult | 2016 |
Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Cell Count; Cyclosporine; Dogs; Dose-Response Relationship, Radiation; Everolimus; Female; Gamma Rays; Graft Rejection; Graft Survival; Graft vs Host Disease; HLA Antigens; Immunosuppressive Agents; Male; Models, Animal; Mycophenolic Acid; Retrospective Studies; Risk Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2016 |
Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Leukemia, Myeloid, Acute; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Risk; Survival Rate; Tissue Donors; Young Adult | 2016 |
Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event.
Topics: Adult; Biopsy; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sebaceous Gland Diseases; Sebaceous Glands; Stem Cell Transplantation | 2016 |
Azithromycin for the Treatment of Ciclosporin-Induced Gingival Hyperplasia.
Topics: Adult; Allografts; Anti-Bacterial Agents; Azithromycin; Cyclosporine; Female; Gingival Hyperplasia; Gingivitis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral | 2016 |
[Two Kinds of HLA-mismatched Allogeneic Hematopoictic Stem Cell Transplantation for Treatment of Hematologic Malignancies].
Topics: Antilymphocyte Serum; Busulfan; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Incidence; Leukemia; Mycophenolic Acid; Stem Cell Transplantation; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Cyclosporine; Cytokines; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Immunosuppressive Agents; Liver; Male; Maraviroc; Mice, Inbred BALB C; Mice, Inbred C57BL; Receptors, CCR5; T-Lymphocytes; Triazoles | 2016 |
[Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; China; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Incidence; Male; Retrospective Studies; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2016 |
Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Biomarkers; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk; Survival Analysis; Transplantation, Homologous; Young Adult | 2016 |
Donor Lymphocyte Infusion-Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell Transplantation.
Topics: Animals; Blood Donors; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Lymphocyte Depletion; Lymphocyte Transfusion; Swine; Transplantation Chimera; Transplantation Conditioning; Transplantation, Haploidentical; Whole-Body Irradiation | 2016 |
Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors | 2016 |
Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Female; Gels; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Miconazole; Middle Aged; Retrospective Studies; Tacrolimus; Young Adult | 2016 |
Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cyclosporine; Disease-Free Survival; Female; Fetal Blood; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Tacrolimus; Transplantation Conditioning; Treatment Outcome | 2017 |
Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
Topics: Animals; Antigens; Bone Marrow Cells; Composite Tissue Allografts; Cyclosporine; Dogs; Graft Rejection; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Immunosuppression Therapy; Leukocytes; Mycophenolic Acid; Reproducibility of Results; Skin Transplantation; Transplantation Conditioning; Transplantation Tolerance; Transplantation, Homologous | 2016 |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Topics: Adolescent; Adult; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Survival Rate; Tacrolimus | 2017 |
Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intestinal Diseases; Leukemia, Myeloid, Acute; Methotrexate; Mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Quality of Life; Remission Induction; Severity of Illness Index; Skin Diseases; Survival Rate; Transplantation, Homologous; Young Adult | 2017 |
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mortality; Mycophenolic Acid; Neutrophils; Premedication; Retrospective Studies; Stem Cell Transplantation; Unrelated Donors; Young Adult | 2017 |
[Ocular graft-versus-host disease: An often misdiagnosed etiology of dry eye syndrome].
Topics: Blepharitis; Cyclosporine; Diagnostic Errors; Dry Eye Syndromes; Graft vs Host Disease; Humans; Male; Middle Aged | 2017 |
Measurements of Catheter, Venous, and Capillary Cyclosporine A Blood Are Comparable and Useful in Pediatric Hematopoietic Stem Cell Transplant Recipients.
Topics: Adolescent; Allografts; Catheterization; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male | 2017 |
Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Risk Factors; Treatment Outcome | 2008 |
[Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Male; Middle Aged; Mycophenolic Acid; Transplantation Conditioning | 2008 |
Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy; Infant; Leukemia, Myeloid, Acute; Male; Melphalan; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2008 |
Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Topics: Animals; CD3 Complex; CD56 Antigen; Cells, Cultured; Cyclosporine; Cytotoxicity, Immunologic; Fetal Blood; Graft vs Host Disease; Humans; Immunosuppressive Agents; Immunotherapy, Adoptive; Interleukin-15; K562 Cells; Killer Cells, Natural; Mice | 2008 |
Determination of initial i.v. CYA dosage to achieve target AUC values in pediatric hematopoietic stem cell transplant patients.
Topics: Administration, Oral; Area Under Curve; Body Surface Area; Body Weight; Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Injections, Intravenous; Metabolic Clearance Rate; Prospective Studies; Transplantation, Homologous | 2008 |
Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Budesonide; Chronic Disease; Cyclosporine; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Remission Induction; Transplantation, Homologous | 2008 |
Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis.
Topics: Adolescent; Adult; Cohort Studies; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mucositis; Mycophenolic Acid; Prospective Studies; Transplantation Conditioning; Young Adult | 2009 |
Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo.
Topics: Anilides; Animals; B-Lymphocytes; Calcium Channel Blockers; Cyclosporine; Graft vs Host Disease; Hypersensitivity, Delayed; Interferon-gamma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; T-Lymphocytes, Cytotoxic; Th1 Cells; Thiadiazoles | 2008 |
Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.
Topics: Antiviral Agents; Child; Child, Preschool; Chimerism; Cidofovir; Cyclosporine; Cytosine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Organophosphonates; Treatment Failure; Wiskott-Aldrich Syndrome | 2009 |
The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cohort Studies; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Donor Selection; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Living Donors; Lymphocyte Depletion; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2008 |
Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Topics: Adult; Aged; Antineoplastic Agents; Cyclosporine; Disease-Free Survival; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2008 |
Importance of CsA drug monitoring in SCT recipients to minimize GVHD and maximize graft vs. leukemia.
Topics: Cyclosporine; Drug Monitoring; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Transplantation Immunology | 2009 |
The use of pharmacokinetic models in paediatric onco-haematology: effects on clinical outcome through the examples of busulfan and cyclosporine.
Topics: Bayes Theorem; Busulfan; Child; Computer Simulation; Cyclosporine; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Models, Biological; Myeloablative Agonists; Treatment Outcome | 2008 |
[Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Young Adult | 2008 |
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Melphalan; Methotrexate; Middle Aged; Mycophenolic Acid; Premedication; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2009 |
Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Antibodies, Anti-Idiotypic; Antineoplastic Agents; Benzamides; Cord Blood Stem Cell Transplantation; Cyclosporine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Graft vs Host Disease; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Piperazines; Pyrimidines; Splenectomy; Transfusion Reaction; Transplantation Conditioning; Young Adult | 2009 |
[Retrospective analysis of posterior reversible encephalopathy syndrome after allogeneic stem cell transplantation].
Topics: Acute Disease; Adolescent; Adult; Calcineurin Inhibitors; Creatinine; Cyclosporine; Encephalitis; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Syndrome; Tacrolimus; Transplantation, Homologous; Young Adult | 2009 |
Does extra alemtuzumab remove the graft-versus-leukemia effect after allogeneic stem cell transplantation in chronic lymphocytic leukemia?
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cohort Studies; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Donor Selection; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Living Donors; Lymphocyte Depletion; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2009 |
[Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation].
Topics: Anti-Infective Agents; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Laser-Doppler Flowmetry; Leg Ulcer; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Patient Compliance; Pentoxifylline; Peripheral Blood Stem Cell Transplantation; Physical Therapy Modalities; PUVA Therapy; Scleroderma, Localized; Transplantation, Homologous; Vasodilator Agents | 2009 |
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Topics: Acute Disease; Clinical Trials, Phase III as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Diseases; Methotrexate; Organ Specificity; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy.
Topics: Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Intestinal Perforation; Lymphoma, Follicular; Male; Microcirculation; Purpura, Thrombotic Thrombocytopenic; Transplantation Conditioning | 2009 |
Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
Topics: Acyclovir; Adrenoleukodystrophy; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclosporine; Epstein-Barr Virus Infections; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Remission Induction; Rituximab; Tumor Virus Infections; Virus Activation | 2009 |
A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT.
Topics: Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Middle Aged; Multiple Myeloma; Skin Diseases; Transplantation, Autologous | 2010 |
Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Female; Graft vs Host Disease; Humans; L-Lactate Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation, Homologous | 2009 |
Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Male; Middle Aged; Mycophenolic Acid; Pancreatic Neoplasms; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Tumor Necrosis Factor-alpha; Vidarabine; Whole-Body Irradiation | 2009 |
Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.
Topics: Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Tacrolimus | 2010 |
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Young Adult | 2010 |
Ocular findings after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Eye Diseases; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intraocular Pressure; Male; Methotrexate; Middle Aged; Ophthalmoscopy; Retrospective Studies; Transplantation, Homologous; Visual Acuity | 2009 |
High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.
Topics: Administration, Topical; Adult; Aged; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein; Fluorescent Dyes; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Retreatment; Retrospective Studies; Severity of Illness Index; Sjogren's Syndrome; Staining and Labeling; Xerophthalmia | 2009 |
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Cerebral Hemorrhage; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Meningoencephalitis; Middle Aged; Myeloablative Agonists; Nervous System Diseases; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Postoperative Complications; Recurrence; Retrospective Studies; Risk Factors; Stroke; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2009 |
CsA exposure is associated with acute GVHD and relapse in children after SCT.
Topics: Acute Disease; Adolescent; Area Under Curve; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Matched-Pair Analysis; Methotrexate; Survival Rate; Tacrolimus; Tissue Donors | 2009 |
Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies.
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome; Young Adult | 2009 |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease.
Topics: Adult; Aged; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Safety; Tacrolimus; Time Factors; Transplantation, Homologous; Young Adult | 2009 |
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Siblings; Survival Rate; Transplantation, Homologous | 2010 |
Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mucositis; Retrospective Studies; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2010 |
Graft-versus-host disease-related polymyositis.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Polymyositis | 2010 |
MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.
Topics: Adult; Aged; Chromosome Aberrations; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Rate; Thalassemia; Treatment Outcome; Young Adult | 2010 |
Cyclosporine dose intensity and risk of acute graft-versus-host disease: trough versus area under the curve.
Topics: Area Under Curve; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Risk | 2010 |
Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation.
Topics: Adoptive Transfer; Animals; Antibodies; CD40 Antigens; CD40 Ligand; Cell Proliferation; Cells, Cultured; Cyclosporine; Disease Models, Animal; Forkhead Transcription Factors; Graft Rejection; Graft vs Host Disease; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Isoantigens; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mycophenolic Acid; Sirolimus; Skin Transplantation; T-Lymphocytes, Regulatory; Time Factors; Transplantation Tolerance; Transplantation, Homologous | 2010 |
180-day screening study for predicting the risk factors for developing acute oral Graft-versus-Host disease in paediatric patients subjected to allogenic haematopoietic stem cells transplantation.
Topics: Acute Disease; Adolescent; Antigens, Viral; Child; Child, Preschool; Cyclosporine; Cytomegalovirus; Female; Follow-Up Studies; Forecasting; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Mouth Diseases; Oral Hemorrhage; Oral Ulcer; Predictive Value of Tests; Prospective Studies; Risk Factors; Sex Factors; Stomatitis; Transplantation Conditioning; Transplantation, Homologous; Xerostomia | 2010 |
[Prophylactic effect of CsA, MTX, MMF combined with ATG on GVHD in patients underwent unrelated peripheral blood hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Young Adult | 2010 |
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Topics: Adult; Antineoplastic Agents; Asparaginase; Combined Modality Therapy; Cyclosporine; Drug Resistance, Neoplasm; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Methotrexate; Natural Killer T-Cells; Neoplasm Recurrence, Local; Nose Neoplasms; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
[Change in regulations for dispensing immunosuppressants to patients who have undergone a kidney transplant].
Topics: Compassionate Use Trials; Cyclosporine; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Graft Rejection; Graft vs Host Disease; Health Services Accessibility; Humans; Immunosuppressive Agents; Informed Consent; Kidney Transplantation; Mycophenolic Acid; Off-Label Use; Pharmacies; Pharmacy Service, Hospital; Quality of Life; Rural Population; Sirolimus; Spain | 2010 |
Transmission of familial Mediterranean fever mutation after bone marrow transplantation and successful treatment with anakinra.
Topics: Anemia, Aplastic; Anti-Bacterial Agents; Antilymphocyte Serum; Antirheumatic Agents; Bone Marrow Transplantation; Cyclosporine; Familial Mediterranean Fever; Graft vs Host Disease; Humans; Immunosuppressive Agents; Informed Consent; Interleukin 1 Receptor Antagonist Protein; Male; Mutation; Stroke Volume; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Dogs; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hyaluronan Receptors; Immunosuppressive Agents; Major Histocompatibility Complex; Methotrexate; Models, Animal; Mycophenolic Acid; Transplantation Conditioning | 2010 |
Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.
Topics: Animals; Bone Marrow Transplantation; Chronic Disease; Colonic Diseases; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Liver Diseases; Mice; Mice, Inbred C3H; Toll-Like Receptors; Transplantation, Isogeneic | 2010 |
Post-hematopoietic stem cell transplantion immune-mediated cytopenias.
Topics: Adult; Aged; Bone Marrow; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunoglobulins, Intravenous; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Postoperative Complications; Red-Cell Aplasia, Pure; Remission Induction; Thrombocytopenia; Transplantation Conditioning | 2009 |
Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Topics: Adolescent; Cell Separation; Child; Cyclosporine; Flow Cytometry; Forkhead Transcription Factors; Genetic Diseases, X-Linked; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Infant; Male; Mycophenolic Acid; Myeloablative Agonists; Reverse Transcriptase Polymerase Chain Reaction; Syndrome; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2010 |
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Drug Interactions; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Retrospective Studies; Risk; T-Lymphocytes; Transplantation, Homologous; Young Adult | 2010 |
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Blood Platelets; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Neutrophils; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult | 2011 |
Influence of dosing schedule on organ exposure to cyclosporin in pediatric hematopoietic stem cell transplantation: analysis with a PBPK model.
Topics: Animals; Area Under Curve; Child; Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Rats; Retrospective Studies; Tissue Distribution | 2010 |
Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
Topics: Administration, Topical; Adolescent; Adult; Aged; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lissamine Green Dyes; Male; Middle Aged; Neoplasms; Retrospective Studies; Surveys and Questionnaires; Tears; Treatment Outcome | 2010 |
Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; CD52 Antigen; Chromosome Aberrations; Cyclosporine; Disease-Free Survival; Female; Glycoproteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Recurrence; Retrospective Studies; Risk Factors; Siblings; South Africa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2011 |
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Topics: Adult; Antilymphocyte Serum; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sirolimus; Survival Analysis; Tacrolimus; Thrombotic Microangiopathies; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Links between cyclosporin exposure in tissues and graft-versus-host disease in pediatric bone marrow transplantation: analysis by a PBPK model.
Topics: Adolescent; Area Under Curve; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Models, Biological; Retrospective Studies; Tissue Distribution | 2011 |
Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.
Topics: Antilymphocyte Serum; Cyclosporine; Dyskeratosis Congenita; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Mycophenolic Acid; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult | 2010 |
Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymorphism, Single Nucleotide; Tacrolimus | 2011 |
[Preliminary study on role of endothelial cells and tissue factor in graft-versus-host disease].
Topics: Cells, Cultured; Coculture Techniques; Cyclosporine; Endothelial Cells; Graft vs Host Disease; Humans; Interleukin-2; Lymphocytes; Thromboplastin | 2010 |
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.
Topics: Adult; Benzamides; Blast Crisis; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Piperazines; Pyrimidines; Remission Induction; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience.
Topics: Adolescent; Antigens, CD; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Infant; Male; Myeloablative Agonists; Risk Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion.
Topics: Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Myeloablative Agonists; Posterior Leukoencephalopathy Syndrome; Transplantation Conditioning; Transplantation, Homologous | 2011 |
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Standard of Care; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2011 |
Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT.
Topics: Adolescent; Adult; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pain; Radiography; Retrospective Studies; Syndrome; Tacrolimus; Transplantation, Homologous | 2012 |
A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT.
Topics: Acute Disease; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Ferritins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Middle Aged; Retrospective Studies; Survival Rate; Transplantation Conditioning | 2012 |
[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
Topics: Acute Kidney Injury; Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Encephalitis, Varicella Zoster; Graft vs Host Disease; Herpesvirus 3, Human; Humans; Immunosuppressive Agents; Male; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Time Factors; Virus Activation | 2011 |
T-cell depletion in GVHD: less is more?
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Long-term results of placental blood allografting using reduced-intensity conditioning: multicenter experience in a developing country.
Topics: Adolescent; Adult; Aged; Busulfan; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Mexico; Middle Aged; Prospective Studies; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2011 |
Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model.
Topics: Animals; Cyclosporine; Graft Survival; Graft vs Host Disease; Heart Transplantation; Immunosuppressive Agents; Interferon-gamma; Lymphocyte Activation; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mycophenolic Acid; Sirolimus; T-Lymphocytes; Transplantation, Homologous | 2011 |
Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Opportunistic Infections; Quality of Life; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2012 |
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.
Topics: Adult; Aged; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Recurrence; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
Topics: Adolescent; Adult; Aged; Area Under Curve; Bayes Theorem; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Models, Biological; Prospective Studies; Sampling Studies; Transplantation, Homologous; Young Adult | 2012 |
Vascularized bone marrow transplantation model in rats as an alternative to conventional cellular bone marrow transplantation: preliminary results.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Cell Proliferation; Chimerism; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Models, Animal; Rats; Rats, Inbred BN; Rats, Inbred Lew; Species Specificity; Stem Cells | 2011 |
Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe₃O₄ combined with cyclosporin A in murine models.
Topics: Animals; Cyclosporine; Disease Models, Animal; Drug Carriers; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocytochemistry; Intestines; Leukocyte Count; Leukocytes; Liver; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organ Specificity; Skin; Survival Analysis; Transplantation, Homologous | 2011 |
Graft-versus-host disease prophylaxis: does drug dosage matter?
Topics: Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Tacrolimus | 2012 |
Extensive gingival and respiratory tract Kaposi sarcoma in a child after allogenic hematopoietic stem cell transplantation.
Topics: Child; Cyclosporine; Gingival Neoplasms; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Prednisolone; Sarcoma, Kaposi; Transplantation, Homologous | 2012 |
Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients.
Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Child, Preschool; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Retrospective Studies; Young Adult | 2012 |
Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Opportunistic Infections; Recurrence; Retrospective Studies; Transplantation Chimera; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Unrelated Donors | 2012 |
Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Carmustine; Central Nervous System; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2012 |
Bone mineral density in ex-thalassemic pediatric patients.
Topics: Adrenal Cortex Hormones; beta-Thalassemia; Bone Density; Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male | 2012 |
Transfusion induced Graft versus host disease - Case report in a 2 year child.
Topics: Anemia; Child, Preschool; Cyclosporine; Fatal Outcome; Fathers; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Steroids; Transfusion Reaction | 2012 |
Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.
Topics: Adult; Aged; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Male; Middle Aged; Mycophenolic Acid; Recurrence; Severity of Illness Index; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2012 |
Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin-NFAT pathway.
Topics: Animals; Biphenyl Compounds; Bone Marrow Transplantation; Calcineurin; Cyclosporine; Drug Resistance; Graft vs Host Disease; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Nitrophenols; Piperazines; Receptors, Antigen, T-Cell; Signal Transduction; Sulfonamides; T-Lymphocytes | 2012 |
Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
Topics: Adolescent; Adult; Bayes Theorem; Child; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Half-Life; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Intestinal Absorption; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Reproducibility of Results; Tunisia; Young Adult | 2012 |
Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Folic Acid Antagonists; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leucovorin; Male; Methotrexate; Mucositis; Retrospective Studies; Severity of Illness Index; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Vitamin B Complex | 2013 |
On the importance of blood sampling for ciclosporin pharmacokinetic studies.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male | 2013 |
The effect of cyclosporine initiation time on the outcome of matched allogeneic stem-cell transplantation following fludarabine-based conditioning.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2012 |
Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
Topics: Adolescent; Area Under Curve; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infusions, Intravenous; Linear Models; Male; Myeloablative Agonists; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2013 |
Treosulfan-thiotepa-fludarabine-based conditioning regimen for allogeneic transplantation in patients with thalassemia major: a single-center experience from north India.
Topics: Adolescent; beta-Thalassemia; Busulfan; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; India; Male; Myeloablative Agonists; Retrospective Studies; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2013 |
High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Fibrinolytic Agents; Glucocorticoids; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infant; Liver; Male; Methylprednisolone; Myeloablative Agonists; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2013 |
Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
Topics: Adult; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Movement; Chemokine CCL20; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunologic Memory; Interferon-gamma; Interleukin-17; Male; Middle Aged; Multivariate Analysis; NK Cell Lectin-Like Receptor Subfamily B; Phenotype; Receptors, CCR6; Stem Cell Transplantation; T-Lymphocytes; Transplantation, Homologous; Young Adult | 2012 |
[Comparative study on the efficacy and safety of continuous versus twice-daily 3-hour infusion of cyclosporine A in pediatric hematopoietic stem cell transplantation].
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Retrospective Studies; Transplantation, Homologous | 2012 |
Atopic dermatitis-like presentation of graft-versus-host disease: a novel form of chronic cutaneous graft-versus-host disease.
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Dermatitis, Atopic; Diagnosis, Differential; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Skin; Skin Diseases; T-Lymphocytes; Young Adult | 2013 |
A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Transplantation, Homologous; Treatment Outcome | 2002 |
[Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Female; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Methotrexate; Mice; Mice, Inbred C57BL; Models, Animal; Mycophenolic Acid; Time Factors; Transplantation, Homologous | 2002 |
[Treatment of two case childhood acute lymphoblastic leukemia by HLA-mismatched unrelated umbilical cord blood transplantation].
Topics: Child, Preschool; Cyclosporine; DNA Fingerprinting; DNA, Neoplasm; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning | 2002 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome | 2002 |
[Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases].
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2002 |
Reduced CTLA-4 protein and messenger RNA expression in umbilical cord blood T lymphocytes.
Topics: Abatacept; Adult; Aging; Antigens, CD; Antigens, Differentiation; Cell Division; CTLA-4 Antigen; Cyclosporine; DNA-Binding Proteins; Fetal Blood; Flow Cytometry; Gene Expression Regulation; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immune Tolerance; Immunoconjugates; Immunosuppressive Agents; Infant, Newborn; Lymphocyte Activation; NFATC Transcription Factors; Nuclear Proteins; Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Transcription Factors; Transcription, Genetic | 2002 |
Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant.
Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Choroid Diseases; Conjunctival Diseases; Cyclosporine; Female; Fluorescein Angiography; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Multiple Myeloma; Retinal Diseases; Vision Disorders; Visual Acuity | 2002 |
Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.
Topics: Animals; Cyclosporine; Deoxyguanine Nucleotides; Dogs; Drug Therapy, Combination; Graft vs Host Disease; Growth Inhibitors; Humans; Immunosuppressive Agents; Lymphocytes; Macaca fascicularis; Mice; Mice, Inbred BALB C; Mice, SCID; Purine Nucleosides; Pyrimidinones; Pyrroles; Rats; Rats, Sprague-Dawley; Survival Rate; Transplantation, Heterologous | 2002 |
Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
Topics: Animals; Cyclosporine; Disease Models, Animal; Drug Administration Schedule; Female; Ganciclovir; Genetic Therapy; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Leukemia; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; T-Lymphocytes; Thymidine Kinase; Transduction, Genetic; Transplantation, Homologous | 2002 |
Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract.
Topics: Administration, Oral; Animals; Bone Marrow Transplantation; Cyclosporine; Cytokines; Female; Graft vs Host Disease; Immunosuppressive Agents; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Phytotherapy; Plant Extracts; Spleen; T-Lymphocytes, Cytotoxic; Transplantation, Homologous; Tripterygium | 2002 |
Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease.
Topics: ABO Blood-Group System; Adult; Blood Group Incompatibility; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Isoantibodies; Male; Peripheral Blood Stem Cell Transplantation; Red-Cell Aplasia, Pure; Transplantation, Homologous | 2002 |
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cyclosporine; Cytarabine; Data Collection; Etoposide; Female; Follow-Up Studies; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2002 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine | 2002 |
Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Bone Marrow Transplantation; Calcineurin Inhibitors; CD40 Ligand; Cyclosporine; Drug Evaluation, Preclinical; Drug Synergism; Female; Graft Survival; Graft vs Host Disease; Immune Tolerance; Immunosuppressive Agents; Lymphocyte Count; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Radiation Chimera; Sirolimus; Skin Transplantation; Specific Pathogen-Free Organisms; T-Lymphocyte Subsets; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2002 |
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce dura
Topics: Adult; Aged; Child; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Remission Induction; Survival Rate; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2003 |
Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha.
Topics: Blast Crisis; Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction | 2002 |
Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Bone Diseases; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Cross-Sectional Studies; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Necrosis; Stem Cell Transplantation; Stromal Cells; Transplantation, Homologous; Ultrasonography | 2002 |
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
Topics: Acute Disease; Anemia, Sickle Cell; Blood Platelets; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Neutrophils; Survival Rate; Thalassemia; Transplantation, Homologous; Treatment Outcome | 2003 |
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
Topics: Acute Disease; Adult; Bile Duct Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Hepatitis; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow; Cell Lineage; Child; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haplotypes; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Lenograstim; Leukemia; Life Tables; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Recurrence; Risk Factors; Survival Analysis; T-Lymphocytes; Treatment Outcome | 2002 |
Severe neurologic complications after hematopoietic stem cell transplantation in children.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Electroencephalography; Female; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Metabolism, Inborn Errors; Nervous System Diseases; Neurologic Examination; Neurotoxicity Syndromes; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplantation, Homologous; Whole-Body Irradiation | 2002 |
Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adolescent; Adult; Cyclosporine; Erythrocytes; Erythropoiesis; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Red-Cell Aplasia, Pure; Transplantation, Homologous; Treatment Outcome | 2002 |
Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Plasmapheresis; Retrospective Studies; Tacrolimus; Thrombosis | 2003 |
Psychological factors and survival after bone marrow transplantation in patients with leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Mood Disorders; Sex Distribution | 2003 |
Chronic graft-versus-host disease complicated by acute hepatitis B.
Topics: Acute Disease; Alanine Transaminase; Aspartate Aminotransferases; Bile Ducts; Biopsy; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Liver; Male; Middle Aged | 2003 |
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence; Remission Induction; Tissue Donors; Transplantation Chimera; Transplantation Conditioning | 2003 |
Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
Topics: Child; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; Immunotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous | 2002 |
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.
Topics: Adult; Chronic Disease; Cyclosporine; Ficusin; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Middle Aged; Photochemotherapy; Prednisone; Ultraviolet Rays | 2003 |
Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome.
Topics: Antilymphocyte Serum; Busulfan; Cyclosporine; Fetal Blood; Gastroenteritis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Salmonella Infections; Severe Combined Immunodeficiency; Stem Cell Transplantation; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
Central and extrapontine myelinolysis following allogeneic peripheral haematopoietic progenitor cell transplantation. Favourable outcome in a patient with chronic myeloid leukaemia.
Topics: Brain; Central Nervous System Diseases; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Stem Cell Transplantation; Treatment Outcome | 2003 |
Chronic graft versus host disease after allogeneic peripheral blood transplantation.
Topics: Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Incidence; Peripheral Blood Stem Cell Transplantation; Transplantation, Homologous | 2003 |
One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
Topics: Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Risk; Risk Factors; Transplantation, Homologous | 2003 |
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Topics: Aged; Bone Marrow Transplantation; Busulfan; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Intestines; Life Tables; Liver; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Severity of Illness Index; Skin; Survival Analysis; Time Factors; Tissue Donors; Transplantation Conditioning; Vidarabine; Washington; Whole-Body Irradiation | 2003 |
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Metalloendopeptidases; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; von Willebrand Factor | 2003 |
Do the immunosuppressive drugs used as treatment for graft-versus-host disease directly inhibit lymphoid tumor cell growth?
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Mice; Mice, SCID; Prednisone; Tumor Cells, Cultured | 2003 |
[Cyclosporin A withdrawal causes spontaneous remission of recurrent subcutaneous tumors after allogeneic peripheral blood stem cell transplantation for adult T-cell leukemia/lymphoma].
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Leukemia-Lymphoma, Adult T-Cell; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Peripheral Blood Stem Cell Transplantation | 2003 |
[Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Chronic Disease; Cyclosporine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
Topics: Administration, Oral; Adult; Biological Availability; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Regression Analysis; Retrospective Studies; Time Factors | 2003 |
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Thalidomide; Transplantation, Homologous | 2003 |
Allogeneic PBPC transplantation in children.
Topics: Adolescent; Anemia; Antigens, CD34; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Stem Cells; Transplantation, Homologous | 1999 |
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Aged; Cyclosporine; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Psoriasis; Remission Induction; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2003 |
[Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
[Successful treatment of refractory peripheral T-cell lymphoma by allogeneic peripheral blood stem cell transplantation].
Topics: Adult; Cyclosporine; Graft vs Host Disease; Humans; Lymphoma, T-Cell, Peripheral; Male; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
[Cyclosporine A and mycophenolate mofetile as prophylactics for GVHD in a murine model of H-2 haploidentical nonmyeloablative bone marrow transplantation].
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; H-2 Antigens; Hematopoiesis; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Models, Animal; Mycophenolic Acid; Transplantation Chimera | 2003 |
Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
Topics: Animals; Chimera; Cyclosporine; Epstein-Barr Virus Infections; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immune Tolerance; Immunosuppressive Agents; Leukocyte Transfusion; Leukocytes; Lymphoma, B-Cell; Mice; Mice, SCID; Receptors, Interleukin-2 | 2003 |
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
Topics: Adult; Bone Marrow Diseases; Bone Marrow Transplantation; Brain; Calcineurin Inhibitors; Central Nervous System Diseases; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2003 |
Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Topics: Antigens, CD34; Antineoplastic Agents; Cell Separation; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Interferon-gamma; Male; Middle Aged | 2003 |
Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.
Topics: Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Middle Aged; Myeloid Cells; Prospective Studies; T-Lymphocytes; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2003 |
Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation.
Topics: Administration, Oral; Animals; Cyclosporine; Drug Synergism; Everolimus; Graft Rejection; Graft vs Host Disease; Host vs Graft Reaction; Immunosuppressive Agents; Intestine, Small; Male; Models, Animal; Organ Transplantation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sirolimus | 2003 |
CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD34; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leucovorin; Leukemia, Myeloid; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2003 |
[Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid | 2003 |
Effect of cyclophosphamide on serum cyclosporine levels at the conditioning of hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Cyclophosphamide; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
Cyclosporin A-associated status epilepticus related to hematopoietic stem cell transplantation for thalassemia.
Topics: Anticonvulsants; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease Susceptibility; Epilepsy, Generalized; Female; Graft vs Host Disease; Hallucinations; Humans; Hypertension; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Peripheral Blood Stem Cell Transplantation; Premedication; Status Epilepticus; Thalassemia; Transplantation Conditioning | 2003 |
Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Basiliximab; Coculture Techniques; Cyclosporine; Daclizumab; Graft vs Host Disease; Humans; Immunoglobulin G; Interleukin-2; Isoantigens; Lymphocyte Culture Test, Mixed; Phytohemagglutinins; Prednisolone; Receptors, Interleukin-2; Recombinant Fusion Proteins; T-Lymphocytes | 2003 |
Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease.
Topics: Bone Marrow Transplantation; Cyclosporine; Epidermolysis Bullosa Acquisita; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Penicillamine; Scleroderma, Systemic | 2003 |
Transfusion-associated GVHD: 10 years' experience at the American University of Beirut-Medical Center.
Topics: Adult; Aged; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Medical Records; Middle Aged; Muromonab-CD3; Steroids; Transfusion Reaction | 2003 |
Resolution of Behçet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Behcet Syndrome; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Transplantation Conditioning | 2004 |
CD4+ T cells mediate murine syngeneic graft-versus-host disease-associated colitis.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Movement; Colitis; Cyclosporine; Graft vs Host Disease; Immunohistochemistry; Immunophenotyping; Intestinal Mucosa; Lymphocyte Depletion; Mice; Mice, Inbred C3H; T-Lymphocyte Subsets; Transplantation, Isogeneic | 2004 |
Increased incidence of acute graft-versus-host disease with the continuous infusion of cyclosporine A compared to twice-daily infusion.
Topics: Acute Disease; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Kidney Diseases; Leukemia; Male; Multivariate Analysis; Retrospective Studies; Risk Factors; Treatment Outcome | 2004 |
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.
Topics: Adolescent; Adult; Bronchiolitis Obliterans; Case-Control Studies; Cryptogenic Organizing Pneumonia; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lung Diseases, Interstitial; Male; Middle Aged; Prednisone; Respiratory Function Tests; Retrospective Studies; Risk Factors; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2004 |
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Combined Modality Therapy; Cyclosporine; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2004 |
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Breast Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Cytokines; Cytotoxicity, Immunologic; Fas Ligand Protein; Female; Gene Expression Regulation; Graft vs Host Disease; Granzymes; Humans; Lymphocyte Activation; Membrane Glycoproteins; Middle Aged; Perforin; Pore Forming Cytotoxic Proteins; Serine Endopeptidases; T-Lymphocytes, Cytotoxic; Transplantation, Autologous | 2004 |
Rectal inflammation as first manifestation of graft-vs-host disease: radiologic-pathologic findings.
Topics: Adult; Biopsy, Needle; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunohistochemistry; Myelodysplastic Syndromes; Prednisolone; Proctitis; Rectum; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Recurrence | 2004 |
[Sequential and quantitative analysis of chimerism after non-myeloablative stem cell transplantation].
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Tandem Repeat Sequences; Transplantation Chimera | 2004 |
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Population Surveillance; Postoperative Care; Retrospective Studies; Risk Assessment; Severity of Illness Index; Siblings; Stem Cell Transplantation | 2004 |
Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.
Topics: Adult; Blood Cells; Bone Marrow Transplantation; Chronic Disease; Cohort Studies; Cyclosporine; Drug Therapy, Combination; fas Receptor; Female; Genetic Predisposition to Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interleukins; Male; Methotrexate; Middle Aged; Polymorphism, Genetic; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2004 |
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
Topics: Adult; Busulfan; Carcinoma, Renal Cell; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Vidarabine | 2004 |
CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease.
Topics: Alopecia; Animals; Autoimmunity; CD4-Positive T-Lymphocytes; CD8 Antigens; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Immunosuppressive Agents; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Peripheral Blood Stem Cell Transplantation; Skin; Transplantation, Autologous | 2004 |
Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation.
Topics: Adult; Biomarkers; Bone Density; Bone Marrow Transplantation; Bone Resorption; Cohort Studies; Cyclosporine; Cytokines; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Interleukin-6; Male; Prednisolone; Prospective Studies; Tumor Necrosis Factor-alpha | 2004 |
Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
Topics: Adult; Aged; Blood Platelets; Cyclosporine; Feasibility Studies; Female; Fetal Blood; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neutrophils; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2004 |
[Graft versus host disease after liver transplantation: a report of 3 cases].
Topics: Cyclosporine; Erythema; Fatal Outcome; Female; Fever; Graft vs Host Disease; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pancytopenia; Polymerase Chain Reaction; Prognosis; Skin; Tacrolimus | 2004 |
Steroid-sparing effect of extracorporeal photopheresis in the treatment of graft-vs-host disease.
Topics: Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Humans; Immunosuppressive Agents; Photopheresis; Prednisone; Retrospective Studies; Stem Cell Transplantation; Treatment Outcome | 2004 |
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Jap
Topics: Acute Disease; Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Siblings; Stem Cell Transplantation; Tacrolimus; Time Factors; Tissue Donors; Treatment Outcome | 2004 |
Early central nervous system complications after reduced-intensity stem cell transplantation.
Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Brain Diseases, Metabolic; Central Nervous System Diseases; Cerebrovascular Disorders; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Limbic Encephalitis; Male; Middle Aged; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 2004 |
[Cyclosporin A-induced posterior reversible encephalopathy syndrome (PRES) in MRI].
Topics: Brain Diseases; Carcinoma, Renal Cell; Cyclosporine; Female; Graft vs Host Disease; Homeostasis; Humans; Hypertensive Encephalopathy; Immunosuppressive Agents; Kidney Neoplasms; Magnetic Resonance Imaging; Middle Aged; Stem Cell Transplantation; Syndrome; Time Factors | 2004 |
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHD.
Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Contraindications; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infection Control; Infections; Leukemia, Myeloid; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2004 |
[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Hypercholesterolemia; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
[Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2004 |
Acute polymyositis after donor lymphocyte infusion.
Topics: Cyclosporine; Disease Susceptibility; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA-DR Antigens; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Middle Aged; Polymyositis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Steroids; Time Factors; Transplantation Chimera; Transplantation, Homologous | 2005 |
Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease.
Topics: Animals; Biological Availability; Cyclosporine; Dogs; Drug Evaluation, Preclinical; Drug Implants; Electroretinography; Eye; Female; Graft vs Host Disease; Immunosuppressive Agents; Keratoconjunctivitis; Male; Rabbits; Retina; Safety; Sclera | 2005 |
Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Blood Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; T-Lymphocytes; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2005 |
Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Interferon-gamma; Middle Aged; Transplantation, Homologous | 2005 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation.
Topics: Acute Kidney Injury; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Renal Dialysis | 2005 |
Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hydrocortisone; Lymphocyte Activation; Lymphocyte Transfusion; Male; Mice; Mice, Inbred BALB C; Transplantation Chimera; Transplantation, Homologous | 2005 |
Optimal initial dose of oral cyclosporine in relation to its toxicities for graft-versus-host disease prophylaxis following reduced-intensity stem cell transplantation in Japanese patients.
Topics: Administration, Oral; Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Immunosuppressive Agents; Japan; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; CD3 Complex; Child; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukocytes; Lymphocytes; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Recurrence; Risk; Stem Cell Transplantation; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Siblings; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Neutrophils; Time Factors; Transfusion Reaction; Transplantation, Homologous; Treatment Outcome | 2005 |
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Transplantation, Homologous | 2005 |
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Non-Langerhans-Cell; Humans; Immunophenotyping; Infant; Male; Methotrexate; Odds Ratio; Regression Analysis; Reoperation; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility Testing; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Risk Factors; Secondary Prevention; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2005 |
Feasibility of early tapering of cyclosporine following reduced-intensity stem cell transplantation for advanced hematologic or solid malignancies.
Topics: Adult; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Middle Aged; Neoplasms; Retrospective Studies; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Premedication; Retrospective Studies; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine | 2006 |
Late effects of chronic graft-vs.-host disease in minor salivary glands.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biopsy; Bone Marrow Transplantation; Case-Control Studies; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Periodic Acid-Schiff Reaction; Prednisone; Salivary Glands, Minor; Xerostomia | 2005 |
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Karnofsky Performance Status; Male; Methotrexate; Middle Aged; Multivariate Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
[A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
Topics: Administration, Topical; Bone Marrow Transplantation; Cyclosporine; Dry Eye Syndromes; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Sjogren's Syndrome; Time Factors; Treatment Outcome | 2005 |
[Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning].
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Interleukin-2 Receptor alpha Subunit; Karyotyping; Macaca mulatta; Models, Animal; Mycophenolic Acid; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2005 |
[Kinetic patterns of cytokine expressions in H-2 haploidentical nonmyeloablative bone marrow transplantation in mice].
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Cytokines; Gene Expression; Graft vs Host Disease; H-2 Antigens; Interferon-gamma; Interleukin-2; Kinetics; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mycophenolic Acid; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Humans; Ischemic Preconditioning; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Retrospective Studies; Tomography, X-Ray Computed; Transplantation, Homologous | 2005 |
Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A.
Topics: Acute Disease; Animals; Arthritis, Experimental; Bacteria; Cell Proliferation; Cyclosporine; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Graft vs Host Disease; Immunosuppressive Agents; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Prodigiosin; Receptors, Interleukin; T-Cell Antigen Receptor Specificity; Time Factors | 2005 |
Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.
Topics: Adolescent; Capillaries; Cerebral Hemorrhage; Cyclosporine; Dyskeratosis Congenita; Erythrocyte Transfusion; Esophagus; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mucous Membrane; Necrosis; Platelet Transfusion; Time Factors; Transplantation Conditioning; Vascular Diseases | 2005 |
Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation.
Topics: Adolescent; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infant; Lymphoproliferative Disorders; Male; Rabbits; Retrospective Studies; Transplantation Conditioning | 2005 |
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Rituximab; Time Factors; Transplantation Chimera; Transplantation Conditioning; Vincristine; Virus Activation; Whole-Body Irradiation | 2005 |
Graft versus host disease in allogeneic stem cell transplantation--3 1/2 years experience.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Middle Aged; Pakistan; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2005 |
Graft versus host disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Cyclosporine; Developing Countries; Graft vs Host Disease; Humans | 2005 |
Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.
Topics: Adult; Aged; Area Under Curve; Chromatography, High Pressure Liquid; Cyclosporine; Drug Monitoring; Female; Glucuronides; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycophenolic Acid; Neutrophils; Treatment Outcome; Whole-Body Irradiation | 2005 |
Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.
Topics: Cells, Cultured; Cyclosporine; Drug Synergism; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantigens; Lymphocyte Activation; Mesenchymal Stem Cells; T-Lymphocytes, Cytotoxic; Transplantation, Homologous | 2005 |
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myeloid, Acute; Living Donors; Male; Middle Aged; Mycophenolic Acid; Radiotherapy Dosage; Survival Analysis; Time Factors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2006 |
Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antigens, CD34; Cell Count; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2006 |
Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
Topics: Adult; Bone Marrow; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2006 |
[Long-term remission in an acute monoblastic leukemia patient with down syndrome after cord blood transplantation].
Topics: Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Down Syndrome; Graft vs Host Disease; Humans; Leukemia, Monocytic, Acute; Male; Remission Induction; Time Factors; Transplantation Conditioning; Treatment Outcome | 2005 |
Bulbar palsy in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Bulbar Palsy, Progressive; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Nerve Diseases; Cyclosporine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin Light Chains; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pneumonia, Aspiration; Pyrazines; Reflex, Abnormal; Transplantation, Homologous; Vincristine | 2005 |
Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Humans; Male; Mexico; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2006 |
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Cyclosporine; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Recombinant Proteins; Remission Induction; Transplantation, Homologous | 2006 |
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors | 2006 |
Switching immunosuppression medications after renal transplantation--a common practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcineurin Inhibitors; California; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Drug Utilization; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Patient Discharge; Postoperative Period; Practice Patterns, Physicians'; Racial Groups; Reoperation; Risk Factors; Sirolimus; Tacrolimus; Tissue Donors | 2006 |
Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
Topics: Adoptive Transfer; Amino Acid Sequence; Animals; Antigen-Presenting Cells; Antigens, Differentiation, B-Lymphocyte; Apoptosis; Autoimmune Diseases; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; Cyclosporine; Cytokines; Fas Ligand Protein; fas Receptor; Female; Forkhead Transcription Factors; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunophenotyping; Immunosuppressive Agents; Membrane Glycoproteins; Molecular Sequence Data; Protein Structure, Tertiary; Radiation Chimera; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; Self Tolerance; Spleen; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Transplantation, Isogeneic; Tumor Necrosis Factors | 2006 |
Human herpesvirus-6 hepatitis associated with cyclosporine-A encephalitis after bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Bone Marrow Transplantation; Brain; Cyclosporine; Encephalitis; Graft vs Host Disease; Hepatitis, Viral, Human; Herpesviridae Infections; Herpesvirus 6, Human; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Magnetic Resonance Imaging; Male | 2006 |
Allogeneic peripheral blood hematopoietic stem cell transplantation for patients with hematologic malignancies.
Topics: Adolescent; Adult; Child; China; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Sepsis | 2006 |
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Fibrosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Myeloablative Agonists; Scleroderma, Systemic; Skin; Transplantation Conditioning; Transplantation, Homologous | 2006 |
Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
Topics: Adult; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Feasibility Studies; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Pancytopenia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2006 |
Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Mesenchymal Stem Cells; T-Lymphocytes, Cytotoxic | 2006 |
Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.
Topics: Child; Cyclosporine; Drug Hypersensitivity; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2006 |
Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Pain; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Tacrolimus; Transplantation, Homologous | 2006 |
Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infe
Topics: Acute Disease; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Isogeneic; Treatment Outcome; Virus Diseases | 2006 |
Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney; Leukemia; Male; Myelodysplastic Syndromes; Retrospective Studies; Siblings | 2006 |
[Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Graft vs Host Disease; Humans; Infant; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tissue Donors; Transplantation Conditioning; Vidarabine | 2006 |
[Clinical study of unrelated umbilical cord blood transplantation in 32 children patients].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Survival Rate; Transplantation Conditioning | 2006 |
[Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haploidy; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Fusion Proteins; Survival Rate; Transplantation Conditioning; Young Adult | 2006 |
Pleocytosis after hemopoietic stem cell transplantation.
Topics: Adult; Cell Count; Cerebrospinal Fluid; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukocytosis; Male; Premedication; Tacrolimus; Transplantation, Autologous; Transplantation, Homologous | 2006 |
The measurement of whole blood pre-treatment cyclosporine A: metabolite ratios predicts the onset of renal dysfunction in recipients of allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Fluorescence Polarization Immunoassay; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Male; Middle Aged; Reproducibility of Results; Stem Cell Transplantation | 2006 |
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Topics: Acute Disease; Antifungal Agents; Cause of Death; Chronic Disease; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mycoses; Siblings; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure; Treatment Outcome; Vidarabine | 2006 |
Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin.
Topics: Adolescent; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Rabbits; Transplantation, Homologous | 2006 |
Immune-mediated myelopathy following allogeneic stem cell transplantation.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes; Pancytopenia; Spinal Cord Diseases; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous | 2006 |
Ophthalmic cyclosporine use in ocular GVHD.
Topics: Administration, Topical; Adolescent; Adult; Aged; Cyclosporine; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Fluorophotometry; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies | 2006 |
The effect of budesonide mouthwash on oral chronic graft versus host disease.
Topics: Adult; Budesonide; Candidiasis, Oral; Chronic Disease; Cohort Studies; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mouthwashes; Pain Measurement; Peripheral Blood Stem Cell Transplantation; Prednisone; Retrospective Studies; Sodium Chloride; Stomatitis; Transplantation Conditioning; Treatment Outcome | 2007 |
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Topics: Adolescent; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Retrospective Studies; Siblings; Survival Analysis; T-Lymphocyte Subsets; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Pseudotumor cerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis.
Topics: Adolescent; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudotumor Cerebri; Transplantation, Homologous | 2007 |
[Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
Topics: Acute Disease; Adolescent; Basal Ganglia; Brain Edema; Cord Blood Stem Cell Transplantation; Cyclosporine; Diffusion Magnetic Resonance Imaging; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Neurotoxicity Syndromes; Syndrome | 2006 |
Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Biopsy; Chronic Disease; Cyclosporine; Female; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney; Male; Middle Aged; Treatment Outcome | 2007 |
Air-leak syndrome associated with bronchiolitis obliterans after allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mediastinal Emphysema; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Radiography; Syndrome | 2007 |
Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
Topics: Animals; Cyclosporine; Disease Models, Animal; Forkhead Transcription Factors; Graft vs Host Disease; Homeostasis; Immune Tolerance; Immunosuppressive Agents; Interleukin-2; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Signal Transduction; Sirolimus; T-Lymphocytes, Regulatory; Thymus Gland | 2007 |
Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclosporine; Diseases in Twins; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Remission Induction | 2008 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Cochlear Implantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Time Factors; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Expansion of B cell precursors after unrelated cord blood transplantation for an adult patient.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Cell Proliferation; Chromosomes, Human, X; Cord Blood Stem Cell Transplantation; Cyclosporine; Diarrhea; Fatal Outcome; Female; Gastrointestinal Agents; Graft Survival; Graft vs Host Disease; Humans; Ileus; Immunosuppressive Agents; Infliximab; Leukemia-Lymphoma, Adult T-Cell; Neoplasm, Residual; Precursor Cells, B-Lymphoid; Transplantation Chimera; Transplantation Conditioning | 2007 |
[Chronic graft-versus-host disease presenting as nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Nephrotic Syndrome; Time Factors; Transplantation, Homologous | 2007 |
Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspergillosis, Allergic Bronchopulmonary; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Follow-Up Studies; Fungemia; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Trichosporon | 2007 |
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
Induction of murine syngeneic graft-versus-host disease by cells of recipient origin.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, SCID; Models, Animal; Transplantation, Isogeneic | 2007 |
[Preparation of placenta factor and its immunoregulatory effects on lymphocytes in vitro].
Topics: Cyclosporine; Ferritins; Graft vs Host Disease; Humans; Immunosuppressive Agents; K562 Cells; Killer Cells, Natural; Lymphocytes; Oxidoreductases; T-Lymphocytes | 2007 |
[Late-onset noninfectious pulmonary complications after allogeneic peripheral blood stem cell transplantation].
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Humans; Incidence; Leukemia; Lung Diseases, Interstitial; Male; Peripheral Blood Stem Cell Transplantation; Prednisone; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2007 |
Non-myeloablative transplantation for severe congenital neutropenia.
Topics: Child, Preschool; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Neutropenia; Transplantation Conditioning | 2008 |
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Child; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kinetics; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms; Transplantation, Homologous | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Topics: Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Lymphocyte Depletion; Male; Melphalan; Multiple Organ Failure; Postoperative Complications; Reoperation; Retrospective Studies; Spain; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Wiskott-Aldrich Syndrome | 2007 |
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prednisolone; Survival Rate; Transplantation, Homologous; Treatment Outcome | 2007 |
Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Premedication; Retrospective Studies; Risk Factors | 2007 |
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Differential cyclosporin-A sensitivity on survival and activation of umbilical cord and adult peripheral blood CD4+ T cells.
Topics: Adult; CD4-Positive T-Lymphocytes; Cyclosporine; Female; Fetal Blood; Graft vs Host Disease; Humans; Infant, Newborn; Interleukin-15; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Pregnancy; Receptors, Antigen, T-Cell | 2007 |
Atypical acute graft-versus-host disease.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Erythema; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases; Treatment Outcome | 2007 |
Unrelated HSCT in an adolescent affected by congenital erythropoietic porphyria.
Topics: Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Porphyria, Erythropoietic; Quality of Life; Sunlight; Transplantation Conditioning | 2008 |
Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant.
Topics: Adolescent; Adult; Cohort Studies; Cyclosporine; Female; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome | 2007 |
CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease.
Topics: Amino Acid Sequence; Animals; Chemokine CCL8; Child; Child, Preschool; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Molecular Weight; Neoplasm Proteins; Poly I-C; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2008 |
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Topics: Acute Disease; Adolescent; beta-Thalassemia; Blood Platelets; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Myeloablative Agonists; Neutrophils; Peripheral Blood Stem Cell Transplantation; Recovery of Function; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2008 |
[A clinical analysis of severe cyclosporine A-related neurotoxicity after allogenic hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Middle Aged; Neurotoxicity Syndromes; Transplantation, Homologous | 2008 |
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Feasibility Studies; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tissue Donors | 2008 |
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Topics: Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Sirolimus; Tacrolimus | 2008 |
Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infusions, Intravenous; Male; Stem Cell Transplantation; Young Adult | 2009 |
Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Topics: Adult; Age Factors; Aged; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Proportional Hazards Models; Risk; Survivors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Ciclosporin kinetics in children after stem cell transplantation.
Topics: Adolescent; Area Under Curve; Bayes Theorem; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Kinetics; Male; Models, Biological; Sampling Studies; Stem Cell Transplantation; Treatment Outcome | 2008 |
Lead-pipe colon revisited in chronic graft-versus-host disease.
Topics: Child; Colon; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Fungal; Radiography, Abdominal | 2008 |
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases | 1995 |
FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Histocompatibility; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; T-Lymphocytes; Tacrolimus | 1994 |
A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft vs Host Disease; Intestine, Small; Microscopy; Models, Biological; Prospective Studies; Random Allocation; Swine; Tacrolimus | 1995 |
Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation.
Topics: Adolescent; Adult; Antigens, CD; Bone Marrow Transplantation; CD5 Antigens; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunotoxins; Infant; Male; Methylprednisolone; Middle Aged | 1995 |
Graft-versus-host disease after small bowel transplantation is associated with host colonic injury.
Topics: Animals; Colon; Cyclosporine; Graft vs Host Disease; Intestinal Mucosa; Intestine, Small; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew | 1995 |
FK506 in bone marrow transplantation.
Topics: Amino Acid Isomerases; Bone Marrow Transplantation; Calcineurin; Calmodulin-Binding Proteins; Carrier Proteins; Cyclosporine; DNA-Binding Proteins; Graft vs Host Disease; Heat-Shock Proteins; Humans; Immunosuppressive Agents; Peptidylprolyl Isomerase; Phosphoprotein Phosphatases; Protein Binding; Tacrolimus; Tacrolimus Binding Proteins | 1995 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1995 |
High-dose cyclosporine and corticosteroids for prophylaxis of acute and chronic graft-versus-host disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Survival Analysis; Transplantation, Homologous | 1995 |
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Lymphocyte Depletion; Lymphocytosis; Male; Methotrexate; Middle Aged; Pneumonia, Viral; T-Lymphocytes; Transplantation, Homologous | 1995 |
IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft vs Host Disease; Interleukin-2; Mice; Mice, Inbred A; Mice, Inbred C57BL; Specific Pathogen-Free Organisms; Survival Rate; Transplantation, Homologous | 1995 |
Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Methotrexate; Middle Aged | 1995 |
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis | 1995 |
The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
Topics: Animals; Cyclosporine; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Heart Transplantation; Histocompatibility Antigens Class II; Immunotherapy, Adoptive; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes; Transplantation, Homologous | 1995 |
Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Cyclosporine; Cytokines; Disease Models, Animal; Graft vs Host Disease; Male; Rats; Rats, Inbred Lew; T-Lymphocytes; Thymectomy; Transplantation, Homologous; Ultraviolet Rays | 1995 |
Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
Topics: Adult; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leucovorin; Leukemia, Myeloid, Acute; Methotrexate; Neutropenia; Prednisolone | 1993 |
Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; CD8 Antigens; Cyclosporine; Disease Models, Animal; Epitopes; Female; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunity, Cellular; Rats; Rats, Inbred BN; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocyte Subsets; T-Lymphocytes | 1993 |
Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis.
Topics: Animals; Autoantibodies; Basement Membrane; Collagen; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glomerulosclerosis, Focal Segmental; Graft vs Host Disease; Kidney Glomerulus; Lupus Nephritis; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Proteinuria; RNA, Messenger; Time Factors | 1994 |
Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression.
Topics: Animals; Autoimmunity; Bone Marrow Transplantation; Cyclosporine; Female; Gene Expression; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Graft vs Host Disease; Immunity, Cellular; Lymphocyte Depletion; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; RNA, Messenger; T-Lymphocyte Subsets; Thymectomy | 1995 |
Biological effects of cyclosporin A: a new antilymphocytic agent. 1976.
Topics: Animals; Arthritis, Experimental; Cyclosporine; Graft vs Host Disease; History, 20th Century; Lymphocytes | 1994 |
Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia.
Topics: Actuarial Analysis; Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Histocompatibility; Humans; Infections; Leukemia; Lung Diseases, Interstitial; Male; Methylprednisolone; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Tissue Donors; Treatment Outcome; Whole-Body Irradiation; Wisconsin | 1995 |
Intraoral pyogenic granuloma after allogeneic bone marrow transplant. Report of three cases.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Gingival Hyperplasia; Graft vs Host Disease; Granuloma, Pyogenic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Male; Middle Aged; Mouth Diseases | 1994 |
Reusable influence diagrams.
Topics: Acute Disease; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Artificial Intelligence; Bayes Theorem; Bone Marrow Transplantation; Child; Cyclosporine; Decision Support Techniques; Expert Systems; Graft vs Host Disease; Humans; Leukemia, Myeloid; Methotrexate; Models, Biological; Neural Networks, Computer; Patient Care Planning; Prognosis; Sex Factors; Systems Integration | 1994 |
Importance of lymphoid tissue for survival of small bowel allografts.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Disease; Intestine, Small; Lymph Node Excision; Lymphoid Tissue; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous | 1995 |
Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Topics: Antigens, CD; Bone Marrow Transplantation; Breast Neoplasms; Cyclosporine; Cytotoxicity, Immunologic; Gene Expression; Graft vs Host Disease; Histocompatibility Antigens Class I; HLA-D Antigens; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Myeloid, Acute; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Polymerase Chain Reaction; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Skin; T-Lymphocytes; Transplantation, Autologous | 1995 |
Effect of posttransplant cyclosporine treatment on the development of syngeneic GVHD in recipients of UV-B irradiated bone marrow cells.
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Male; Rats; Rats, Inbred Lew; Thymectomy; Transplantation, Isogeneic; Ultraviolet Rays | 1995 |
[Activation of endothelium-dependent hemostatic factors following bone marrow transplantation].
Topics: Adolescent; Adult; Blood Coagulation Factors; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Factor VIII; Graft vs Host Disease; Humans; Middle Aged; Plasminogen Activators; Time Factors; von Willebrand Factor | 1995 |
Correlation between changes in cellular immunity and rejection in rat small bowel transplantation.
Topics: Animals; CD3 Complex; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunity, Cellular; Intestine, Small; Major Histocompatibility Complex; Mice; Rats; Rats, Sprague-Dawley; Rats, Wistar; T-Lymphocyte Subsets; Transplantation, Homologous | 1994 |
Oral microemulsion formulation substitutes for intravenous cyclosporin in child with graft-versus-host disease.
Topics: Administration, Oral; Chemistry, Pharmaceutical; Child; Cyclosporine; Drug Compounding; Emulsions; Graft vs Host Disease; Humans; Infusions, Intravenous; Male | 1994 |
Successful treatment of transfusion-associated graft-versus-host disease.
Topics: Adult; Antibodies, Monoclonal; Base Sequence; Cyclosporine; Cytotoxicity, Immunologic; DNA; Female; Graft vs Host Disease; HLA Antigens; Humans; Lymphocyte Subsets; Molecular Sequence Data; Polymerase Chain Reaction; Pregnancy; Repetitive Sequences, Nucleic Acid; Skin; Transfusion Reaction; Transplantation Chimera | 1994 |
Bone marrow transplantation in Hong Kong.
Topics: Bone Marrow Transplantation; Cyclosporine; Family Health; Graft vs Host Disease; Histocompatibility; Hong Kong; Humans; Methotrexate; Middle Aged; National Health Programs; Tissue Donors; Transplantation, Autologous; Transplantation, Homologous | 1994 |
Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy.
Topics: Antineoplastic Agents; Azathioprine; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Family Health; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Middle Aged; Prednisone; Time Factors; Tissue Donors; Transplantation, Homologous | 1994 |
NK activity during graft-versus-host disease and graft rejection in rats following intestinal semiallogenic and allogenic transplantation with or without mesenteric lymphadenectomy.
Topics: Animals; Cyclosporine; Cytotoxicity, Immunologic; Graft Rejection; Graft vs Host Disease; Intestine, Small; Killer Cells, Natural; Lymph Node Excision; Lymph Nodes; Mesentery; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Survival Rate; Transplantation, Homologous | 1994 |
Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A.
Topics: Acute Disease; Adult; Bone Marrow; Bone Marrow Transplantation; Calcineurin; Calmodulin-Binding Proteins; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Phosphoprotein Phosphatases; T-Lymphocytes, Cytotoxic; Time Factors | 1994 |
Myasthenia gravis after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; HLA-B7 Antigen; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Myasthenia Gravis; Prednisolone; Transplantation, Homologous | 1994 |
Bowenoid change in association with graft-versus-host disease: a cyclosporine toxicity?
Topics: Bone Marrow Transplantation; Bowen's Disease; Cyclosporine; Graft vs Host Disease; Humans; Male; Middle Aged; Skin Neoplasms | 1994 |
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Demyelinating Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Polyradiculopathy; Prednisone; Recurrence; Transplantation, Homologous | 1994 |
15-Deoxyspergualin controls cyclosporin- and steroid-resistant intestinal acute graft-versus-host disease after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Resistance; Graft vs Host Disease; Guanidines; Humans; Immunosuppressive Agents; Intestinal Diseases; Male; Transplantation, Homologous | 1994 |
Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of acute graft-versus-host disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leucovorin; Leukemia; Male; Methotrexate; Middle Aged; Transplantation, Homologous | 1994 |
Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Longitudinal Studies; Male; Middle Aged; Prolactin; Radioimmunoassay; Sex Characteristics; Transplantation, Autologous; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
Bone marrow transplantation for primary refractory acute leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Survival Rate | 1994 |
Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection.
Topics: Animals; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Species Specificity; Time Factors; Transplantation, Heterotopic; Transplantation, Homologous | 1994 |
Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft vs Host Disease; Herpesviridae Infections; Histocompatibility Testing; Humans; Infant; Leukemia; Lymphocyte Depletion; Methotrexate; Middle Aged; Multivariate Analysis; Regression Analysis; Risk Factors; Transplantation, Homologous | 1994 |
Prevention of graft-versus-host disease on an individual basis.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Methotrexate; Retrospective Studies; Risk Factors | 1994 |
Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Bone Marrow Transplantation; CD52 Antigen; Complement System Proteins; Cyclosporine; Female; Glycoproteins; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; T-Lymphocytes | 1994 |
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 1994 |
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation | 1994 |
Bone marrow transplantation in Thailand.
Topics: Anemia, Aplastic; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Fetal Blood; Graft vs Host Disease; Histocompatibility Testing; Humans; Incidence; Leukemia; Methotrexate; Thailand; Thalassemia; Transplantation, Homologous | 1994 |
Bone marrow transplantation in Fanconi anemia using matched sibling donors.
Topics: Abdomen; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Family; Fanconi Anemia; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Male; Prednisone; Thorax; Tissue Donors | 1994 |
In vitro determination of self-reactivity in the early postcyclosporine period.
Topics: Animals; Autoimmunity; Cyclosporine; Female; Graft vs Host Disease; H-2 Antigens; Immunotherapy, Adoptive; Killer Cells, Natural; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Inbred DBA; Radiation Chimera; Spleen; T-Lymphocytes, Cytotoxic; Thymectomy; Time Factors | 1993 |
The immunomodulator LS-2616 (linomide) more effectively than sensitization of the donor enhances graft-versus-host reaction after small bowel transplantation.
Topics: Adjuvants, Immunologic; Animals; Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Graft vs Host Reaction; Heart Transplantation; Hydroxyquinolines; Interleukin-2; Intestine, Small; Male; Molecular Structure; Rats; Rats, Inbred BN; Rats, Inbred Lew; Stimulation, Chemical; T-Lymphocytes; Transplantation, Heterotopic | 1994 |
Thy1+ bone marrow cells regulate the induction of murine syngeneic graft-versus-host disease.
Topics: Animals; Antigens, Surface; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Inflammation; Liver; Lymphocyte Depletion; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Splenomegaly; T-Lymphocytes; Thy-1 Antigens; Tongue; Transplantation, Homologous; Transplantation, Isogeneic | 1993 |
Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Creatinine; Cyclosporine; Drug Combinations; Female; Graft vs Host Disease; Humans; Infusion Pumps; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Postoperative Care; Transplantation, Homologous | 1994 |
Treatment of GVHD with cyclosporin A.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Retrospective Studies; Time Factors | 1993 |
Susceptibility and resistance to cyclosporin A-induced autoimmunity in rats.
Topics: Animals; Autoimmune Diseases; Body Weight; Bone Marrow Transplantation; Cyclosporine; Disease Susceptibility; Female; Graft vs Host Disease; Immunity, Cellular; Immunity, Innate; Immunoenzyme Techniques; Killer Cells, Natural; Langerhans Cells; Rats; Rats, Inbred BN; Rats, Inbred Lew; Thymus Gland | 1993 |
Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Italy; Leukemia; Male; Registries; Risk Factors; Sex Characteristics; Survival Rate; Tissue Donors; Transplantation, Homologous | 1993 |
Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Humans; Incidence; Methotrexate; Prednisone; Prospective Studies; PUVA Therapy; Retrospective Studies; Severity of Illness Index; Stem Cells; T-Lymphocytes, Cytotoxic; Tissue Donors | 1994 |
Oral cytomegalovirus infection in an unrelated bone marrow transplantation with possible mediation by graft-versus-host disease and the use of cyclosporin-A.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoenzyme Techniques; Lymphoma, Follicular; Mouth Diseases; Mouth Mucosa; Tongue Diseases; Ulcer | 1994 |
Successful allogenic transplantation after autologous graft failure.
Topics: Biopsy; Bone Marrow; Bone Marrow Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Middle Aged; Platelet Count; Transplantation, Autologous; Transplantation, Homologous | 1994 |
Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chromatography, High Pressure Liquid; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Retrospective Studies; Time Factors | 1994 |
Cold agglutinin disease following allogeneic bone marrow transplantation.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Incidence; Male; Methotrexate; Prednisolone; Transplantation, Homologous | 1994 |
Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Immunization, Passive; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Rats; Rats, Inbred Lew; Rats, Inbred WF; T-Lymphocytes | 1994 |
Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II-dependent autoaggression.
Topics: Animals; Autoimmunity; Bone Marrow Transplantation; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Histocompatibility Antigens Class II; Homeostasis; Immunotherapy, Adoptive; Rats; Rats, Inbred Lew; Transplantation, Isogeneic | 1993 |
rhGM-CSF after allogeneic bone marrow transplantation from unrelated donors: a pilot study of cyclosporine and prednisone as graft-versus-host disease prophylaxis.
Topics: Adolescent; Adult; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Child, Preschool; Cross Infection; Cyclosporine; Female; Fever; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Histocompatibility; Humans; Immunologic Factors; Male; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Recombinant Proteins; Survival Analysis; Treatment Outcome | 1993 |
Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the in vivo administration of rapamycin but develop an autoimmune-like syndrome.
Topics: Animals; Autoimmune Diseases; Bone Marrow Transplantation; CD4 Antigens; CD8 Antigens; Clonal Deletion; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Polyenes; Receptors, Antigen, T-Cell, alpha-beta; Sirolimus; T-Lymphocyte Subsets; Transplantation, Homologous | 1993 |
Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Survival Rate | 1993 |
[How long should cyclosporin be administered following bone marrow transplantation?].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Creatinine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Middle Aged; Retrospective Studies; Whole-Body Irradiation | 1994 |
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adult; Age Factors; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Family Health; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Time Factors; Tissue Donors | 1993 |
Criteria for use of cyclosporine in adult transplant recipients.
Topics: Cyclosporine; Drug Interactions; Graft Rejection; Graft vs Host Disease; Humans; Hypertension; Organ Transplantation | 1993 |
Demonstration of large-scale migration of cortical thymocytes to peripheral lymphoid tissues in cyclosporin A-treated rats.
Topics: Animals; CD4 Antigens; CD8 Antigens; Cell Movement; Cyclosporine; Female; Graft vs Host Disease; Lymphoid Tissue; Rats; Rats, Inbred Lew; T-Lymphocytes | 1993 |
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Cells; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Retrospective Studies | 1993 |
Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lung Diseases, Obstructive; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Respiratory Function Tests; Retrospective Studies; Risk Factors; Transplantation, Homologous | 1993 |
BMT for severe aplastic anemia using cyclosporine.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Humans; Male; Middle Aged; Survival Rate | 1993 |
Cyclosporin A-induced autoimmune disease in mice.
Topics: Animals; Autoimmune Diseases; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Immunophenotyping; Immunotherapy, Adoptive; Mice; Mice, Inbred Strains; T-Lymphocytes; Thymus Gland; Whole-Body Irradiation | 1993 |
Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse.
Topics: Acute Disease; Base Sequence; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Chronic-Phase; Molecular Sequence Data; Oligonucleotide Probes; Polymerase Chain Reaction; Postoperative Period; Transplantation, Homologous | 1993 |
Bone marrow transplantation for pediatric patients with severe aplastic anemia in Taiwan.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Male; Taiwan | 1993 |
Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMT.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Liver; Male; Time Factors | 1993 |
High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
Topics: Adult; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cyclosporine; DNA, Viral; Graft vs Host Disease; Humans; JC Virus; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA Probes; Transplantation, Homologous; Tumor Virus Infections | 1993 |
Rate of marrow engraftment does not appear to be adversely affected by early marrow infusion after total body irradiation.
Topics: Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Pretreatment with irradiation and donor-specific transfusion prolongs survival in small intestinal transplantation.
Topics: Animals; Blood Transfusion; Cyclosporine; Graft Survival; Graft vs Host Disease; Immunosuppression Therapy; Intestine, Small; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors | 1993 |
Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
Topics: Animals; Bone Marrow Transplantation; CD8 Antigens; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunophenotyping; Lymphocyte Depletion; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes | 1993 |
Rapamycin effects on immunologic reconstitution.
Topics: Animals; Bone Marrow Transplantation; CD4-CD8 Ratio; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Immunosuppressive Agents; Polyenes; Rats; Rats, Inbred Lew; Sirolimus; T-Lymphocyte Subsets; T-Lymphocytes; Whole-Body Irradiation | 1993 |
Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Immunotherapy, Adoptive; Rats; Rats, Inbred Lew; Transplantation, Isogeneic; Whole-Body Irradiation | 1993 |
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Topics: Alleles; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; HLA-DP Antigens; HLA-DP beta-Chains; Humans; Leukemia; Methotrexate; Transplantation, Homologous | 1993 |
Sudden hearing loss in a cyclosporin-treated renal transplantation patient.
Topics: Adult; Cyclosporine; Graft vs Host Disease; Hearing Loss; Humans; Kidney Transplantation; Male; Thromboembolism | 1993 |
Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Infant; Italy; Leukemia; Methotrexate; Middle Aged; Tissue Donors; Transplantation, Homologous | 1993 |
The need for endoscopic biopsy in the diagnosis of upper gastrointestinal graft-versus-host disease.
Topics: Biopsy; Bone Marrow Transplantation; Child; Cyclosporine; Duodenum; Endoscopy; Endoscopy, Gastrointestinal; Graft vs Host Disease; Humans; Male; Methylprednisolone; Prospective Studies; Rectum | 1993 |
[Cyclosporine-induced graft-versus-host disease in a syngeneic bone marrow transplantation].
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy; Leukemia, Myelomonocytic, Acute | 1993 |
Effects of donor pretreatment with antilymphocyte serum and cyclosporin on rejection and graft-versus-host disease after small bowel transplantation in immunosuppressed and nonimmunosuppressed rats.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunosuppression Therapy; Intestine, Small; Rats; Rats, Inbred BN; Rats, Inbred Strains; Tissue Donors; Transplantation, Homologous | 1993 |
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Animals; Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunoglobulin G; Immunosuppression Therapy; Incidence; Infant; Lymphocyte Activation; Male; Middle Aged; Rats; Receptors, Interleukin-2; Survival Rate; Transplantation, Homologous | 1993 |
[An autopsy case report of hemolytic uremic syndrome after allogeneic bone marrow transplantation].
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Intestinal Mucosa; Kidney; Male | 1993 |
Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Risk Factors | 1993 |
Donor buffy coat infusions for a patient with myelodysplastic syndrome who relapsed following allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusion; Male; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Recurrence | 1995 |
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Allogeneic bone marrow transplatation in a patient with Shwachman-Diamond syndrome.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Exocrine Pancreatic Insufficiency; Fatal Outcome; Female; Graft vs Host Disease; Humans; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Pregnancy; Syndrome | 1996 |
Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD.
Topics: Autoimmune Diseases; Bone Marrow Transplantation; CD28 Antigens; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukocyte Count; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Transplantation, Autologous; Treatment Outcome | 1996 |
Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
Topics: Adult; Bone Marrow Transplantation; Breast Neoplasms; Cyclosporine; Dermatitis, Exfoliative; Edema; Epidermis; Female; Gene Expression Regulation; Graft vs Host Disease; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Keratinocytes; Survival Rate | 1996 |
Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
Topics: Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Biphenyl Compounds; Cyclosporine; Graft Survival; Graft vs Host Disease; Graft vs Host Reaction; Host vs Graft Reaction; Immune Tolerance; Immunosuppressive Agents; Intestine, Small; Male; Perfusion; Polyenes; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Sirolimus; Time Factors; Transplantation, Homologous | 1996 |
In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A.
Topics: Animals; Autoimmunity; Cyclosporine; Cytokines; Graft vs Host Disease; Immunosuppressive Agents; Mice; Polyenes; Sirolimus; Syndrome; T-Lymphocytes | 1996 |
Teething and acute graft vs. host disease: a clinical observation.
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Female; Gingiva; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Interleukin-1; Severe Combined Immunodeficiency; Tooth Eruption | 1996 |
Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
Topics: beta-Thalassemia; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cells, Cultured; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Hemoglobin E; Hemoglobinuria; Homozygote; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Reference Values | 1995 |
Donor leucocyte transfusions for relapse in myelodyplastic syndrome after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusion; Male; Myelodysplastic Syndromes; Prednisolone; Recurrence; Transplantation, Autologous | 1996 |
Thalidomide responsive chronic pulmonary GVHD.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Bronchiolitis Obliterans; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Multiple Myeloma; Thalidomide | 1996 |
UVB irradiation of human-derived peripheral blood lymphocytes induces apoptosis but not T-cell anergy: additive effects with various immunosuppressive agents.
Topics: Apoptosis; Azathioprine; Clonal Anergy; Cyclosporine; Cytotoxicity, Immunologic; DNA Damage; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Methylprednisolone; T-Lymphocyte Subsets; Ultraviolet Rays | 1996 |
Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Cytokines; Etoposide; Gene Expression; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Interleukins; Lymphocytes; Methotrexate; Polymerase Chain Reaction; RNA, Messenger; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
Topics: Animals; Body Weight; Cyclosporine; Endotoxins; Graft Rejection; Graft vs Host Disease; Immunosuppressive Agents; Infections; Intestine, Large; Intestine, Small; Prospective Studies; Swine; Tacrolimus; Toxemia | 1996 |
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Whole-Body Irradiation | 1996 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
Antitumor effect in cyclosporine A- or FK506-treated mice after syngeneic bone marrow transplantation.
Topics: Actins; Animals; Antineoplastic Agents; Base Sequence; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cytokines; Cytotoxicity, Immunologic; Graft vs Host Disease; Immunosuppressive Agents; Interleukin-4; Male; Mice; Mice, Inbred DBA; Molecular Sequence Data; Neoplasms, Experimental; Polymerase Chain Reaction; RNA, Messenger; Tacrolimus; Tumor Necrosis Factor-alpha | 1996 |
Quadruple immunosuppression in a pig model of small bowel transplantation.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Graft vs Host Disease; Horses; Immunosuppression Therapy; Injections, Intravenous; Intestine, Small; Leukocyte Count; Prednisolone; Survival Analysis; Swine | 1996 |
Pseudotumor cerebri associated with cyclosporine use.
Topics: Bone Marrow Transplantation; Child; Cyclosporine; Diplopia; Esotropia; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intracranial Pressure; Male; Papilledema; Pseudotumor Cerebri; Transplantation, Homologous | 1996 |
The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease.
Topics: Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Humans; Hydroxychloroquine; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1996 |
Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Male; Middle Aged; Transplantation, Autologous | 1996 |
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow; Catheterization, Central Venous; Child; Cyclosporine; Female; Filgrastim; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Lenograstim; Leukapheresis; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Recombinant Proteins; Retreatment; Retrospective Studies; Safety; Transplantation, Homologous; Treatment Outcome | 1996 |
Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A.
Topics: Bone Marrow; Bone Marrow Transplantation; Cyclosporine; Cytotoxicity, Immunologic; Drug Resistance; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; T-Lymphocytes, Cytotoxic | 1996 |
CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anticonvulsants; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Clonazepam; Coma; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hemosiderosis; Humans; Hypertension; Immunosuppressive Agents; Incidence; Infant; Liver Diseases; Magnesium Deficiency; Magnetic Resonance Imaging; Male; Nervous System Diseases; Retrospective Studies; Risk Factors; Seizures; Tomography, X-Ray Computed; Transplantation Conditioning; Treatment Failure; Vision Disorders | 1996 |
Graft-versus-host disease. Possible higher risk for African American patients.
Topics: Adult; Black People; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Incidence; Male; Methylprednisolone; Retrospective Studies; Risk Factors; Severity of Illness Index | 1996 |
Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous protein antigen, tetanus toxoid.
Topics: Adult; Antigens, Differentiation, B-Lymphocyte; Chloroquine; Cyclosporine; Drug Synergism; Graft vs Host Disease; Histocompatibility Antigens Class II; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lymphocyte Activation; T-Lymphocytes; Tetanus Toxoid | 1996 |
Progressive autologous graft-versus-host disease induced by cyclosporin A.
Topics: Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous | 1996 |
Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Time Factors; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Small intestine transplantation using a ferret model.
Topics: Anastomosis, Surgical; Animals; Aorta, Abdominal; Cyclosporine; Ferrets; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant, Newborn; Intestine, Small; Male; Mesenteric Artery, Superior; Portal Vein; Transplantation, Heterotopic; Transplantation, Homologous | 1996 |
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantatio
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Leukemia; Methotrexate; Middle Aged; Recurrence; Transplantation, Homologous; Treatment Outcome | 1996 |
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infections; Interleukin-12; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Transplantation, Homologous | 1996 |
Seizures in lung transplant recipients.
Topics: Age Factors; Blood-Brain Barrier; Brain; Comorbidity; Cyclosporine; Cystic Fibrosis; Epilepsies, Partial; Graft Rejection; Graft vs Host Disease; Humans; Hypertension; Lung Transplantation; Magnetic Resonance Imaging; Methylprednisolone; Retrospective Studies; Risk Factors; Seizures; Transplantation, Homologous | 1996 |
The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells.
Topics: Adoptive Transfer; Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Separation; Cyclosporine; Female; Flow Cytometry; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunoglobulin Variable Region; Keratinocytes; Lymphocyte Subsets; Phenotype; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta | 1996 |
Neurologic complications after allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Brain Abscess; Busulfan; Cerebrovascular Disorders; Cyclosporine; Encephalitis; Epilepsy, Tonic-Clonic; Graft vs Host Disease; Humans; Incidence; Magnesium Deficiency; Mycoses; Nervous System Diseases; Neuromuscular Diseases; Prednisolone; Transplantation Conditioning | 1996 |
Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.
Topics: Abducens Nerve; Adolescent; Adult; Antiviral Agents; Blepharoptosis; Bone Marrow Transplantation; Cranial Nerve Diseases; Cyclosporine; Cytomegalovirus Infections; Diplopia; Female; Ganciclovir; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Ophthalmoplegia; Viremia | 1997 |
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Extracorporeal Circulation; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichen Planus; Male; Middle Aged; Prednisolone; PUVA Therapy; Remission Induction; Skin Diseases; Transplantation, Homologous | 1997 |
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid | 1997 |
Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Dinucleotide Repeats; Dogs; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Histocompatibility; Histocompatibility Antigens; Immunosuppressive Agents; Mycophenolic Acid; Radiation Chimera; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Topics: Acute Disease; Adrenal Cortex Hormones; Bone Marrow Transplantation; Clinical Protocols; Cyclosporine; Europe; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Surveys and Questionnaires; Transplantation, Homologous | 1997 |
De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant .
Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic; B-Lymphocytes; Bone Marrow Transplantation; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Lymphocyte Count; Lymphocyte Depletion; Male; Retrospective Studies; T-Lymphocytes | 1997 |
Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation.
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Injections, Spinal; Killer Cells, Natural; Male; Methotrexate; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 1997 |
Primary transplantation of allogeneic peripheral blood stem cell for severe aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Stem Cell Transplantation; Transplantation, Homologous | 1997 |
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Transplantation Conditioning | 1997 |
Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Nuclear Family; Remission, Spontaneous; Retrospective Studies; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1997 |
Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Antigens, CD; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Flow Cytometry; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppression Therapy; Infant; Leukocyte Common Antigens; Male; Regeneration; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Thymectomy; Thymus Gland; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study.
Topics: Antineoplastic Agents; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Transplantation, Autologous | 1997 |
Allo- and autotransplantation of carotid artery--a new model of chronic graft vessel disease: evaluation by magnetic resonance imaging and histology.
Topics: Animals; Body Weight; Carotid Arteries; Cyclosporine; Graft vs Host Disease; Magnetic Resonance Imaging; Postmortem Changes; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation Immunology; Transplantation, Autologous; Transplantation, Homologous | 1997 |
Factors influencing haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis. A single-centre experience.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow Transplantation; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neutrophils; Recombinant Proteins; Retrospective Studies; Statistics, Nonparametric; Transplantation, Homologous | 1997 |
Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Purging; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoid Tissue; Male; Methotrexate; Middle Aged; Risk Factors; Survival Rate; Transplantation Conditioning | 1996 |
Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation.
Topics: Azathioprine; Biological Availability; Cyclosporine; Drug Delivery Systems; Emulsions; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisolone | 1997 |
Systemic liberation of interleukin-8 in the perioperative phase of liver transplantation.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Interleukin-8; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Period; Tacrolimus | 1997 |
[Graft-versus-leukemia effect induced by abrupt discontinuation of cyclosporine A following allogeneic bone marrow transplantation].
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged | 1997 |
Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?
Topics: Animals; Cell Survival; Cells, Cultured; Chloroquine; Concanavalin A; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Histocompatibility Antigens Class II; Hydroxychloroquine; Interferon-gamma; Interleukin-2; Kinetics; Lymphocyte Activation; Lysosomes; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Minor Histocompatibility Antigens; Spleen; T-Lymphocytes | 1997 |
Reversible cortical blindness and convulsions with cyclosporin A toxicity in a patient undergoing allogeneic peripheral stem cell transplantation.
Topics: Adult; Blindness, Cortical; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Erythroblastic, Acute; Methylprednisolone; Seizures | 1997 |
Antigen-presenting cells (APC) of mice with chronic graft-versus-host disease (GVHD) cause excessive activation-induced death of T helper cells.
Topics: Animals; Antigen-Presenting Cells; Cell Death; Chronic Disease; Cyclosporine; Enterotoxins; Graft vs Host Disease; Immunization; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; T-Lymphocytes, Helper-Inducer | 1997 |
Linear chronic cutaneous graft-versus-host disease.
Topics: Adult; Basement Membrane; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Cytarabine; E-Selectin; Epidermis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Keratosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Methotrexate; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
DT-Planner: an environment for managing dynamic decision problems.
Topics: Algorithms; Bone Marrow Transplantation; Computer Graphics; Computers; Cyclosporine; Decision Making, Computer-Assisted; Graft vs Host Disease; Humans; Immunosuppressive Agents; Markov Chains; Software; Therapy, Computer-Assisted | 1997 |
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Topics: Adult; Bone Marrow Cells; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Pilot Projects; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous | 1997 |
Combination therapy with a CD4-CDR3 peptide analog and cyclosporin A to prevent graft-vs-host disease in a MHC-haploidentical bone marrow transplantation model.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Graft vs Host Disease; Immunosuppressive Agents; Lymphocyte Culture Test, Mixed; Male; Mice; Oligopeptides; Transplantation, Homologous | 1998 |
A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Disease Management; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukocyte Transfusion; Male; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recombinant Proteins; Recurrence; Remission Induction; Retrospective Studies; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Survival Analysis; Treatment Outcome | 1997 |
Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis.
Topics: Abdominal Pain; Acute Disease; Adult; Amylases; Bile; Biomarkers; Bone Marrow Transplantation; Cause of Death; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Gallbladder; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Neoplasms; Pancreatitis; Prednisone; Prevalence; Risk Factors; Transplantation Conditioning; Whole-Body Irradiation | 1997 |
Pharmacodynamic monitoring of immunosuppressive drugs.
Topics: Azathioprine; Calcineurin; Cyclosporine; Drug Monitoring; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Methyltransferases; Mycophenolic Acid; Polyenes; Ribosomal Protein S6 Kinases; Sirolimus | 1998 |
[Cyclosporine].
Topics: Bone Marrow Transplantation; Cyclosporine; Graft Rejection; Graft vs Host Disease; Graft vs Host Reaction; Humans; Organ Transplantation | 1998 |
Increased LFA-1 expression in intestines of rats with GVHD after small bowel transplantation.
Topics: Animals; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Immunohistochemistry; Intestine, Small; Lymphocyte Function-Associated Antigen-1; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Staining and Labeling; Transplantation, Homologous | 1998 |
Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Dogs; Drug Synergism; Graft vs Host Disease; Histocompatibility Antigens Class I; Histocompatibility Testing; Immunosuppressive Agents; Injections, Intravenous; Mycophenolic Acid; Transplantation, Homologous; Whole-Body Irradiation | 1998 |
A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Prednisolone | 1998 |
Promiscuous recognition of major histocompatibility complex class II determinants in cyclosporine-induced syngeneic graft-versus-host disease: specificity of cytolytic effector T cells.
Topics: Amino Acid Sequence; Animals; Antigens, Differentiation, B-Lymphocyte; Autoantigens; Cyclosporine; Cytotoxicity, Immunologic; Female; Graft vs Host Disease; Histocompatibility Antigens Class II; Molecular Sequence Data; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Spleen; T-Lymphocytes | 1998 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Topics: Adult; Analysis of Variance; Antibodies; Antibodies, Antinuclear; Antiphospholipid Syndrome; Biopsy; Cadaver; Cell Count; Cell Size; Cyclosporine; Female; Follow-Up Studies; Glomerular Mesangium; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Recurrence; Renal Dialysis; Time Factors; Transplantation Conditioning | 1998 |
Successful therapy of refractory graft versus host disease with tacrolimus and Psoralen plus ultraviolet light.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Ficusin; Globulins; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Methylprednisolone; Photosensitizing Agents; Radiotherapy, Adjuvant; Tacrolimus; Ultraviolet Therapy | 1998 |
An immunosuppressive regimen using FTY720 combined with cyclosporin in canine kidney transplantation.
Topics: Animals; Cyclosporine; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Kidney Transplantation; Leukocyte Count; Propylene Glycols; Sphingosine | 1998 |
Transfusion-associated graft-versus-host disease in immunocompetent patient: early diagnosis and therapy.
Topics: Aged; Aortic Aneurysm; Aortic Dissection; Cyclosporine; DNA; Glucocorticoids; Graft vs Host Disease; Guanidines; Humans; Immunocompetence; Immunosuppressive Agents; Male; Methylprednisolone; Microsatellite Repeats; Polymorphism, Genetic; Time Factors; Transfusion Reaction | 1998 |
Proposal for standard recommendations for prophylaxis of graft-versus-host disease in children. European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases and the International Study Committee of the BFM family-subcommitt
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant | 1998 |
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Prognosis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Topics: Adult; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ichthyosis; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Transplantation, Homologous | 1998 |
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Anemia; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukopenia; Male; Middle Aged; Mycophenolic Acid; Prednisolone | 1998 |
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mass Screening; Methotrexate; Multivariate Analysis; Risk Factors; Transplantation, Homologous | 1998 |
The use of topical cyclosporin A in ocular graft-versus-host-disease.
Topics: Administration, Topical; Adult; Bone Marrow Transplantation; Cyclosporine; Eye Diseases; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Transplantation, Homologous | 1998 |
Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infusions, Intravenous; Intestinal Absorption; Metabolic Clearance Rate; Middle Aged; Reproducibility of Results; Time Factors | 1998 |
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Transplantation, Homologous; Treatment Outcome | 1998 |
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Tissue Donors; Transplantation, Homologous | 1998 |
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infections; Life Tables; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Survival Rate; Transplantation, Homologous | 1998 |
Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.
Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intestinal Diseases; Lymphoma, Non-Hodgkin; Male; Middle Aged; Transplantation, Isogeneic | 1998 |
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Sex Factors; Transplantation, Homologous | 1998 |
Characterization of the pathogenic autoreactive T cells in cyclosporine-induced syngeneic graft-versus-host disease.
Topics: Amino Acid Sequence; Animals; Antigens, Differentiation, B-Lymphocyte; Autoimmune Diseases; Autoimmunity; Bone Marrow Transplantation; Cyclosporine; Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Graft vs Host Disease; Histocompatibility Antigens; Histocompatibility Antigens Class II; Interferon-gamma; Interleukins; Lymphokines; Molecular Sequence Data; Polymerase Chain Reaction; Rats; Rats, Inbred Lew; Receptors, Antigen, T-Cell, alpha-beta; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; T-Lymphocytes, Cytotoxic; Th1 Cells | 1998 |
Irradiation or temporal variations in immunosuppressive schedules do not prevent graft-versus-host disease following rat limb allotransplantation.
Topics: Animals; Cyclosporine; Drug Administration Schedule; Extremities; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Whole-Body Irradiation | 1998 |
Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes.
Topics: Animals; Bone Marrow Transplantation; Cell Division; Cyclosporine; Gene Transfer Techniques; Graft vs Host Disease; Humans; Immunosuppressive Agents; In Vitro Techniques; Interferon-gamma; Lymphocyte Depletion; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes; Thymidine Kinase; Transplantation, Homologous | 1998 |
Fulminant, CMV-associated, haemophagocytic syndrome following unrelated bone marrow transplantation.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Histiocytosis, Non-Langerhans-Cell; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Methylprednisolone; Transplantation, Homologous | 1998 |
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Allogeneic BMT for haematological disorders: single centre experience of University Hospital Bratislava.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hospitals, University; Humans; Immunosuppressive Agents; Male; Middle Aged; Slovakia; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Transplantation of allogeneic peripheral blood progenitor cells--a single centre experience.
Topics: Adult; Cyclosporine; Czech Republic; Female; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1998 |
Allogeneic and autologous bone marrow transplantation in single centre experience.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous | 1998 |
Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Transfusion; Male; Middle Aged; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Homologous | 1998 |
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
Topics: Adult; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Cross-Sectional Studies; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Longitudinal Studies; Male; Middle Aged; Prednisolone; Risk Factors; Transplantation, Autologous; Transplantation, Homologous | 1999 |
Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Transplantation, Homologous | 1999 |
Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Retrospective Studies; Transplantation, Homologous | 1999 |
Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Topics: Adolescent; Adult; Antigens, CD19; Antigens, CD34; B-Lymphocyte Subsets; CD4 Antigens; CD8 Antigens; Cell Separation; Chimera; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Infections; Killer Cells, Natural; Kinetics; Leukapheresis; Leukocyte Common Antigens; Lymphocyte Count; Lymphocyte Depletion; Lymphocyte Subsets; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; T-Lymphocyte Subsets; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
[Eczema-like cutaneous graft versus host disease treated by UV-B therapy in a 2-year-old child].
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclosporine; Eczema; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Living Donors; Male; Scalp; Ultraviolet Therapy | 1999 |
Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries.
Topics: Adolescent; Bone Marrow Transplantation; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Female; Finland; Graft vs Host Disease; Humans; Iceland; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome | 1999 |
Rapid tapering of cyclosporin to maximise the graft-versus-leukaemia effect.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Administration Schedule; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute | 1999 |
Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia; Male; Middle Aged; Recurrence; Retrospective Studies; Transplantation, Homologous | 1999 |
Cyclosporin A-induced autologous graft-versus-host disease: a prototypical model of autoimmunity and active (dominant) tolerance coordinately induced by recent thymic emigrants.
Topics: Animals; Autoantigens; Autoimmune Diseases; CD4 Antigens; CD8 Antigens; Cell Movement; Cyclosporine; Female; Graft vs Host Disease; Immune Tolerance; Immunophenotyping; Kinetics; Lymph Nodes; Rats; Rats, Inbred Lew; T-Lymphocyte Subsets; Thymus Gland; Time Factors | 1999 |
Pre-treatment of transplant bone marrow cells with hydrocortisone and cyclosporin A alleviates graft-versus-host reaction in a murine allogeneic host-donor combination.
Topics: Animals; Bone Marrow Transplantation; Cell Differentiation; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Hydrocortisone; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Transplantation, Homologous | 1999 |
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
Topics: Animals; Antibody Formation; Antibody Specificity; Coronary Disease; Cyclosporine; Drug Evaluation, Preclinical; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Heart Transplantation; Histocompatibility; Histocompatibility Antigens; Immunity, Cellular; Immunoglobulin G; Immunosuppressive Agents; Isoantibodies; Male; Nitric Oxide; Rats; Rats, Inbred ACI; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred WF; Reproducibility of Results; Sirolimus; Transplantation, Homologous | 1999 |
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
Topics: Adolescent; Adult; Biomarkers, Tumor; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Gastrointestinal Hemorrhage; Graft Enhancement, Immunologic; Graft vs Host Disease; Graft vs Tumor Effect; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Leukocyte Transfusion; Life Tables; Lymphocyte Depletion; Male; Middle Aged; Neoplasm, Residual; Nuclear Family; Polymerase Chain Reaction; Salvage Therapy; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
Topics: Animals; Antibodies, Monoclonal; Antigens; Antigens, Surface; Colon; Cyclosporine; Cytokines; Cytotoxicity, Immunologic; Graft vs Host Disease; Injections, Intraperitoneal; Interleukin-12; Killer Cells, Natural; Lectins, C-Type; Lymphocyte Depletion; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; NK Cell Lectin-Like Receptor Subfamily B; Proteins; RNA, Messenger; Th1 Cells; Transplantation, Isogeneic | 1999 |
[Switching to Neoral in patients with a stable kidney transplant. Retrospective study].
Topics: Adult; Aged; Creatinine; Cyclosporine; Drug Costs; Female; Gingival Hyperplasia; Graft vs Host Disease; Humans; Immunosuppressive Agents; Italy; Kidney Transplantation; Male; Middle Aged; Retrospective Studies | 1999 |
Primary renal aspergillosis: extremely uncommon presentation in patients treated with bone marrow transplantation.
Topics: Aspergillosis; Aspergillus; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Fatal Outcome; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged | 1999 |
Thrombotic microangiopathy following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Humans; Interferon-gamma; Male; Thrombosis; Transplantation, Homologous | 1999 |
Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Topics: Cell Culture Techniques; Cells, Cultured; Cyclosporine; Female; Fetal Blood; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility Testing; Humans; Immunophenotyping; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1999 |
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Life Tables; Male; Methotrexate; Methylprednisolone; Middle Aged; Nifedipine; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Wiskott-Aldrich Syndrome | 1999 |
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia; Recurrence; Risk; Time Factors | 1999 |
Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; Bone Marrow Transplantation; CTLA-4 Antigen; Cyclosporine; Dogs; Graft vs Host Disease; Hematopoietic Stem Cells; Histocompatibility Testing; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Leukocyte Count; Lymph Nodes; Lymphocyte Count; Lymphocyte Culture Test, Mixed; Mycophenolic Acid; Platelet Count; Transplantation Chimera; Transplantation, Homologous; Whole-Body Irradiation | 1999 |
Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multiple Myeloma; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1999 |
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Alleles; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; HLA-A2 Antigen; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Middle Aged; Minor Histocompatibility Antigens; Nuclear Family; Oligopeptides; Parity; Retrospective Studies; Risk; Severity of Illness Index; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Neoplasms, Second Primary; Proportional Hazards Models; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors | 1999 |
Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Interferon-gamma; Killer Cells, Natural; Leukemia, Myeloid, Acute; Male; Middle Aged; Skin; T-Lymphocyte Subsets | 1999 |
Effect of Tranilast on chronic graft vascular disease and tracheal proliferation in a rat allograft model.
Topics: Animals; Cell Division; Chronic Disease; Coronary Disease; Cyclosporine; Graft vs Host Disease; Heart Transplantation; Male; ortho-Aminobenzoates; Platelet Aggregation Inhibitors; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Trachea; Transplantation, Heterotopic; Transplantation, Homologous | 1999 |
Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema.
Topics: Adult; Bone Marrow Transplantation; Brain; Brain Edema; Cyclosporine; Diffusion; Graft vs Host Disease; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Neurotoxicity Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1999 |
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Recurrence; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 2000 |
Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.
Topics: Animals; CD3 Complex; Chlorocebus aethiops; Cyclosporine; Diabetes Mellitus, Type 1; Diphtheria Toxin; Fasting; Glucose Tolerance Test; Graft vs Host Disease; Immunoglobulin Fragments; Immunosuppressive Agents; Immunotoxins; Islets of Langerhans; Islets of Langerhans Transplantation; Macaca fascicularis; Macaca mulatta; Methylprednisolone; Organ Size; Recombinant Fusion Proteins; Transplantation, Heterologous | 2000 |
Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Transplantation Conditioning | 2000 |
FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Child, Preschool; Cyclosporine; Dementia, Vascular; Electroencephalography; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Magnetic Resonance Imaging; Male; Seizures; Tacrolimus | 2000 |
Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model.
Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; Bone Marrow Transplantation; CTLA-4 Antigen; Cyclosporine; Dogs; Graft vs Host Disease; Histocompatibility Testing; Immunoconjugates; Immunoglobulin Fc Fragments; Immunosuppressive Agents; Methotrexate; Recombinant Fusion Proteins; Transplantation Immunology; Transplantation, Homologous | 2000 |
Complexity of effector mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.
Topics: Animals; Bone Marrow Transplantation; CD8-Positive T-Lymphocytes; Clone Cells; Coculture Techniques; Cyclosporine; Cytokines; Down-Regulation; Female; Graft vs Host Disease; Interferon-gamma; Interleukin-2; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transplantation, Isogeneic | 2000 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous | 2000 |
Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin.
Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Prednisolone; Severity of Illness Index; Thalassemia; Transplantation Conditioning; Treatment Outcome | 1999 |
Two cases of chronic graft-versus-host disease with elevated levels of soluble Fas ligand in serum.
Topics: Adolescent; Chronic Disease; Cyclosporine; Fas Ligand Protein; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Liver; Male; Membrane Glycoproteins; Middle Aged; Prednisolone; Solubility | 2000 |
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
Topics: Adolescent; Adult; Antibody Specificity; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Isoantibodies; Leukemia; Lymphocyte Depletion; Middle Aged; Nuclear Family; Registries; Retrospective Studies; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous | 2000 |
Nonmyeloablative transplants: preclinical and clinical results.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Dogs; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Host vs Graft Reaction; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pentostatin; Purine Nucleosides; Radiation Chimera; Transplantation Chimera; Transplantation Conditioning; Whole-Body Irradiation | 2000 |
Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia.
Topics: Adult; Anemia, Sideroblastic; Blood Transfusion; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Steroids; Transplantation, Homologous | 2000 |
Induction of autologous graft-versus-host disease with cyclosporin A after peripheral blood stem cell transplantation: analysis of factors affecting induction.
Topics: Adult; Cyclosporine; Cytotoxicity, Immunologic; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Interferon-gamma; Lymphocytes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Transplantation Conditioning; Transplantation, Autologous | 2000 |
Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.
Topics: Adolescent; Adrenal Cortex Hormones; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Data Collection; Global Health; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Infant, Newborn; International Agencies; Lymphocyte Depletion; Methotrexate; Practice Guidelines as Topic; T-Lymphocytes; Transplantation, Homologous | 2000 |
Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cataract; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Heterologous; Whole-Body Irradiation | 2000 |
[Tacrolimus administration to a patient with cyclosporine-induced encephalopathy after allogeneic bone marrow transplantation].
Topics: Adult; Bone Marrow Transplantation; Brain Diseases; Cyclosporine; Female; Graft vs Host Disease; Humans; Postoperative Complications; Tacrolimus; Transplantation, Homologous | 2000 |
Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Proportional Hazards Models; Reoperation; Retrospective Studies; Statistics, Nonparametric; Transplantation, Homologous; Treatment Outcome | 2000 |
Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Cell Count; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Retrospective Studies; Statistics, Nonparametric; T-Lymphocytes | 2000 |
Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Prednisone; Treatment Outcome | 2000 |
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous | 2000 |
Plasma endothelin-1 levels after stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Cyclosporine; Endothelin-1; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Middle Aged | 2000 |
Characterization of graft-versus-host disease in SCID mice and prevention by physicochemical stressors.
Topics: Animals; Antibodies; Bone Marrow Transplantation; Cyclosporine; Cytokines; Disease Models, Animal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Major Histocompatibility Complex; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, SCID; Oxidative Stress; T-Lymphocytes; Tissue Donors; Transplantation, Homologous | 2000 |
Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation.
Topics: Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Immunosuppressive Agents; Male; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2001 |
Comment: drug-herb interaction.
Topics: Cyclosporine; Drug Interactions; Graft Rejection; Graft vs Host Disease; Humans; Hypericum; Immunosuppressive Agents; Organ Transplantation; Plants, Medicinal | 2001 |
[Prolactin as pro-inflammatory cytokine--considerations on consolidated immunotherapy after high dosage therapy].
Topics: Breast Neoplasms; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Prolactin | 2000 |
Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
Topics: Adolescent; Adult; Ambulatory Care; Busulfan; Child; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neural Tube Defects; Program Evaluation; Recurrence; Survival Analysis; Thalassemia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria.
Topics: Antilymphocyte Serum; Busulfan; Cladribine; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; Humans; Immunosuppressive Agents; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nuclear Family; Recurrence; Retrospective Studies; Survival Rate; Whole-Body Irradiation | 2001 |
Cyclosporine A downregulates intragraft platelet-derived growth factor-alpha mRNA expression after clinical heart transplantation.
Topics: Biopsy; Cyclosporine; Follow-Up Studies; Gene Expression Regulation; Graft vs Host Disease; Heart Transplantation; Humans; Immunosuppressive Agents; Platelet-Derived Growth Factor; Regression Analysis; RNA, Messenger; Statistics, Nonparametric; Time Factors; Transcription, Genetic; Transforming Growth Factor beta | 2001 |
Tolerance to cyclosporin A-induced autologous graft-versus-host disease is mediated by a CD4+CD25+ subset of recent thymic emigrants.
Topics: Administration, Oral; Animals; CD4 Antigens; CD4-CD8 Ratio; Cell Movement; Cyclosporine; Female; Graft vs Host Disease; Immune Tolerance; Immunophenotyping; Injections, Subcutaneous; Lymph Nodes; Rats; Rats, Inbred Lew; Receptors, Interleukin-2; T-Lymphocyte Subsets; Thymus Gland; Transplantation, Autologous | 2001 |
Polymyositis--an unusual manifestation of chronic graft-versus-host disease.
Topics: Adolescent; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Cyclosporine; Diagnosis, Differential; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, B-Cell; Polymyositis; Recurrence; Steroids; Treatment Outcome | 2001 |
Autoimmune-mediated vasculopathy.
Topics: Adoptive Transfer; Animals; Antigens, Differentiation, B-Lymphocyte; Arteriosclerosis; Autoimmune Diseases; Chloroquine; Cyclosporine; Cytotoxicity, Immunologic; Disease Progression; Female; Graft Rejection; Graft vs Host Disease; Heart Transplantation; Histocompatibility Antigens Class II; Immunosuppressive Agents; Lymphocyte Depletion; Lymphokines; Macromolecular Substances; Postoperative Complications; Radiation Chimera; Rats; Rats, Inbred Lew; T-Lymphocytes; Th1 Cells; Th2 Cells; Thymectomy; Transplantation, Isogeneic; Tunica Intima; Tunica Media; Vasculitis | 2001 |
Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Interferon-alpha; Leukemia; Leukocyte Transfusion; Male; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Transplantation, Homologous | 2001 |
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Topics: Adolescent; Adult; Cholestasis, Intrahepatic; Cyclosporine; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Methotrexate; Prednisone; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2001 |
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.
Topics: Adult; Base Sequence; Breast Neoplasms; CD8-Positive T-Lymphocytes; Clone Cells; Complementarity Determining Regions; Cyclosporine; Cytotoxicity Tests, Immunologic; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunoglobulin Joining Region; Immunoglobulin Variable Region; Lymphoma, Non-Hodgkin; Male; Middle Aged; Phenotype; Receptors, Antigen, T-Cell; T-Lymphocytes; Transplantation, Autologous | 2001 |
Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lenograstim; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Nuclear Family; Psoriasis; Recombinant Proteins; T-Lymphocyte Subsets; Transplantation Chimera; Vidarabine | 2001 |
MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation.
Topics: Acute Disease; Animals; Biomarkers; Bone Marrow Transplantation; Calcitriol; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Liver; Models, Animal; Rats; Rats, Inbred Lew; Skin; Spleen | 2001 |
Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Female; Gastrointestinal Hemorrhage; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hypertension; Infections; Male; Methotrexate; Middle Aged; Musculoskeletal Diseases; Prednisone; Retrospective Studies; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous | 2001 |
Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease.
Topics: Acute Disease; Animals; Cyclosporine; fas Receptor; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Liver; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organ Specificity; Spleen; T-Lymphocytes; T-Lymphocytes, Cytotoxic | 2001 |
A short course of high-dose cyclophosphamide induces long-term survival of intestinal allografts in mice.
Topics: Animals; Cyclophosphamide; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Transplantation, Homologous | 2001 |
Single institution outcomes of treatment of severe aplastic anaemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2001 |
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Topics: Adolescent; Adult; Cause of Death; Child; Child, Preschool; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Odds Ratio; Prednisone; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2001 |
Severe oral manifestations of chronic graft-vs.-host disease.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Betamethasone; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Methotrexate; Mouth Diseases; Mouthwashes; Mycophenolic Acid; Oral Hygiene; Prednisone; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Brain; Brain Diseases; Child; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Headache; Humans; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Nervous System Diseases; Syndrome | 2001 |
Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
Topics: Acute Disease; Adult; Cyclosporine; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Prednisolone | 2001 |
Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus.
Topics: Adult; Anemia, Aplastic; Anticonvulsants; Blood-Brain Barrier; Bone Marrow Transplantation; Brain Diseases; Brain Edema; Ceftazidime; Cerebral Hemorrhage; Cyclosporine; Diagnosis, Differential; Diuretics; Endothelium, Vascular; Epilepsy, Generalized; Female; Fluconazole; Graft vs Host Disease; Headache; Humans; Immunosuppressive Agents; Intracranial Hypertension; Magnetic Resonance Imaging; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients.
Topics: Adolescent; Adult; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Killer Cells, Natural; Leukemia; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Tetanus Toxin; Transplantation, Homologous | 2001 |
Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Immunosuppression Therapy; Immunosuppressive Agents; Lipopolysaccharides; Mice; Mice, Inbred C3H; Transplantation Immunology; Transplantation, Isogeneic | 2001 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load | 2002 |
Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Blood Transfusion; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Depletion; Male; Prednisolone; Remission Induction; Thalidomide; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2001 |
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting | 2001 |
Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Infant; Leukemia; Life Tables; Male; Methylprednisolone; Middle Aged; Premedication; Retrospective Studies; Risk; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Isogeneic; Treatment Outcome | 2002 |
Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
Topics: Animals; Antiviral Agents; Cell Division; Combined Modality Therapy; Cyclosporine; Female; Ganciclovir; Genetic Therapy; Genetic Vectors; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 1, Human; Immunosuppressive Agents; Mice; Mice, Transgenic; Models, Animal; T-Lymphocytes; Thymidine Kinase; Transplantation, Homologous | 2002 |
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.
Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatitis C; HIV; HIV Infections; Humans; Leukemia, Myeloid, Acute; Remission Induction; RNA, Viral; Transplantation, Homologous; Viremia | 2002 |
Intravenous cyclosporine-rifampin interaction in a pediatric bone marrow transplant recipient.
Topics: Antibiotics, Antitubercular; Bacteremia; Bone Marrow Transplantation; Child; Cyclosporine; Drug Interactions; Female; Fever; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neutropenia; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2002 |
Chlamydia pneumoniae respiratory infection after allogeneic stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Chlamydia Infections; Chlamydophila pneumoniae; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Penicillium; Respiratory Tract Infections; Transplantation, Homologous; Whole-Body Irradiation | 2002 |
Elevated blood drug levels obtained from indwelling silicon catheters during oral cyclosporine A administration.
Topics: Administration, Oral; Anemia, Aplastic; Catheters, Indwelling; Child; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Male; Monitoring, Immunologic; Silicon | 2002 |
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Topics: Adult; Age Factors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
Allogeneic bone marrow transplantation: the Huddinge experience.
Topics: Adult; Anemia; Bone Marrow Transplantation; Candidiasis; Child; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia; Male; Methotrexate; Neoplasms; Retrospective Studies; Risk Factors; Sweden; Transplantation, Homologous | 1992 |
Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease.
Topics: Acute Disease; Adult; Antigens, Viral; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukocytes, Mononuclear; Lymphocyte Depletion; Male; Methotrexate; Simplexvirus | 1992 |
Prevention and therapy of graft-versus-host disease. Report from a work-shop.
Topics: Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Graft vs Host Disease; Humans; Lymphocyte Depletion; Methotrexate; T-Lymphocytes | 1992 |
Reduction of graft-versus-host reactivity after small bowel transplantation: ex vivo treatment of intestinal allografts with an anti-T cell immunotoxin.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; CD5 Antigens; Cell Movement; Cyclosporine; Graft Enhancement, Immunologic; Graft vs Host Disease; Immunotoxins; Intestine, Small; Lymph Node Excision; Organ Size; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Ricin; Spleen; T-Lymphocytes | 1992 |
[Bone marrow transplantation for therapy of leukemia].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Leukemia; Male; Methotrexate; Middle Aged; Pulmonary Fibrosis; Survival Rate | 1992 |
Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.
Topics: Animals; Cells, Cultured; Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Hematopoietic Stem Cells; Immune Tolerance; Mice; Mice, Inbred Strains; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 1992 |
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; DNA, Neoplasm; Drug Therapy, Combination; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; RNA, Messenger; Transcription, Genetic | 1992 |
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Leukemia; Lymphoma; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors; Sex Factors; Survival Analysis; Tissue Donors; Transplantation, Homologous; Whole-Body Irradiation | 1992 |
Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bilirubin; Biopsy; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Feces; Graft vs Host Disease; Humans; Middle Aged; Skin; Whole-Body Irradiation | 1992 |
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplanta
Topics: Acute Disease; Adult; beta-Thromboglobulin; Bone Marrow Transplantation; Cyclosporine; Factor VIII; Fibrin Fibrinogen Degradation Products; Graft vs Host Disease; Humans; Microcirculation; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Factor 4; Prospective Studies; Severity of Illness Index; Tissue Plasminogen Activator; Transplantation, Autologous; Transplantation, Homologous; Tumor Necrosis Factor-alpha; Vascular Diseases; von Willebrand Factor | 1992 |
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.
Topics: Adolescent; Adult; Aged; Bacteria, Anaerobic; Bone Marrow Transplantation; Child; Cyclosporine; Family; Female; Graft vs Host Disease; Humans; Intestines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Tissue Donors | 1992 |
Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Subsets; Male; Middle Aged; Recurrence; Transplantation, Homologous | 1992 |
Graft-versus-host disease or graft-versus-host-like syndrome.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Skin; Syndrome; T-Lymphocyte Subsets | 1992 |
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
Topics: Acute Disease; Adolescent; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Methotrexate; Regression Analysis; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1992 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Inhibition of natural killer (NK) cell prevents graft-vs-host-disease after small bowel transplantation in rats.
Topics: Animals; Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Immunity, Cellular; Intestine, Small; Killer Cells, Natural; Rats; Rats, Inbred Strains; Skin; Survival Analysis; T-Lymphocytes | 1992 |
Cyclosporine in bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Male; Middle Aged | 1992 |
Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Candidiasis, Oral; Chi-Square Distribution; Cyclosporine; Facial Pain; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nutritional Status; Oral Hemorrhage; Random Allocation; Stomatitis, Herpetic | 1992 |
Disturbance in renal haemodynamics and physiology in bone marrow transplant recipients treated with ciclosporin A.
Topics: Adolescent; Adult; Aldosterone; Atrial Natriuretic Factor; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Fibrinolysin; Glomerular Filtration Rate; Graft Rejection; Graft vs Host Disease; Hemodynamics; Humans; Kidney; Male; Radioisotope Renography; Regional Blood Flow; Renin | 1992 |
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; HLA Antigens; Humans; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Survival Rate | 1992 |
Fooled by blood cyclosporin levels.
Topics: Blood Specimen Collection; Bone Marrow Transplantation; Catheters, Indwelling; Cyclosporine; Graft vs Host Disease; Humans | 1992 |
Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoiesis; Histocompatibility Antigens; Leukocyte Count; Lymphocyte Depletion; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Inbred Lew; Rats, Inbred Strains; Time Factors; Transplantation, Homologous | 1992 |
Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
Topics: Adult; Antibodies, Antinuclear; Biopsy; Bone Marrow Transplantation; Cyclosporine; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Kidney; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Prednisolone | 1992 |
Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits.
Topics: Adolescent; Adult; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Whole-Body Irradiation | 1992 |
Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Epidermolysis Bullosa Acquisita; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Prednisone; Remission Induction; Transplantation, Homologous | 1992 |
Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Skin; Skin Diseases | 1992 |
Pharmacodynamic studies of cyclosporine in marrow transplant recipients. A comparison of three assay methods.
Topics: Adult; Bone Marrow Transplantation; Chromatography, High Pressure Liquid; Cyclosporine; Fluorescence Polarization Immunoassay; Graft vs Host Disease; Humans; Middle Aged; Radioimmunoassay; Risk Factors | 1992 |
An immunosuppressive regimen that reduces graft cell emigration following small bowel transplantation.
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Drug Administration Schedule; Graft Rejection; Graft vs Host Disease; Histocompatibility Antigens Class I; Intestine, Small; Lymph Nodes; Peyer's Patches; Rats; Rats, Inbred Strains; Spleen; Transplantation, Homologous | 1992 |
Lethal graft-vs-host disease after cyclosporine therapy in recipients of sensitized small bowel allografts.
Topics: Animals; Antilymphocyte Serum; Cyclosporine; Graft vs Host Disease; Immunosuppression Therapy; Immunotherapy, Adoptive; Intestine, Small; Rats; Rats, Inbred BN; Rats, Inbred Lew; Skin; Spleen; Transplantation, Homologous | 1992 |
Small bowel transplantation in the rat: the effect of donor-specific transfusion 24 hours pretransplant and cyclosporine.
Topics: Animals; Blood Transfusion; Cyclosporine; Graft Survival; Graft vs Host Disease; Immunosuppression Therapy; Intestine, Small; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Transplantation, Heterotopic; Transplantation, Homologous | 1992 |
The effect of ultraviolet B-irradiated leukocyte transfusions in intestinal transplantation.
Topics: Animals; Blood Transfusion; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Disease; Immunosuppression Therapy; Intestine, Small; Leukocyte Transfusion; Leukocytes; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Ultraviolet Rays | 1992 |
Orthotopic porcine small bowel transplantation using low-dose cyclosporine in triple immunosuppressive therapy.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Host Reaction; Intestine, Small; Methylprednisolone; Swine; Transplantation, Homologous | 1992 |
The effect of blood transfusions on graft-versus-host disease in small intestine transplantation in rats.
Topics: Animals; Blood Transfusion; Combined Modality Therapy; Crosses, Genetic; Cyclosporine; Graft vs Host Disease; Intestine, Small; Male; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Heterotopic; Transplantation, Homologous | 1992 |
Histologic classification of pancreatic allograft rejection in the rat.
Topics: Animals; Arteries; Cyclosporine; Diabetes Mellitus, Experimental; Endothelium, Vascular; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Inflammation; Pancreas Transplantation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors | 1992 |
Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Cytotoxicity, Immunologic; Drug Synergism; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunization, Passive; Immunotherapy; Interferon-gamma; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Recombinant Proteins; Spleen | 1992 |
Microangiopathic hemolytic anemia in a graft-versus-host disease patient treated with cyclosporine A and prednisolone.
Topics: Adult; Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Male; Prednisolone | 1992 |
Interaction between cyclosporin A and anticonvulsants. Bone Marrow Transplantation Team.
Topics: Adult; Anticonvulsants; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Epilepsy; Female; Graft vs Host Disease; Humans | 1992 |
The role of ultraviolet B-irradiated leukocyte transfusions and cyclosporine in intestinal transplantation.
Topics: Animals; Blood Transfusion; Cyclosporine; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Intestine, Small; Leukocytes; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Homologous; Ultraviolet Rays | 1992 |
Selective expansion of idiotype sharing T and B cells in cyclosporin A-mediated autoimmunity.
Topics: Animals; Antibodies, Monoclonal; Autoantibodies; Autoimmunity; B-Lymphocytes; Cyclosporine; Epitopes; Graft vs Host Disease; Hybridomas; Immunoglobulin Idiotypes; Immunoglobulin Variable Region; Mice; Mice, Inbred CBA; Receptors, Antigen, T-Cell; T-Lymphocytes | 1991 |
Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A.
Topics: Adolescent; Adult; Alpha-Globulins; beta 2-Microglobulin; Bone Marrow Transplantation; Child; Creatinine; Cyclosporine; Female; Graft vs Host Disease; Humans; Infections; Kidney; Kidney Diseases; Male; Middle Aged; Protease Inhibitors | 1991 |
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Polyenes; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Sirolimus; Tacrolimus; Transplantation, Homologous | 1991 |
Fulminant graft-versus-host disease after FK 506 treatment in fully allogeneic small bowel transplantation.
Topics: Animals; Cyclosporine; Graft Rejection; Graft Survival; Graft vs Host Disease; Intestine, Small; Rats; Rats, Inbred BN; Rats, Inbred Strains; Tacrolimus; Transplantation, Homologous | 1991 |
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infant; Male; Methotrexate; Whole-Body Irradiation | 1992 |
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes | 1991 |
[The analysis of leukemic relapse after allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Homologous | 1991 |
Cyclosporin-induced hypertriglyceridemia with prompt response to plasma exchange therapy.
Topics: Adolescent; Bezafibrate; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Hypertriglyceridemia; Immunoglobulins, Intravenous; Plasma Exchange; Postoperative Complications; Prednisone | 1991 |
Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up.
Topics: Abdomen; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Male; Methotrexate; Middle Aged; Multivariate Analysis; Thorax | 1991 |
Nephrotoxicity in bone marrow transplant recipients receiving aminoglycoside plus cyclosporine or aminoglycoside alone.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Bone Marrow Transplantation; Child; Creatinine; Cyclosporine; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Nephrons; Retrospective Studies; Transplantation, Autologous; Transplantation, Homologous | 1991 |
Microvasculopathy in the ocular fundus after bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Fundus Oculi; Graft vs Host Disease; Humans; Ischemia; Male; Middle Aged; Optic Disk; Prospective Studies; Retinal Diseases; Retinal Vessels; Risk Factors; Whole-Body Irradiation | 1991 |